










Optimisation of protocols for ex vivo expansion of limbal 
stem cells and their enrichment 
 
Sanja Bojic, MD 
 
Thesis submitted to Newcastle University in candidature for the 
degree of 
Doctor of Philosophy 
 
Institute of Genetic Medicine 






























The corneal epithelial cells are constantly replaced by the stem cells located at the 
limbus, the peripheral edge of the cornea, therefore known as limbal stem cells 
(LSCs). LSCs can be destroyed by numerous factors which results in the condition 
called limbal stem cell deficiency (LSCD). 
Ex vivo expansion of LSCs is a well-established technique used successfully to cure 
patients with LSCD. Therapeutic use of LSCs must be performed in compliance with 
good manufacturing practice (GMP) as a quality assurance system. However, 
traditional culture media for ex vivo expansion of LSCs contains a number of 
ingredients derived from animal sources which may compromise its safety profile for 
human transplantation. The first aim of the study was to define new GMP grade 
medium for cultivation and maintenance of LSCs in vitro. Formulation of new GMP 
compliant media resulted in equal growth to non-GMP grade media.  
Strick regulations for cell therapy promote centralization of culture units, therefore 
definition of reliable and practical transportation strategies is vitally important. The 
second aim of this study was to optimise the transport conditions for limbal biopsies 
(LBs) and cultured limbal epithelial cells (LECs). Transport of LBs at room 
temperature proved to be significantly superior to 4°C transport. We also showed that 
cultured LECs may be stored in serum-free media and transported up to 7 days at 
23°C without any negative effect on cell number, viability, colony forming efficiency or 
gene expression profile. 
Due to the absence of specific LSC markers, identification and isolation of putative 
LSCs is a complicated task. The third and final aim of this study was to identify novel 
cell surface markers for LSCs. We reported herein the identification of a new cell 
surface marker for LSCs (CD200) as well as a cell surface marker for proliferating 
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Chapter 1. Introduction 
 
1.1 Corneal structure and function 
The cornea is a transparent dome-shaped window at the front of the eye with 
significant refractive and barrier functions (Eghrari et al., 2015). Major function of the 
cornea is enabling the transmission and focussing of light, together with the 
crystalline lens, onto the retina at the back of the eye for visual perception. The 
cornea is also a major protective shield of the interior of the eye functioning as a 
barrier to debris and infection. A damage of the corneal tissue, if not promptly 
treated, could lead to scarring and consequential visual impairment and often 
blindness (Hertsenberg and Funderburgh, 2015). Millions of people worldwide suffer 
from blindness and visual impairment caused by corneal opacities. According to the 
World Health Organization data from 2002 corneal scaring and opacity are listed as 
the fourth most common cause of blindness globally, causing around 5.1% of all 
registered cases of blindness around the world (World Health Organization; Resnikoff 
et al., 2008).  
The anterior surface of the eye is composed of the cornea centrally and the sclera 
and conjunctiva peripherally. The human cornea measures approximately 11.5 mm 
horizontally and 10.5 mm vertically. Its transparency and anterior radius of curvature 
centrally of 7.8 mm makes the cornea responsible for three-fourths of the total 
refractive power of the human eye (Eghrari et al., 2015). Therefore, preservation of 
its transparency is vital for this role. The central corneal thickness is approximately 
520 µm and increases towards the periphery where it can reach up to 650 µm. The 
junction region where the cornea becomes continuous with the sclera, approximately 
1.5–2 mm in width, is known as the limbus (Figure 1.1). The limbus is demarcated on 
the corneal side by the termination of the Bowman’s layer. At the limbus, the corneal 
avascular epithelium continues into the vascular conjunctival epithelium, the corneal 
stroma into the sclera and the corneal endothelium continues into the anterior 
surface of the iris and the suprachoroidal space (Takacs et al., 2009).  
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The presence of an intact limbal epithelium is essential for maintaining corneal 
transparency in two different ways. Firstly, the limbal epithelium acts as a barrier that 
prevents the conjunctival epithelium and its stromal blood vessels from encroaching 
onto the cornea, thereby impairing its clarity (Chen and Tseng, 1991). Secondly, the 
limbal epithelium also harbours the limbal stem cells which proliferate and 
differentiate to provide a lifetime source of corneal epithelial cells (Dua and Azuara-
Blanco, 2000; Daniels et al., 2001; Sangwan et al., 2003).  
Human cornea is composed of three cellular layers: the outer epithelial layer of 
ectodermal origin, the stroma and the endothelium, both of mesenchymal origin 
(Cvekl and Tamm, 2004; Takacs et al., 2009). Although the outermost epithelial layer 
is the most exposed to environmental damage it also has the best mechanism of a 
constant self-renewal assured by corneal epithelial stem cells. On the contrary, cell 
turnover in the corneal stroma is very slow (Doutch et al., 2012) and long believed 
non existing in corneal endothelial layer of the adult organism (Takacs et al., 2009). 
However, some recent findings indicate that progenitor cells may be found in these 
layers as reviewed by Hertsenberg and Funderburgh (Hertsenberg and Funderburgh, 
2015). 
Corneal development begins with primitive formation of epithelium and lens from the 
surface ectoderm, followed by waves of migration of neural crest cells between these 
two structures to create the stroma and endothelium. Descemet membrane is 
secreted by the endothelial layer and gradually thickens (Eghrari et al., 2015). The 
stream of neural crest cells migrates between the lens and presumptive corneal 
epithelium to form the corneal endothelium and stromal keratocytes (Lwigale, 2015). 
The corneal stroma and epithelium are abundantly innervated by the sensory nerves 
that originate from the neural crest- and ectodermal placode-derived trigeminal 
ganglion. Simultaneous with the corneal innervation is the formation of the limbal 
vascular plexus and the establishment of corneal avascularity (Lwigale, 2015). Unlike 
most tissues in the body, the cornea contains no blood vessels. Avascularity, 
together with a highly organized architecture, is essential for corneal transparency 
and normal vision. Instead, it receives all nutrients including glucose and oxygen 
essential for maintenance of normal metabolic functions from the limbal circulation, 
the aqueous humour and the tear film (Utheim, 2013). On the other hand, it is heavily 
innervated, with the density of nerve endings approximately 300-400 times greater 





Figure 1.1 The location of the limbus on the ocular surface. The limbus represents 
the interface between the peripheral cornea and neighbouring conjunctiva. 
 
In humans, the corneal tissue is arranged in five distinct layers (three cellular layers 
with two thinner layers or membranes between them), each having an important 
function (Figure 1.2): 
1. Corneal epithelium 
 
The epithelium is the most anterior layer that serves as the principal barrier to 
fluid and foreign materials including pathogens and dust, a function performed 
through production of tight junctions and constant turnover of cells. It is 
supported posteriorly by basement membrane and Bowman's layer and 
assists in the maintenance of stromal dehydration. It also provides a smooth 
surface that absorbs oxygen and cell nutrients from tears, and then distributes 
these nutrients to the other layers of the cornea. The epithelium is filled with 
thousands of nerve endings that make the cornea extremely sensitive to pain. 
The corneal epithelium is composed of five to six layers (4-6) of non-
keratinized, stratified squamous epithelial cells, comprising about 10% of the 
corneal thickness. In humans it’s approximately 50 µm thick (Eghrari et al., 
2015). Its transparency is a result of the homogeneity of the refractive index of 
all its constituent cells (Dohlman, 1971). Superficial two to three layers are 
composed of flat and polygonal cells with apical microvilli and microplicae and 
covered by a charged glycolcalyx which maximizes surface area with the 
mucinous layer of the tear film (Eghrari et al., 2015). The most superficial cells 
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of the corneal epithelium are attached by tight junctions that prevent the 
penetration of the tear film and its components and assist in the prevention of 
pathogenic organisms from entering the cornea. Directly posterior, two to three 
layers of cuboid “wing” or suprabasal cells demonstrate tight junction 
complexes while basal, columnar cell layer is anchored to the basal lamina via 
hemidesmosomes (Alison et al., 2002; Eghrari et al., 2015). In humans, the 
density of hemisdesmosomes is higher in the cornea compared to the limbus 
(Gipson, 1989). Similarly, the density of anchoring fibrils and adhesion 
plaques is also higher in the cornea compared to the limbus (Keene et al., 
1987; Gipson, 1989). The lower density of all these structures in the limbus 
may be compensated by the undulating nature of the limbal epithelial-stromal 
interface.  
The outermost layer of the corneal epithelial cells is continuously shed and 
replenished by proliferation of wing and basal cells (Thoft and Friend, 1983). 
The lifespan of epithelial cells is 7-14 days on average (Cenedella and 
Fleschner, 1990; Eghrari et al., 2015; Gonzalez et al., 2018).    
The limbal epithelium, the thickest of the ocular surface, is composed of 7-10 
layers of stratified epithelial cells. Unlike the central corneal epithelium, the 
limbal epithelium contains also other cell types such as melanocytes and 
antigen-presenting Langerhans cells (Dziasko and Daniels, 2016).  
 
 
2. Bowman’s layer 
 
Bowman’s layer is a thin acellular condensation of the outer portion of the 
corneal stroma consisting mainly of collagen type I and type III fibres and 
proteoglycans. It’s approximately 8-12 µm thick and decreases in thickness 
over time. Unlike the epithelial layer, it has no regenerative potential (Eghrari 
et al., 2015). If injured, it can form a scar as it heals. If large and centrally 
located, these scars may cause vision loss. 
 
3. Corneal stroma 
 
The stroma composes the majority of corneal volume, around 90% of the total 
corneal thickness, measuring approximately 500 µm in humans. The corneal 
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stroma plays several pivotal roles within the eye - optically it is the main 
refracting lens and mechanically it has to be extremely tough to protect the 
inner contents of the eye. Both these functions are governed by its structure at 
all hierarchical levels (Meek and Knupp, 2015). Beside it provides support and 
clarity, it also assists in ocular immunity (Eghrari et al., 2015).  
The stroma contains densely packed, tough yet transparent connective tissue. 
The transparency of the stroma originates from its regularly ordered and 
equally spaced collagen bundles that are produced by the corneal fibrocytes 
known as keratocytes (Takacs et al., 2009). 
The stroma consists of an extracellular matrix made up of collagens (type I, V 
and VI) and proteoglycans (decorin associated with dermatan-sulfate and 
lumican associated with keratin-sulfate). The collagen fibrils are regularly 
arranged into bundles or lamellae in order to allow corneal transparency. 
There are about 300 lamellae of parallel collagen fibrils in the centre of the 
cornea reaching to nearly 500 lamellae at the limbus (Radner et al., 1998). 
The orientation of the alternate lamellae differs with each other, but they are 
all parallel with the corneal surface. Keratocytes from which the collagen fibrils 
are produced during development are scattered throughout the stroma 
between the lamellae. Whilst the corneal stroma is avascular tissue, the limbal 
stroma is heavily vascularized (Goldberg and Bron, 1982). 
 
4. Descemet’s membrane 
 
Descemet’s membrane is the thick basement membrane of the corneal 
endothelium and measures approximately 3 µm in thickness in children, 
gradually thickening to 10 µm in adults. Similar to the stroma it contains 
laminin and fibronectin as well as keratin sulfate, heparin sulfate and dermatan 
sulfate. On the other hand, it contains collagen IV and VIII fibrils. In contrast to 
other basal membranes throughout the body in which collagen type IV is 
common, collagen type VIII is relatively specific to the Descemet’s membrane 









The endothelium is the most posterior layer and it separates the cornea from 
the aqueous humour of the anterior chamber of the eye. It provides nutrients 
for stromal keratocytes and participates in the maintenance of the stromal 
transparency (Takacs et al., 2009). The posterior cornea, composed of 
Descemet membrane and endothelium, is essential for stromal dehydration, 
maintained through tight junctions and endothelial ionic pumps located in 
basolateral plasma membranes. Beside tight junctions, gap junctions are also 
present in corneal endothelium and contribute to the electrical coupling of 
endothelial cells (Eghrari et al., 2015). Insufficiency of the endothelial pump 
function results in corneal oedema, that leads to loss of corneal clarity and 
vision impairment (Takacs et al., 2009). 
The corneal endothelium is composed of a single layer of closely 
interdigitating, flat, polygonal cells which line the posterior surface of the 
cornea. Unlike corneal epithelial cells, corneal endothelial cells do not 
proliferate in vivo and cell replacement does not occur through mitosis but 
through cell migration. Therefore, central loss of cells results in centripetal 
migration of adjacent endothelial cells with subsequent formation of tight 






Figure 1.2 Schematic diagram of a sagittal section of the anterior portion of the 
human eye (left) and corneal structure (right). The cornea is a transparent dome-
shaped window at the front of the eye that covers the iris, pupil, and anterior chamber. 
It is composed of five distinct layers, three cellular layers with two thinner membranes 
between them. From the outside to inside the layers of the human cornea are the 
corneal epithelium, Bowman’s membrane, corneal stroma, Descemet’s membrane and 
corneal endothelium. 
 
In conclusion, corneal transparency essential for normal vision, is determined by: 
- a smooth epithelium with no invasion of conjunctival cells (Puangsricharern 
and Tseng, 1995); 
- the absence of vasculature (Utheim, 2013); 
- a highly organized stromal architecture (Fini and Stramer, 2005); 
- a functional endothelium that regulates corneal hydration (Meek et al., 2003); 






1.2 Corneal epithelial stem cells 
1.2.1 Stem cells 
 
Stem cell is an undifferentiated cell, which can self-renew to replicate itself as well as 
give rise to the specialized cells under appropriate conditions (Weissman, 2000). 
Tissue-specific or adult stem cells are found in almost every adult tissue, with 
exception of the heart, and are able to maintain and regenerate the given tissue for a 
lifetime (Alison et al., 2002; Takacs et al., 2009) (Figure 1.3). Adult stem cells are 
either multipotent or unipotent (Wagers and Weissman, 2004). Multipotent stem cells 
can differentiate into many cell types but within a particular lineage while unipotent 
stem cells can differentiate towards only one cell type. 
 
Figure 1.3 Adult stem cells, types and examples. Differentiation capacity of adult 
stem cells is ranging from multipotent to unipotent. Multipotent stem cells are capable 
to develop into multiple specialised cell types present in a specific tissue or organ whilst 
unipotent stem cells are capable to generate only one specialised cell type. 
 
The adult stem cells form a very small percentage of the total cellularity. For 
example, in the mouse small intestine there are 4–5 stem cells found at the bottom of 
the crypt out of a total crypt population of about 250 cells (Bjerknes and Cheng, 
1999). In skeletal muscle, similarly, satellite cells comprise about 5% of all nuclei 
while in the bone marrow the multipotent haematopoietic stem cell is even rarer, with 
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a frequency of only 1 in 10 000 or more amongst all blood cells (Alison et al., 2002). 
Most of the time stem cells remain in growth arrested state but can enter the cell 
cycle on demand (e.g. tissue injury) and give a rise to a differentiating and highly 
proliferating progeny – transient amplifying cells. Transient amplifying cells (TACs) 
have a lower proliferative potential compared to stem cells, but still have some self-
renewal capacity which contributes to cellular turnover and regeneration. These fast 
dividing progenitors represent the vast majority of the proliferative cells in the 
corneal/limbal epithelium (Schlotzer-Schrehardt and Kruse, 2005). 
Stem cells are characterized by the following properties (Alison et al., 2002; Takacs 
et al., 2009): 
1. Unlimited self-renewal and asymmetric cell division. For normal homeostasis 
and functioning of some tissue is vital that a constant pool of stem cells is 
maintained throughout the lifetime (Kolli et al., 2009). That is achieved by so-
called asymmetric cell division, giving rise to one daughter cell that remains 
stem cell and a second daughter cell that will enter differentiation and become 
TAC (Figure 1.4). Thanks to this process, stem cells have a long life and 
possess the ability to proliferate indefinitely during the lifetime of the organism 
in which they reside (Kolli et al., 2009). The main purpose of TACs is to 
increase the number of cells resulting from each stem cell division (Kolli et al., 
2009) and protect stem cells of going through the cell cycle often and 
accumulate DNA damage over time. Both stem cells and TACs belong to the 
proliferative tissue compartment. TACs differentiate into post-mitotic cells 
(PMCs) which fall belong to the non-proliferative (differentiation) tissue 
compartment and are not capable of further divisions (Kolli et al., 2009). PMCs 
are irretrievably committed to cellular differentiation and mature into terminally 
differentiated cells (TDCs) (Kolli et al., 2009) which are carriers of the 






Figure 1.4 Asymmetric cell division. Through asymmetric cell division stem cell 
produces two daughter cells with different cellular fates, one daughter cell is identical 
to mother cell and will re-enter the niche to maintain the pool of stem cells whilst a 












Figure 1.5 The hierarchy of cells in the adult stem cell system including the 
corneal epithelium. The corneal epithelium is composed of pyramid structure of cells, 
with only a few stem cells (SCs) at the top of the pyramid, greater but still relatively 
small number of TACs in the middle of the pyramid and the majority of PMCs that give 
rise to TDCs in the base of the pyramid. Therefore there are three different cell 
compartments present: the stem cell compartment (I), the proliferative compartment 
(II) and differentiation compartment (III). 
 
 
2. Relatively undifferentiated state but high differentiation potential, implying that 
despite the stem cells do not have the functional specializations of the 
progeny they give rise to, they have the ability to differentiate into all cell types 
of their home tissue; 
 
3. Slow cell cycle but high clonogenic potential, meaning that stem cells divide 
less frequently than transient-amplifying cells in order to lower accumulation of 
DNA errors because DNA synthesis can be error-prone. For that reason, stem 
cells divide less frequently than TACs. In hair follicles for example, the hair 
haft and its surrounding sheaths are produced by the hair matrix, which is 
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itself replenished by the bulge stem cells. The bulge cells divide less 
frequently, but are more clonogenic than the TACs of the hair matrix (Oshima 
et al., 2001). 
 
 
1.2.2 Limbal stem cells  
 
The corneal epithelium is rapidly regenerating stratified squamous epithelium in a 
state of constant renewal as the superficial terminal cells are naturally continuously 
shed into the tear film. As one of the most rapidly regenerating mammalian tissues, it 
is estimated that the corneal epithelial cell layers turn over every 7-14 days 
(Cenedella and Fleschner, 1990; Eghrari et al., 2015; Gonzalez et al., 2018). In vivo, 
the corneal epithelium is renewed every 9–12 months (Utheim, 2013). The central 
corneal epithelium in humans has no capacity to renew (Ebato et al., 1988). Instead, 
it is widely accepted that, during normal homeostasis, the corneal epithelium is 
maintained by the stem cells located at the peripheral edge of the cornea known as 
limbus that proliferates slowly unless stimulated by injury (Davanger and Evensen, 
1971; Cotsarelis et al., 1989). Due to their anatomical location these corneal 
epithelial stem cells are more commonly known as limbal stem cells (LSCs).  LSCs 
give rise to fast-dividing TACs, which migrate centripetally in the basal layer of the 
corneal epithelium (Kinoshita et al., 1981; Buck, 1985; Nagasaki and Zhao, 2003). 
Here they proliferate for a limited time before undergoing a final division, whereupon 
both daughter cells usually detach from the basement membrane, move vertically 
(apically) through the suprabasal layers, becoming terminally differentiated and are 







1.2.3 Location of limbal stem cells 
  
The existence of epithelial stem cells in the limbus has been proposed in 1971 by 
Davanger and Evensen (Davanger and Evensen, 1971). The limbus is a specialized 
region, the narrow band of tissue which encircles the cornea, which is “highly 
vascularized, innervated and protected from potential UV light damage by the 
presence of melanin pigmentation” (Schlotzer-Schrehardt and Kruse, 2005). 
Over the years numerous experimental and clinical observations supported 
hypothesis that the basal layer of the limbal epithelium harbour the stem cells for the 
corneal epithelium: 
1. Pigment migration studies – Davanger and Evensen were the first to 
propose the basal layer of limbal epithelium as a “generative organ for corneal 
epithelial cells”. Their study with guinea pigs, which naturally have pigmented 
basal layer of the limbal epithelium, showed that the cornea was healed by the 
pigmented epithelium when the normally non-pigmented central corneal 
epithelium was removed (Davanger and Evensen, 1971). 
 
2. Cell culture studies – Many studies suggested the presence of cells with high 
proliferative potential in the limbal basal epithelium. Ebato and co-workers 
showed that in vitro cultured human limbal epithelium has a higher proliferative 
potential compared to the corneal and conjunctival epithelium. Having in mind 
that proliferative potential is a vital property of stem cells, this finding provided 
further evidence of the limbal location of the corneal epithelial stem cells 
(Ebato et al., 1988). Other studies showed that cells from the central cornea 
generated mostly paraclones (terminally differentiated epithelial colonies) that 
could not be passaged more than twice while cells from the limbal region 
could proliferate for many generations (between 80-100 doublings) and form 
holoclones (large colonies with regular borders) (Lavker et al., 1991; Pellegrini 
et al., 1999a).  
 
3. Radio labelled thymidine studies – Stem cells have a slower cell cycle and 
can be detected experimentally as label retaining cells (Bickenbach, 1981) 
using pulse/chase experiments with a DNA precursor such as tritiated 
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thymidine (3HT) or 5-bromo-2′-deoxyuridine (BrdU) (Rodriguez and Nguyen, 
2018). Following a chase period of 4-8 weeks, rapidly dividing cells lose the 
label but slow dividing cells will remain labelled. Lavker and Cotsarelis were 
the first to show that label retaining cells were found exclusively in the basal 
layer of the limbal epithelium but were completely absent in the central cornea. 
They also showed using tritiated thymidine to label cells in S phase of the cell 
cycle in mouse cornea that the basal cells of the limbal epithelium are normally 
slow cycling cells but upon wounding of the central corneal epithelium can be 
stimulate to proliferate more rapidly (Cotsarelis et al., 1989). Label retaining 
studies further showed that the percentage of stem cells represents less than 
10% of the total limbal population (Lavker et al., 1991). Recently, Sartaj and 
colleagues localized, purified, and characterized slow cycling cells in the 
cornea in an inducible transgenic “pulse-chase” murine model (Sartaj et al., 
2017).  
 
4. Animal studies – Corneal wound healing studies in rabbits showed that 
surgical removal of the limbus resulted in insufficient re-epithelization and 
conjunctival invasion of the corneal surface (Kruse et al., 1990; Huang and 
Tseng, 1991).  
 
5. Clinical studies – There are several pieces of clinical evidence that confirm 
limbal location of corneal epithelial stem cells. Firstly, it was observed that 
larger peripheral corneal epithelial wounds heal significantly faster than 
smaller central wounds (Matsuda et al., 1985). Secondly, clinical studies 
showed that limbal transplantation leads to long term restoration of the corneal 
surface in patient with limbal damage (Kenyon and Tseng, 1989; Holland and 
Schwartz, 1996). Finally, corneal tumours almost exclusively arise from the 
limbus (Waring et al., 1984) that further corroborate the limbal location of 
corneal epithelial stem cells (Reya et al., 2001).  
 
6. Lineage tracing experiments – In 2015, Amitai-Lange et al. provided a direct 
evidence of limbal cell migration under both homeostasis or injury using a 
mouse model, R26R-Confetti mouse, that allows multicolour lineage tracing of 
limbal and corneal cytokeratin 14 positive cells (Amitai-Lange et al., 2015). 
They reported that in homeostasis limbal epithelial cells undergo slow 
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centripetal migration of 4–5 months until reaching the corneal centre, while 
upon wounding, they observed significant corneal contribution to the healing 
process and rapid appearance of limbal stripes (Amitai-Lange et al., 2015). 
The same year, another two research groups reported very similar findings 
using lineage tracing mouse models, confirming that labelled clones appeared 
at the periphery of the cornea and extended centripetally as radial stripes (Di 
Girolamo et al., 2015; Dora et al., 2015).  
 
Over the years lots of other evidences further supported the limbal location of the 
corneal epithelial cells such as a lack of the corneal epithelial differentiation 
associated cytokeratin pair CK3/12 in the limbal basal cells (Schermer et al., 1986; 
Rodrigues et al., 1987; Kasper et al., 1988; Kurpakus et al., 1994). Also, most 
epithelial tumours of the ocular surface originate from the limbal area. Likewise, the 
limbus is a common region for certain congenital abnormalities to occur, such as 
limbal dermoids with ectopic brain or bone tissue, which suggest the presence of 
undifferentiated cells (Emamy and Ahmadian, 1977; Weinstein et al., 1979). 
This widely accepted LSC dogma is, however, challenged by several studies which 
reported that the murine cornea remained healthy following deletion of the entire 
limbal epithelium (Vauclair et al., 2007; Majo et al., 2008). Moreover, the central 
cornea of patients with a destroyed limbus remained transparent for over 60 months 
(Dua et al., 2009). These contradictions were recently addressed by Nasser and 
colleagues who reported that “committed corneal cells possess plasticity to 
dedifferentiate, repopulate the stem cell pool, and correctly re-form the tissue 
boundary in the presence of intact stroma” (Nasser et al., 2018). Furthermore, the 
lineage‐tracing experiments clearly demonstrate that during normal homeostasis, 
cells labelled in adult mice generate clones of cells that emerge from the limbus and 
extend across the corneal radius toward the centre. The distributions of labelled 
clones are inconsistent with the “corneal epithelial stem cell hypothesis” and strongly 
support the conventional “limbal epithelial stem cell hypothesis” (Amitai-Lange et al., 




1.3 Limbal stem cell niche 
Stem cells are dispersed and kept in a unique anatomic location of each self-
renewing tissue called niche, where they maintain quiescence while performing self-
renewal to replenish the stem cell population lost to progeny production. The concept 
that a stem cell niche provides a unique microenvironment to support self-renewal 
and multipotent activity was first proposed in the late 1970s by Scofield (Schofield, 
1978). According to the stem cell niche hypothesis stemness is maintained by certain 
extrinsic factors in the niche microenvironment which regulate stem cell fate 
decisions and prevent differentiation (Watt and Hogan, 2000). Removal of stem cells 
from the niche leads to loss of their stem cell identity, self-renewal capacity, and 
consequential onset of differentiation (Voog and Jones, 2010).  
Variety of the limbal niche components ensure preservation of LSC activity including 
the limbal extracellular matrix (ECM), vasculature and surrounding cells (Nowell and 
Radtke, 2017). The limbal stroma is heavily vascularised and contains different ECM 
components compared to the corneal stroma, in particular α1 and α2 collagen IV, β2 
laminin and fibronectin (Dziasko and Daniels, 2016). The limbal niche is populated by 
various cell types which are in close contact with the corneal epithelial layer such as 
melanocytes, vascular cells, nerve cells, immune cells and mesenchymal stromal 
cells (Yazdanpanah et al., 2019). The expression of specific biochemical factors by 
limbal stromal cells including Wnt ligands (Nakatsu et al., 2011; Han et al., 2014), 
various cytokines and chemokines has proven to be important for LSC preservation.  
There are three different groups of cytokines in the limbus initially described by Li 
and Tseng (Li and Tseng, 1995), according to their interaction with surrounding cells:  
1. type I cytokines released by the epithelium with their receptors found mainly 
in stromal cells: TGFβ, IL-1β, PDGFβ, NGF, GDNF (Li and Tseng, 1995; Qi et 
al., 2007), 
2. type II cytokines with receptors found both in stromal and epithelial cells: 
IGF1, TGFβ1, TGFβ2, βFGF, NT-3, NT-4 (Li and Tseng, 1995; Qi et al., 2007) 
and  
3. type III cytokines released by the stroma whereas their receptors are found in 
the epithelium: KGF, HGF, BDNF (Li and Tseng, 1995; Qi et al., 2007).  
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Importantly, many of these cytokines, including KGF, HGF, NGF, TGFβ1, TGFβ2, 
βFGF, have been identified in human amniotic membrane (HAM), which can support 
in vitro growth and undifferentiated phenotype of limbal epithelial cells in the absence 
of feeder cells and therefore can serve as surrogate LSC niche (Grueterich et al., 
2003a). 
Touhami and co-workers examined the expression of different members of the 
neurotrophin family of growth factors and their receptors in the human limbal 
epithelium and found the high expression of the TrkA receptor in limbal basal 
epithelial cells, suggesting that nerve growth factor (NGF) signalling is involved in the 
control of the LSC behaviour (Touhami et al., 2002). Recently, Kolli et al. reported 
that NGF signalling is indeed a key promoter of LSC proliferation, colony-forming 
efficiency, and a maintainer of the LSC phenotype (Kolli et al., 2019). 
Another feature of the stem cell niche that has been shown to be important in 
preserving stem cell function is the mechanical properties of the surrounding tissue. 
Every stem cell niche is composed of different ECM components which results in 
different mechanical properties of the tissue. Factors, such as elasticity and 
topography, have been shown to influence how a cell responds to other 
microenvironmental cues. For example, the specific ECM composition of the limbal 
stroma may confer distinct mechanical properties compared to the central conea and 
favour stem cell maintenance at that specific location. Engler et al. were the first to 
demonstrate the influence of substrate stiffness on stem cell differentiation. They 
reported that mesenchymal stem cells show sensitivity to tissue-level elasticity and 
capability to “respond” by either muscle, bone, or neural cell differentiation depending 
on substrate elasticity (Engler et al., 2006). Related to the corneal tissue in particular, 
Moers et al. reported that corneal epithelial cells grown on substrates of physiological 
stiffness maintained an early differentiation state while on the contrary growth on 
unphysiologically stiff substrates induced their differentiation (Moers et al., 2013). 
Another study, using very soft uncompressed and compressed collagen gels, 
showed not only that corneal epithelial cells exhibited differentiation on the stiffer gels 
but also that the cellular layer exhibited better stratification on the stiffer gel (Jones et 
al., 2012).  
Apart from the functional aspects, the LSC niche has also anatomic dimensions. 
Anatomically, the LSC niche is located at the Palisades of Vogt, a series of radially 
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orientated fibro-vascular ridges at the limbus, proposed for the first time in 1971 as a 
location of the cells responsible for renewal of the corneal epithelium (Figure 1.6) 
(Davanger and Evensen, 1971). These papillae-like structures are located in the sub-
epithelial connective tissue at the limbus and more prominent along the superior and 
inferior limbus, where the upper and lower eyelids provide protection to the LSCs 
(Davanger and Evensen, 1971). The region in between the palisades, interpalisade 
ridges, are occupied by the epithelial rete pegs which consist of 10 to 15 layers of 
limbal epithelial cells (Townsend, 1991). The Palisades of Vogt can be seen and 
observed clinically, using a slitlamp microscope on the surface of the limbus, giving it 
a corrugated appearance (Goldberg and Bron, 1982; Townsend, 1991). These 
structures are easily identified in darkly pigmented individuals due to a concentration 
of melanin- containing cells and limbal melanocytes lining the interpalisade ridges 





Figure 1.6 The Palisades of Vogt. Magnified view of the limbal area demonstrating 
visible corrugations, projections of limbal stroma into the epithelium, the palisades of 
Vogt (PV), and the rich blood supply (blood vessels, BV). 
 
In corneal tissue sections, putative stem cells have been detected at the bottom of 
the epithelial papillae between the palisades, which provide a protective environment 
for LSCs (Schlotzer-Schrehardt and Kruse, 2005). Not only this junction between the 
limbal epithelial and stroma shelters LSCs from stress but also the neighbouring 
blood vessels supply them with nutrients and growth factors (Boulton and Albon, 
2004). 
In addition to these visible undulations of the limbal basement membrane, some later 
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studies reported existence of deeper epithelial outgrowths into the limbal stroma. In 
2005, Dua et al. described structures named “limbal epithelial crypts” as 
invaginations that were perpendicular to the surface epithelium and then extended 
parallel to the surface (Dua et al., 2005). These invaginations provide even closer 
proximity and increased contact with the limbal microenvironment. Limbal epithelial 
crypts are therefore putatively similar to intestinal crypts where stem cells reside in 
the base of the crypts. In 2007 Shortt et al. revealed further ultrastructural details of 
the LSC niche using in vivo confocal microscopy and three-dimensional 
reconstruction. They identified two novel candidate niche structures, the first named 
as “limbal crypts” located between the palisades of Vogt, and the second named as 
“focal stromal projections” which project upwards at the open end (facing the cornea) 
of the crypts (Shortt et al., 2007a). Limbal crypts are downward projections of the 
limbal epithelium that are open to the corneal surface and are in close association 
with the limbal vasculature. Focal stromal projections are, on the other side, finger-
like projections of stroma containing a central blood vessel surrounded by small, 
tightly packed epithelial cells. The highest number of putative stem cells, p63α and 
ABCG2 positive cells, were observed in the basal epithelial layers of these two 
described structures (Shortt et al., 2007a). 
Dziasko et al. identified cells with the stem cell like morphology exclusively within the 
basal layer of the limbal crypts using high-resolution imaging and showed these cells 
are capable of holoclone formation in vitro. They also confirmed that these cells are 
in direct contact with cells in the underlying stroma and that the contact is facilitated 





Figure 1.7 Simplified model of the LSC niche and niche cells. The LSCs that reside 
in the basal layer of the limbal epithelium are uniquely positioned to receive cellular 
signals from a variety of sources both by direct cell contact and diffusible cytokines. 
Daughter TACs divide and migrate centripetally towards central cornea where they 
terminally differentiate and eventually shed from the ocular surface. According to the 
recent findings, LSC are closely associated with limbal mesenchymal cells and limbal 
melanocytes. Besides these two cell types, limbal and corneal fibroblasts and 
Langerhans cells are also important components of the limbal stem cell niche.  
 
The limbal stem cell niche is highly pigmented due to the presence of melanocytes 
(Davanger and Evensen, 1971; Higa et al., 2005; Dziasko et al., 2015) and is 
infiltrated with antigen-presenting Langerhans’s cells (Baum, 1970; Vantrappen et al., 
1985) and suppressor T lymphocytes (Vantrappen et al., 1985). The niche cells 
provide sheltering environment that protects stem cells from stimuli that may promote 
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differentiation or apoptosis, threatening stem cell reserves (Moore and Lemischka, 
2006). For example, melanocytes, distributed in the limbal basal layer with their 
cellular projections extending to surrounding basal epithelial cells, produce and 
transport melanin pigments into epithelial cells. Melanin minimizes damage caused 
by ultraviolet irradiation together by the upper and lower eyelids that covers the 
superior and inferior limbus, where Palisades of Vogt are primarily located 
(Hertsenberg and Funderburgh, 2015). A three dimensional reconstruction of the 
LSC niche was proposed by Dziasco et al. in which the stem cell is closely 
associated and maintained by both dendritic pigmented limbal melanocytes and 
elongated limbal stromal cells (Dziasko et al., 2014). Limbal epithelial cells co-
cultured in vitro with mitotically active human limbal melanocytes were able to 
generate large epithelial colonies of small and compact cells with morphological stem 
cell characteristics, positive for the expression of the putative stem cell markers 
CK15, Bmi-1 and p63α and negative for the marker of terminal cell differentiation 
CK3 (Dziasko et al., 2015). It is also generally accepted that mesenchymal cells from 
the limbal stroma play a role in the maintenance and support of LSCs and are 
considered as an important element of the stem cell niche (Chen et al., 2011; Li et 
al., 2014b; Nakatsu et al., 2014). 
 
1.4 Corneal epithelial cell turnover 
The “X, Y, Z hypothesis of corneal epithelial maintenance” proposed by Thoft and 
Friend in 1983, prior to our knowledge of the existence of stem cells in the cornea, 
summarize the movement of cells in a healthy corneal epithelium (Thoft and Friend, 
1983). Since there is a continual loss of the superficial epithelial cells through 
desquamation while the epithelial mass remains relatively constant, they 
hypothesized that the corneal epithelium required continual replacement of naturally 
lost epithelial cells. According to their hypothesis corneal epithelial maintenance can 
be defined by the equation: X + Y = Z, where X is the proliferation of the basal 
epithelial cells and their movement towards the corneal epithelial surface, Y is the 
movement of the peripheral cells to the central corneal epithelium and Z is the loss of 
cells from the corneal epithelial surface due to constant desquamation (Figure 1.8). 
This equation states that cell loss (Z) must be balanced by cell replacement (X+Y) to 




Figure 1.8 The X, Y, Z hypothesis of corneal epithelial maintenance. X represents 
the migration of epithelial cells from the basal layer of the corneal epithelium to the 
epithelial surface. Y represents the migration of epithelial cells from periphery to the 
centre of the cornea. Z represents the loss of epithelial from the corneal surface from 
which terminally differentiated cells continuously slough off. For maintaining the 
corneal homeostasis it’s important that the sum of X and Y is equal to Z. 
 
Although it was questioned, there is a plenty of evidence that supported the original 
observations of the hypothesis. Different radio-labelling studies have been proved the 
movement of epithelial cells from the basal layer of the corneal epithelium towards 
the epithelial surface (Hanna and O'Brien, 1960; Lavker et al., 1991). The movement 
of epithelial cells from the periphery of the cornea is also confirmed by numerous 
studies (Buck, 1979; Kaye, 1980; Kinoshita et al., 1981; Dua and Forrester, 1990). 
Clinical observations confirmed that the cell movement from the peripheral corneal 
epithelium ends in eventual loss of cells from the central corneal surface (Lemp and 
Mathers, 1989). 
 
1.5 Characteristics of limbal stem cells 
LSCs fulfil all the criteria which apply to other types of stem cells such as low level of 
differentiation with a primitive phenotype, slow cell cycle, high proliferative potential 
after activation by wounding or in vitro culture conditions and capacity for unlimited 
self-renewal (Schlotzer-Schrehardt and Kruse, 2005). 
The capability to generate new cells is important characteristic of both stem cells and 
TACs. To be able to fulfil this function, they first need to replicate their 
deoxyribonucleic acid (DNA), through a process known as DNA replication which 
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occurs in the S phase of the cell cycle. Both tritiated thymidine and 5-bromo-2’-
deoxyuridine (BrdU) have been used to label cells in the S phase (Bickenbach, 1981; 
deFazio et al., 1987; Ahmad et al., 2006). Whilst stem cells go through the cell cycle 
slowly and retain these S phase markers for longer periods of time (Morris et al., 
1985; Kruse and Tseng, 1992; Ahmad et al., 2006), TACs continuously generate new 
cells and therefore cycle more rapidly. Consequently they retain S phase markers for 
shorter periods of time. The “label retaining property” has traditionally been used to 
distinguish stem cells from TACs. Using the proportion of label retaining cells present 
in the limbal region of the human cornea reported by Lavker and colleagues, it has 
been estimated that the percentage of stem cells may represent less than 10% of the 
total basal cell population (Lavker et al., 1991). 
Further characteristics that distinguish LSCs from TACs are morphological criteria 
and difference in cell size (Schlotzer-Schrehardt and Kruse, 2005). The smallest cells 
are located in the basal layer of the limbal epithelium as compared to the basal 
corneal epithelium (10.1±0.8 vs. 17.1±0.8 µm) (Romano et al., 2003). Another 
striking characteristic of limbal basal cells is their pigmentation that is result of 
intrinsic melanogenesis and play role in the protection of these cells from solar 
damage (Davanger and Evensen, 1971; Wolosin et al., 2000). Recently, Liu et al. 
showed association between pigmentation and differentiation, using a comparative 
transcriptomic analysis, with the p63+ population being the most pigmented and 
immature of the progenitors compared to ABCB5+, p63+ABCB5+ and 
p63+ABCB5+CK3+ populations (Liu et al., 2018). The limbal epithelial cells in the 
basal layer of the limbal epithelium show characteristics of immature cells including 
small cell size, high nuclear-cytoplasmic ratio, euhromatin-rich nuclei, hardly 
detectable nucleoli and cytoplasm rich in tonofilaments (Chen et al., 2004). 
Schlotzer-Schrehardt and Kruse reported that the adult LSCs exist in close spatial 
relationship with their early progenitor cells (Schlotzer-Schrehardt and Kruse, 2005). 
Using transmission electron microscopy, they observed “groups of small, roundish, 
densely packed cells at the bottom of the epithelial papillae forming the palisades of 
Vogt”, putative stem cell niche. Two different cell types could be observed within 
these clusters: one or few small, primitive appearing putative stem cells surrounded 
by larger melanin-containing early progenitor cells – putative TACs. The putative 
stem cells lay on a delicate basement membrane without forming cytoplasmic 
processes. Moreover, hemi-desmosomes and intercellular junctions are absent in this 
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region. On the other hand, the putative TACs possess cell processes which  
interdigitate with the matrix underneath and also have numerous hemi-desmosomes 
(Schlotzer-Schrehardt and Kruse, 2005). Additionally, the putative stem cells showed 
a high nuclear-cytoplasmic ratio, heterochromatin-rich nuclei without visible nucleoli, 
sparse cytoplasm with small melanin granules, few intermediate filaments, few 
mitochondria and ribosomes (Schlotzer-Schrehardt and Kruse, 2005). In contrast, the 
putative TACs have nuclei with increased euchromatin and distinct nucleoli, 
prominent melanin granules and tonofilament bundles (Schlotzer-Schrehardt and 
Kruse, 2005). 
 
1.6 Molecular markers of limbal stem cells 
Although a variety of putative LSC markers have been proposed up to date, 
identification of specific markers that would precisely identify LSC remains elusive 
and their role in identification of LSCs is still controversial. One of the possible 
reasons may be a very low number of LSCs present, probably as few as 100 in the 
mouse limbus (Collinson et al., 2002). The major markers proposed for epithelial 
stem cells in ocular or non-ocular tissues can be categorized into at least three 
groups: A) nuclear proteins such as the transcription factors p63 and PAX6, and 
signalling protein WNT7A B) cell membrane or transmembrane proteins including 
integrins (integrin β1, α6, α9), receptors (epidermal growth factor receptor - EGFR, 
transferrin receptor CD71, nerve growth factor receptor TrKA etc.), and drug 
resistance transporters (ABCG-2, ABCB5), and C) cytoplasmic proteins such as 
cytokeratin 19 (CK19), nestin, and α-enolase (Chen et al., 2004). In addition, a 
variety of differentiation markers have also been proposed to distinguish stem cells 
from differentiated cells. These include cytokeratin 3 and 12 (CK3 and CK12), 
involucrin, intercellular adhesive molecule E-cadherin, and gap junction protein 
Connexin 43, etc. (Chen et al., 2004). Notable markers are summarized in Table 1.1. 
Prominent candidate markers of LSC include transcription factor p63, C/EBPδ, Bmi1, 
ABCG2, and Notch-1 and recently proposed ABCB5 whilst most studied negative 
markers are cytokeratin dimer 3/12 and Connexin 43 (Pellegrini et al., 2001; Chen et 
al., 2004; Schlotzer-Schrehardt and Kruse, 2005; Barbaro et al., 2007; Notara et al., 
2010; Joe and Yeung, 2014; Ksander et al., 2014). Many of the markers associated 
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with limbal basal cells in the past, such as α9 and β1 integrins, α-enolase, and 
Connexin 43, are widely believed to be associated with increased mitotic activity 
related to TACs, but not with true quiescent stem cells (Schlotzer-Schrehardt and 
Kruse, 2005; Notara et al., 2010; Pellegrini et al., 2011). For many years, this area 






















Table 1.1 Putative LSC markers (with corresponding references).  
 
Putative Markers 
Presence (+) or 









(Pellegrini et al., 
2001) 
C/EBPδ + (Barbaro et al., 2007) 
Bmi1  (Barbaro et al., 2007) 
PAX6  (Ouyang et al., 2014) 
WNT7A  (Ouyang et al., 2014) 




(Zieske and Wasson, 
1993) 
TrKA + (Touhami et al., 2002) 
CD71 + (Hayashi et al., 2008) 
RHAMM/HMMR - (Ahmad et al., 2008) 
Notch-1 + (Thomas et al., 2007) 
Transporters 
ABCG2 + (de Paiva et al., 2005) 
ABCB5 + (Ksander et al., 2014) 
Adhesion proteins 
Integrin β1 & α9 + 




Connexin 43 - 
(Matic et al., 1997) 
Connexin 50 - 
III CYTOSOLIC AND CYTOSKELETON PROTEINS 
Cytokeratins 
CK3 - (Rodrigues et al., 




CK13 - (Merjava et al., 2011) 
CK14 + (Bickenbach, 2005) 
CK15 + (Ohyama et al., 2006) 
CK19 + (Michel et al., 1996) 
Intermediate 
filament proteins 
Vimentin + (Kasper et al., 1988) 










and Kruse, 2005) 
α-enolase + (Zieske et al., 1992) 




(Steuhl and Thiel, 
1987) 
Protein kinase C-γ + (Tseng and Li, 1996) 






p63 is a transcription factor which belongs to a family of tumour suppressor proteins 
including also p53 and p73 (Benard et al., 2003) and is involved in morphogenesis 
(Mills et al., 1999). 
TP63, the gene encoding p63, produces six isoforms by the use of two promoters, 
TA and ΔN, and alternative splicing at the 3’-terminus (Aberdam and Mantovani, 
2009). All isoforms consist of a DNA-binding domain and a carboxyl-terminal 
oligomerization domain. Isoforms with an added amino-terminal transactivation 
domain are named - TAp63 and those without - ΔNp63 (also known as p40) (Ahmad 
et al., 2006). In addition, three forms of the carboxyl-terminal oligomerization domain 
exist – α, β and γ (Ahmad et al., 2006). This results in a total of six p63 isoforms, 
three with an added transactivation domain (TAp63 α, β and γ) and three without 
(ΔNp63 α, β and γ) (Ahmad et al., 2006), of which ΔNp63α is most highly associated 
with LSCs (Di Iorio et al., 2005). ΔNp63α is shown to be more specific to LSCs 
compared to the other isoforms (Di Iorio et al., 2005), and its expression increases in 
limbal basal cells during wound healing (Barbaro et al., 2007). Moreover, ΔNp63α is 
thought to be a marker of both resting (quiescent) and activated LSCs (Barbaro et al., 
2007). While some studies showed that ΔNp63α is expressed in holoclones (formed 
by stem cells) but not paraclones (formed by TACs) in quiescent cornea (Barbaro et 
al., 2007), numerous studies, on the other hand, showed that ΔNp63α is also 
expressed by early TACs (Du et al., 2003; Espana et al., 2004; Harkin et al., 2004; 
Joseph et al., 2004). 
However, it is important that higher ΔNp63α expression in limbal epithelial grafts is 
associated with greater success in clinical LSC transplantation, whereas grafts 
containing less than 3% of ΔNp63α - bright cells are at an increased risk for failure 
(Rama et al., 2010). 
Beta and gamma isoforms of ΔNp63 are expressed in the suprabasal layers of the 
limbal and corneal epithelia in response to wounding and are expressed in more 
differentiated cells (Daniels et al., 2006a). 
Biological processes known to require p63 include epidermal lineage commitment, 
epidermal differentiation, cell adhesion, and basement membrane formation (Koster, 
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2010). Aberdam and colleagues suggested a key role of p63 in BMP-4 induced 
epidermal commitment of embryonic stem cells. They showed that although ΔNp63 is 
not required for ectodermal fate it enhances embryonic stem cell-derived ectodermal 
cell proliferation and epidermal commitment (Aberdam et al., 2007). ΔNp63 may be 
dispensable for some epithelial differentiation, but is necessary for the commitment of 
embryonic stem cells into CK5/CK14 positive squamous stratified epithelial cells 
(Medawar et al., 2008). 
In vivo studies, transgenic and knock-out mice have demonstrated that p63 plays an 
essential role in squamous epithelial development and regeneration (Mills et al., 
1999; Yang et al., 1999; Rinne et al., 2006; Aberdam et al., 2007; Rinne et al., 2007). 
The generation of mouse models lacking p63 led to severe changes in their 
phenotype: the mice die soon after birth with severe defects in limbs, craniofacial 
development, and absence of skin (Mills et al., 1999; Yang et al., 1999) . The fact 
that p63 knockout mice suffer from severe abnormalities in their epithelial 
development and lack of stratified epithelium suggests that p63 might be involved in 
maintaining the stem cell population (Celli et al., 1999). It is thought to regulate the 
stem cell population by promoting cell senescence and genomic stability, thereby 
sustaining their proliferative potential (Su et al., 2009). 
p63 is consistently expressed in the basal cells of stratified epithelia  and was 
previously identified as a stem cell marker for keratinocytes (Pellegrini et al., 2001). 
Later studies showed that p63 was not an exclusive LSC marker and it’s expressed 
not only in LSC, but also in some TACs, especially proliferative epithelial cells (Kim et 
al., 2009). It is highly expressed in both epidermal and limbal holoclones (Mills et al., 
1999; Yang et al., 1999; Pellegrini et al., 2001). Studies on human corneas partially 
supported these findings, demonstrating predominant immuno-localization of p63 in 
the nuclei of the limbal epithelial basal layer scattered in between the patches of p63 
negative cells (Chen et al., 2004; Schlotzer-Schrehardt and Kruse, 2005). Another 
study, on the other hand, reported positive p63 staining not only in the limbal region 
but also among most of the basal cells of the peripheral and central corneal 
epithelium (Dua et al., 2003). Opposite to the observations in human corneas, 
studies on murine corneas showed p63 expression not only in the limbal region but 




1.6.2 Cytokeratins  
 
Cytokeratins or keratins are a group of cytoskeletal proteins that form intermediate 
filaments in epithelial cells and are expressed in distinct patterns during epithelial 
development and differentiation. They are expressed in different combinations 
according to the type of epithelium and its state of differentiation (Sun et al., 1983; 
Schlotzer-Schrehardt and Kruse, 2005).  
Cytokeratins have been intensively studied and represent either markers of 
differentiation (CK3, CK12) (Rodrigues et al., 1987; Kasper et al., 1988; Liu et al., 
1993), or unspecific markers of limbal basal cells (CK5, CK14, CK15, CK19). Some 
of these cytokeratins were also found in conjunctival epithelium (CK5, CK14, CK19) 
(Merjava et al., 2011). CK14 has been proposed as a marker of proliferating 
keratinocytes in the skin (Bickenbach, 2005) as well as CK19  that was used to 
localize epidermal stem cells in hair follicles (Michel et al., 1996). CK19 together with 
another structural protein, vimentin, have also been foundin the basal cells of both 
humane and murine limbal epithelium (Kasper et al., 1988; Kasper, 1992; Lauweryns 
et al., 1993; Schlotzer-Schrehardt and Kruse, 2005). Cells which co-express both of 
these proteins were found to be equivalent to label retaining cells (Kasper, 1992). 
CK15 is the one that deserves a particular attention as reported to be a marker of 
hair follicular bulge stem cells (putative epidermal stem cells) and also considered as 
a marker of LSC (Ohyama et al., 2006; Yoshida et al., 2006). However, CK15 is also 
widely expressed in limbal basal cells and has not been directly linked to LSC 
functions such as clonogenicity or self-renewal (Joe and Yeung, 2014). On the other 
hand, dimer CK3/12 identifies more differentiated cells in corneal epithelium 
(Schermer et al., 1986; Kurpakus et al., 1990). This dimer is absent in LSCs and 
early TACs and therefore represents an important negative marker for LSCs.  
1.6.3 Connexin 43 and Connexin 50 
 
Connexin 43 and connexion 50, the gap junction proteins, are other important 
negative markers of LSC. They are abundantly expressed in the corneal epithelium, 
Connexin 50 throughout all layers whilst Connexin 43 is mainly confined to the basal 
cell layer (Dong et al., 1994; Matic et al., 1997; Wolosin et al., 2002). In contrast, they 
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are both absent from the basal layer of human, mouse, chicken and neonatal rabbit 
limbal epithelium where both LSCs and early TACs reside. It has been suggested 
that the absence of gap junction communication and consequential metabolic 
isolation from differentiating signals is an important characteristic of stem cells (Matic 
et al., 1997). 
1.6.4 C/EBPδ and Bmi1 
 
Transcription factor CCAAT enhancer binding protein δ (C/EBPδ) is expressed in 
many epithelial cell types and is involved in cell cycle arrest (Barbaro et al., 2007). 
Bmi1, a polycomb ringfinger protein, has also been detected in human limbus 
(Barbaro et al., 2007) but was also reported in stem cells in a number of other organs 
(Molofsky et al., 2003; Park et al., 2003; Iwama et al., 2004). Similarly to ΔNp63α, 
C/EBPδ and Bmi1 are expressed in holoclones but not paraclones (Pellegrini et al., 
2011). Coexpression of C/EBPδ, Bmi1 and ΔNp63α is thought to identify mitotically 
quiescent limbal cells. Both C/EBPδ and Bmi1 are involved in regulation of LSC 
quiescence, and the expression of both factors becomes downregulated upon 
corneal injury. LSC continue to express ΔNp63α during the initial proliferative phase, 
but lose this expression on terminal differentiation (Barbaro et al., 2007). However, 
more recent findings demonstrated that despite the fact that Bmi1 positive cells did 
participate in tissue replenishment within the central cornea, they were unable to 
maintain homeostasis of the cornea for more than 3 months, suggesting their status 
as progenitor rather than stem cells (Kalha et al., 2018).  
1.6.5 ABCG2 and ABCB5 
 
ABCG2, an ATP-binding cassette transporter protein, is expressed in stem cells in 
various tissues (Zhou et al., 2001). In these cells ABCG2 is responsible for the efflux 
of different anticancer drugs but also for their capability to exclude Hoechst 33342 
dye that can be detected by flow cytometry (Zhou et al., 2001). The exclusion of 
Hoechst 33342 dye is a unique property of the so called side-population (SP) cells. 
This characteristic has been associated with stem and progenitor cells in many 
tissues (including blood and skeletal muscle) and potentially can be used for cell 
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purification (Goodell et al., 1996; Chang et al., 2011; Ergen et al., 2013). However, 
this isolation strategy is not entirely specific on its own, and should be used only in 
combination with other positive or negative stem cell markers. ABCG2 is expressed 
by only a small subset of limbal basal cells (less than 1%) but interestingly its 
expression was not associated with extensive colony forming capacity (Umemoto et 
al., 2006). 
ABCB5, ATP-binding cassette, sub-family B, member 5, is firstly identified as a 
marker of skin progenitor cells (Frank et al., 2003) and melanoma stem cells 
(Schatton et al., 2008). It functions as a regulator of cellular differentiation (Frank et 
al., 2003) and is required for LSCs maintenance, corneal development and repair 
(Ksander et al., 2014). ABCB5 expression on label-retaining LSCs in mice and p63α 
positive LSCs in humans, along with reduced ABCB5 positive limbal cell frequency in 
LSC-deficient patients, suggest that ABCB5 preferentially marks LSCs (Ksander et 
al., 2014). Ksander at al. also showed that isolated humane or murine ABCB5 
positive cells possess the exclusive capacity to fully restore the cornea upon grafting 
to LSC-deficient mice (Ksander et al., 2014). Moreover, they showed that depletion of 
quiescent LSCs due to enhanced proliferation and apoptosis in Abcb5 knockout mice 
results in defective corneal differentiation and wound healing (Ksander et al., 2014). 
Recently however, another research group reported that p63 is superior to ABCB5 as 
a marker for stemness, whilst ABCB5, either alone or in co‐expression patterns with 
p63 and CK3, identifies more committed progenitor cells (Liu et al., 2018).  
1.6.6 PAX6 and WNT7A 
 
In 2014, Quyang and colleagues reported that “the transcription factors p63 and 
PAX6 (paired box protein PAX6) act together to specify LSCs and WNT7A controls 
corneal epithelium differentiation through PAX6” (Ouyang et al., 2014). Additionally, 
they showed that loss of either WNT7A or PAX6 induces change of LSCs into skin-
like epithelium and furthermore that transduction of PAX6 in skin epithelial stem cells 
is sufficient to convert them to LSC-like cells. Importantly, these reprogrammed skin 
epithelial stem cells were able to repair damaged corneal surface and regenerate 
corneal epithelium upon transplantation in a rabbit corneal injury model (Ouyang et 
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al., 2014). Taken together, their findings suggested a central role of the WNT7A-
PAX6 axis in corneal epithelial cell fate determination. 
1.6.7 Notch-1 
 
Notch-1 is a transmembrane receptor involved in maintaining cells in an 
undifferentiated state and has been proposed as a potential LSC marker by Tomas 
and co-workers. It has been found that Notch-1 expression was localised to a small 
number of cells in the limbal epithelial basal layer expressing also ABCG2. While all 
Notch-1 positive cells were ABCG2 positive, not all ABCG2 positive cells expressed 
Notch-1. It seems to be highly expressed in quiescent cells, supporting the notion 
that it could be an LSC marker (Thomas et al., 2007). 
1.6.8 RHAMM/HMMR  
 
RHAMM/HMMR, the hyaluronan receptor, is located in all layers of corneal 
epithelium and in the suprabasal layers of the limbal epithelium but is completely 
absent from the basal layer of the limbus. Moreover, the absence of RHAMM/HMMR 
expression is correlated with properties associated with LSC. Namely, 
RHAAM/HMMR negative limbal epithelial cells are smaller in size, express negligible 
CK3 but higher levels of ΔNp63α and have higher colony forming efficiency 
compared to RHAAM/HMMR positive limbal epithelial cells. For all this reason, 
RHAMM/HMMR represents a putative negative marker of LSC (Ahmad et al., 2008). 
1.6.9 Periostin 
 
Periostin is a non-structural matricellular protein originally found in murine 
osteoblasts (Takeshita et al., 1993). Later studies have shown that periostin is 
produced not only by stromal tissues, but also by epithelial tissues including epithelial 
cells in prostatic, ovarian and oral tumours (Gillan et al., 2002; Siriwardena et al., 
2006; Tsunoda et al., 2009). Recently, periostin was found to be exclusively localized 
in the basal layer of human limbal epithelium and co-localized with p63 but not with 
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corneal differentiation marker CK3. In primary human limbal epithelial cells, periostin 
expression at both mRNA and protein levels was significantly higher in sub-confluent 
cultures at exponential growth stage than in confluent cultures at slow growth 
condition. Moreover, periostin expression increased significantly during epithelial 
regeneration in wound healing process, especially 16-24h at the wound edge, similar 
to activation and upregulation of p63 and integrin β1 (Qu et al., 2015). 
 
1.7 Limbal stem cell deficiency 
According to the World Health Organization, as the 4th cause of blindness globally 
(5.1%), corneal blindness is one of the major causes of visual deficiency after 
cataract, glaucoma and age-related macular degeneration (World Health 
Organization). It has been estimated that corneal vascularisation and opacity cause 
blindness in 8 million people worldwide each year. 
Corneal integrity and function depend on self-renewing properties of the corneal 
epithelium. The corneal surface is constantly renewed by the stem cells located at 
the peripheral edge of the cornea, in a region known as limbus. These cells can be 
destroyed by numerous factors, including chemical and thermal burns, infections or 
autoimmune diseases, which result in the condition called limbal stem cell deficiency 
(LSCD), very painful and debilitating eye disease (O'Callaghan and Daniels, 2011; 
Ahmad, 2012).  
The cornea is surrounded by the conjunctiva which lays on fibrovascular connective 
tissue containing blood vessels and lymphatics (Utheim, 2013). Numerous cell types 
are interspersed within the conjunctival epithelium including lymphocytes, 
melanocytes, Langerhans cells and goblet cells. Goblet cells produce mucin, 
essential for maintenance of the tear film and ocular surface integrity, and are 
present exclusively in conjunctival but not in healthy corneal epithelium (Utheim, 
2013). The limbus acts as a barrier separating the clear avascular corneal epithelium 
from the surrounding vascular conjunctival tissue.  
LSCD is characterized by either a loss or dysfunction of the stem cells in the limbus 
(Ahmad, 2012). In LSCD both the stem cell function and the barrier function of the 
limbus fail (Ahmad et al., 2010).  Either loss or dysfunction of LSCs lead to failure of 
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corneal epithelial healing, therefore persistent corneal epithelial defects appear. 
These epithelial defects cause chronic ocular surface discomfort and pain. The 
failure of the barrier function, on the other side, will allow conjunctival epithelium 
along with its blood vessels to invade the corneal surface. This phenomenon is 
known as conjunctivalization of the cornea that leads to loss of corneal clarity with 
consequent visual impairment or blindness (Ahmad, 2012).  
 
1.7.1 Etiology and classification of LSCD 
 
The two pathologic mechanisms of LSCD are the direct destructive loss of LSCs and 
the loss of the limbal microenvironment/niche needed for LSC survival (Le et al., 
2018). Many acquired and congenital diseases may cause LSCD either by the direct 
loss of LSC pool, by the destruction of their niche or both (Li et al., 2007; Le et al., 
2018).  
There are many known causes of LSCD, if the cause is unknown these cases are 
classified as idiopathic (Espana et al., 2002) (Table 1.2). Primary LSCD is a direct 
result of genetic mutations that lead to LSC dysfunction or destruction. Some 
hereditary diseases including the limbus such as aniridia, a developmental 
dysgenesis of the anterior segment of the eye (Nishida et al., 1995; Ramaesh et al., 
2005; Skeens et al., 2011), keratitis associated with multiple endocrine deficiencies 
(Puangsricharern and Tseng, 1995; Mohammadpour and Javadi, 2006), dyskeratosis 
congenita (Aslan and Akata, 2010; Aslan et al., 2012), ectodermal dysplasia (Di Iorio 
et al., 2005; Felipe et al., 2012), Turner syndrome (Strungaru et al., 2014), lacrimo-
auriculo-dento-digital (LADD) syndrome (Cortes et al., 2005), and xeroderma 
pigmentosum (Fernandes et al., 2004) are connected with LSCD.  
Secondary LSCD results from external factors that directly destroy LSCs, damage 
the stem cell niche or both. The most common acquired LSCD is caused by chemical 
or thermal injuries (Sangwan, 2001; Le et al., 2010; Ahmad, 2012; Sejpal et al., 
2013), while other possible acquired causes are contact lens wear and ocular surface 
inflammatory diseases such as Stevens-Johnson syndrome, ocular cicatricial 
pemphigoid, and chronic limbitis (Puangsricharern and Tseng, 1995; Dua and 
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Azuara-Blanco, 2000; Sridhar et al., 2001; Bhatia et al., 2009).  Other inflammatory 
conditions including severe chronic vernal keratoconjunctivitis and microbial infection 
involving the limbus can directly destroy the stem cells too (Sangwan et al., 2011). In 
contact lens wear, LSCD may be caused by either toxicity of the contact lens solution 
or chronic mechanical micro trauma, hypoxia and inflammation of the limbus as a 
result of contact lens friction (Utheim, 2013). Iatrogenic causes are also present: 
extensive cryotherapy, radiation, multiple ocular surgeries involving the limbal region, 
toxicity from topical medications such as mitomycin C and 5-FU can also directly 
destroy LSC and their niche (Pires et al., 2000; Dudney and Malecha, 2004; Utheim, 
2013). LSCD secondary to other ocular surface disorders has also been reported; 
these disorders include neurotrophic (neural and ischemic) keratopathy (Bonini et al., 
2003), bullous keratopathy (Paris Fdos et al., 2010), and extensive ocular surface 
tumours (Gupta et al., 2011). In most of the acquired cases of LSCD, probably both 
















Table 1.2 Causes of limbal stem cell deficiency.  
I PRIMARY / HEREDITARY 
 Aniridia 
 Multiple endocrine deficiency 
 Ectodermal dysplasia 
 Ectrodactyly–ectodermal dysplasia–cleft (EEC) syndrome 
 Keratitis-ichthyosis-deafness (KID) syndrome 
 Dyskeratosis congenital 
 Turner syndrome  
 Xeroderma pigmentosum 
 Lacrimo-auriculo-dento-digital (LADD) syndrome 
 
II SECONDARY / AQUIRED 
 Chemical or thermal injury 
 Contact lens wear  
 Ocular surface inflammatory diseases 
 Stevens-Johnson syndrome / toxic epidermal necrolysis 
 ocular cicatricial pemphigoid 
 chronic limbitis (vernal / atopic conjunctivitis) 
 Iatrogenic causes 
 extensive cryotherapy 
 radiotherapy 
 multiple ocular surgeries involving the limbal region 
 cytotoxic agents (mitomycin C and 5-fluorouracil) 
 Severe microbial infections involving limbus 
 Mechanical trauma 
 Pterygium 
 Limbal tumours and extensive ocular surface tumours 
 Neurotrophic keratopathy  
 Bullous keratopathy 
 





1.7.2 Presentation of LSCD 
 
LSCD can affect both eyes (bilateral) and just one eye (unilateral). Depending on the 
extent of the disorder LSCD is classified as either partial or total (Kolli et al., 2010). 
Depending on the severity of the disease, LSCD can present with various symptoms 
and signs. Characteristic symptoms and signs can be easily understood by 
considering the main functions of limbus, the stem cell function and barrier function.  
As a result of either loss or dysfunction of LSCs corneal epithelial defects start to 
appear and fail to heal normally (Utheim, 2013). Recurrent corneal erosion or 
persistent epithelial defects together with inflammation cause severe pain, irritation, 
redness, tearing, photophobia, epiphora, blepharospasm and reduced vision and 
may lead to scarring, corneal thinning and even perforation (Espana et al., 2002). As 
the barrier function of limbus also fail conjunctival epithelium along with blood vessels 
encroach and invade the corneal surface. This process known as conjunctivalization 
of the cornea and represents the hallmark of LSCD. The conjunctivalization causes 
loss of corneal clarity and consequential visual impairment. 
The direct loss of LSCs and the conjunctivalization of the corneal surface lead to a 
number of clinical signs (Dua et al., 2000; Kolli et al., 2009; Sejpal et al., 2013): 
Corneal epithelial haze. As a direct consequence of scarring and the 
conjunctivalization the corneal epithelium loses its transparency and becomes hazy 
(Figure 1.9). Normal corneal epithelial cells are attached by tight junctions but the 
cellular connections between conjunctival epithelial cells are much looser making the 
conjunctival epithelium more permeable for hydrophilic molecules such as fluorescein 
compared to corneal epithelium (Kolli et al., 2009). This fact results in the late 
staining of conjunctivalized corneal epithelium with fluorescein usually seen in LSCD 
(Kolli et al., 2009). Moreover, these loose connections between the conjunctival 
epithelial cells permit entry of leucocytes from the tear film which then contribute to 









Figure 1.9 Clinical signs of limbal stem cell deficiency showing corneal haziness, 
conjunctivalization and neovascularisation of the corneal surface. The photo is taken 
from the paper “Successful clinical implementation of corneal epithelial stem cell 
therapy for treatment of unilateral limbal stem cell deficiency” (Kolli et al., 2010). 
 
Persistent epithelial defects. Failure of corneal epithelial healing due to loss or 
dysfunction of LSCs lead to formation of persistent corneal epithelial defects. These 
persistent epithelial defects may lead to scarring, ulceration, stromal 
neovascularisation, corneal thinning, secondary stromal infiltration and melting or 
even perforation of the cornea (Kolli et al., 2009). 
Loss of limbal architecture. In LSCD, there is loss of the palisades of Vogt and 
characteristic late irregular and radial staining of the limbal epithelium with 
fluorescein due to conjunctival invasion (Kolli et al., 2009). The absence of Palisades 
of Vogt alone, however, does not indicate LSCD (Zheng and Xu, 2008). 
Corneal neovascularisation. Conjunctival cells unlike corneal cells are not capable 
of secretion of anti-angiogenic factors that leads to the development of both 
superficial in milder and deep corneal vascularization in more severe cases of LSCD 
(Kolli et al., 2009). Neovascularisation is often seen but may not be present in some 
cases (Figure 1.9). 
Corneal scarring. In case the epithelial defects do not progress to thinning and 
perforation, remodelling of the affected epithelial tissue occurs and forms a scar 
tissue resulting in further loss of vision (Kolli et al., 2009).  
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Keratinization. If there is also a presence of tear deficiency, keratinisation may 
occur. 
 
Clinical manifestation of LSCD varies depending on severity and extent of 
involvement (Dua et al., 2000). In partial LSCD only one segment of the limbus is 
involved and clinical presentation is milder compared to total LSCD characterised by 
a complete absence of LSC population accompanied by conjunctivalization of the 
entire corneal surface (Sejpal et al., 2013). Recurrent epithelial defects cause severe 
pain, photophobia and together with conjunctivalization, vascularisation and scarring 
will result in functional blindness. 
 
1.7.3 Diagnosis of LSCD 
 
Accurate diagnosis of LSCD is crucially important because appropriate treatment can 
prevent progression of the condition and further damage to the ocular surface. 
Although the diagnosis of LSCD is mainly made on clinical grounds (Ahmad et al., 
2010), laboratory tests are necessary to confirm the diagnosis and monitor the 
disease progression. Inherent limitations are associated with the interpretation of 
clinical signs (Dua et al., 2009). For example, the presence of a fibrovascular pannus 
may be caused by previous infectious keratitis rather than by LSCD (Le et al., 2018). 
Beside patient’s medical history and slit-lamp examination, laboratory tests, such as 
corneal impression cytology and in vivo confocal microscopy, are useful diagnostic 
methods used to confirm the diagnosis of LSCD and monitor success of surgical 
interventions. Sophisticated testing is not required for the patients with condition 
known to cause LSDC, such as chemical injuries and Stevens-Johnson syndrome, 
with typical clinical signs (loss of the Palisades of Vogt, conjunctivalization and 
persistent epithelial defects) (Utheim, 2013). In patients with the less clear symptoms 
and signs, however, additional diagnostic tools including corneal impression cytology 
and in vivo confocal microscopy are of a great importance, especially if LSC 




1.7.3.1 Clinical examination  
The slit-lamp examination have been the main basis for the diagnosis and 
classification of LSCD (Le et al., 2018). The slit-lamp examination reveals a dull and 
irregular reflex from the conjunctivalized corneal surface (Dua et al., 2000). So-called 
“waterfall” or “whorled” epithelium is often present along with the loss of the 
Palisades of Vogt (Liang et al., 2009). Corneal haze, recurrent erosions or persistent 
epithelial defects and neovascularisation are also seen during the examination 
together with abnormal fluorescein staining. In advanced cases of LSCD, 
fibrovascular pannus and corneal scaring predominate (Dua et al., 2000). 
Clinical findings under slit-lamp biomicroscopy were summarized by Le and 
colleagues (Le et al., 2018): 
 Mild stage LSCD 
- Dull/irregular corneal surface with loss of light reflex  
- Corneal epithelial opacity  
- Fluorescein epithelial staining  
- Loss of palisades of Vogt 
 Moderate stage LSCD 
- Vortex keratopathy 
- Superficial vascularisation and peripheral pannus 
 Severe stage LSCD 
- Recurrent/persistent epithelial defects  
- Stromal neovascularisation 
- Stromal scarring and opacity.  
 
 
1.7.3.2 Corneal impression cytology  
 
Impression cytology is the gold standard diagnostic test for LSCD (Puangsricharern 
and Tseng, 1995). A nitrocellulose acetate filter paper (Egbert et al., 1977; Singh et 
al., 2005) or a polytetrafluoroethylene membrane (Thiel et al., 1997) may be pressed 
onto the corneal surface under the topical anesthesia to remove superficial cells 
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which can be then subjected to histological, immunohistological or molecular 
analysis. Thereafter the epithelial morphology and the presence of markers of 
conjunctivalization are evaluated. The presence of goblet cells on the cornea proves 
conjunctival epithelial invasion, since these cells are not normally present within the 
corneal epithelium. Besides the goblet cells other commonly used markers specific to 
conjunctival cells are CK7, CK13, mucin-1 and less specific CK19 (Barbaro et al., 
2010; Jirsova et al., 2011; Ramirez-Miranda et al., 2011). However, in some cases, 
such as those arising from severe chemical injury or Stevens-Johnson syndrome, 
goblet cells are often absent leading to false negative results (Liang et al., 2009). 
Sangwan et al. showed that even one third of patients with clinical diagnosis of LSCD 
demonstrated the absence of goblet cells (Sangwan et al., 2005). These patients 
received transplantation of ex vivo cultured LSCs which resulted in restoration of the 
ocular surface (Utheim, 2013). 
1.7.3.3 In vivo confocal microscopy  
Using in vivo confocal microscopy for examination in patients with LSCD the loss of 
normal limbal architecture, cystic changes in the epithelium and sub-epithelial fibrosis 
can be seen (Nubile et al., 2013). The main advantages of in vivo confocal 
microscopy compared to impression cytology are the possibility of non-invasive 
examination that does not require removal of corneal epithelial cells and obtaining 
information about both the superficial and deeper zones of the limbal area (Deng et 
al., 2012; Nubile et al., 2013). Using this technique normal corneal epithelial cells 
with bright well-defined membranes can be observed in contrast to hyper-reflective 
conjunctival epithelial cells with ill-defined membranes (Dua et al., 2009). Although 
the quality of images generated is outstanding, there are some disadvantages of 
using in vivo confocal microscopy such as a need of direct physical contact between 
the imaging probe and the epithelium examined and a small field of view (Utheim, 
2013). Spectral domain optical coherence tomography represents an alternative 
technique allowing larger field of view in non-invasive manner but with significantly 





1.7.4 Management of LSCD 
 
Successful reconstruction of the ocular surface in LSCD requires not only restoration 
of LSC number (by LSCs transplantation) but also restoration of the normal LSC 
niche environment (normal lid function and tear function, possible use of amniotic 
membrane and autologous serum etc.) (Kolli et al., 2009). Optimization of the ocular 
surface health is the very first step in the management of both partial and total LSCD. 
In partial LSCD improvement of the ocular surface health provides a better 
environment for the remaining LSCs to survive whilst in total deficiency cases these 
measures provide the best chance for the transplanted tissue to survive. 
LSCD treatment is usually complex and varies a lot among patients. The choice of 
treatment depends on severity (mild, moderate, severe LSCD) and extent of the 
disease (partial or total LSCD). For milder and moderate cases, treatment involve the 
control of the symptoms and causes. For patients with severe LSCD, the ocular 
surface reconstruction is required. Moreover, although for milder cases conservative 
management can be sufficient, if the pupillary area of the eye is covered by 
encroaching conjunctival tissue, surgical intervention is also required (Utheim, 2013). 
Various surgical procedures have been developed over the past 30 years to treat and 
reconstruct severely damaged or diseased ocular surface epithelia including amniotic 
membrane transplantation, conjunctival limbal grafting, simple limbal epithelial 
transplantation and cultivated limbal and oral mucosal epithelial transplantation (Yin 
and Jurkunas, 2018). 
There are at least five main principles in the management of LSCD, as summarized 
by Fernandez-Buenaga and colleagues (Fernandez-Buenaga et al., 2018): 
1. Understanding and control of inflammation; 
2. Correcting lid malposition and fornix adhesions;  
3. Managing dry eye disease; 
4. Partial versus total LSCD – since one of the main goals of ocular surface 
reconstruction is vision improvement, involvement of the central cornea is an 
important indication for surgical reconstruction; 
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5. Unilateral versus bilateral LSCD – knowing of LSCD aetiology is important in 
determining the surgical options, mainly in terms whether autograft or allograft 
procedures should be employed. 
 
1.7.4.1 Partial LSCD treatment  
 
Partial LSCD involves only a few sectors of the cornea and can be treated 
conservatively with frequent ocular lubrication and topical steroid therapy. Repeated 
mechanical scraping of the conjuntivalized epithelium, known as the sequential 
sector conjunctival epitheliectomy, may be performed to allow regrowth of normal 
corneal epithelium in its place providing there is some remaining healthy corneal 
tissue with functional stem cells left (Dua, 1998). Amniotic membrane transplantation 
and ipsilateral limbal translocation are also suggested as an early therapeutic option 
(Anderson et al., 2001; Nishiwaki-Dantas et al., 2001). Amniotic membrane 
transplantation helps to recreate the integrity of the ocular surface by promoting 
epithelialization, reducing angiogenesis and inflammation (Koizumi et al., 2001) and 
could be used with a high success instead of limbal transplantation in the 
management of partial LSCD.  
 
1.7.4.2 Complete LSCD treatment 
 
In case of total LSCD, whether unilateral or bilateral, the treatment of choice is 
surgical. Conventional corneal transplantation replaces only the central cornea and 
cannot successfully treat the ocular surface with extensive and complete LSCD. 
Therefore, therapeutic strategies evolved to replace limbal epithelium with or without 
corneal transplantation surgery.  
Jose Barraquer was the first to report managing “superficial burns” of one eye using 
“epithelial conjunctivocorneal limbus taken from the other eye” in 1964 (Holland, 
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2015). Thoft later reported “initial transplantation of conjunctiva, then lenticules of 
peripheral cornea, from cadaveric eyes” (Thoft, 1977). 
In unilateral cases of LSCD, donor tissue is obtained from the healthy fellow eye, 
called limbal autograft; in bilateral cases of LSCD, donor tissue is obtained from an 
allogeneic source (cadaveric, living related and unrelated donors), called limbal 
allograft. Both procedures have the same purpose - a transplantation of a new 
source of epithelium after the removal of the patient’s scarred and diseased 
epithelium (Thoft, 1977; Thoft, 1984). Allogeneic transplantation requires prolonged 
systemic immunosupression since the procedure carries the risk of rejection. It was 
also reported that long time survival of allografts is worse than autologous grafts (Miri 
et al., 2010). 
The corneal transplantation (penetrating keratoplasty) cannot restore sight to an eye 
blinded by LSCD before functional LSCs are restored (Dua et al., 2000). Corneal 
transplantation can be performed either simultaneously with limbal grafting or after 
the limbal grafting procedure has proven to be successful, which is more common. 
Restoration of the tear film may be achieved with frequent lubrication and use of 
autologous serum drops (Liang et al., 2009). In case the tear film is not efficiently 
restored, the resulting dryness contributes to the failure of traditional corneal 
transplantation. In that case keratoprosthesis is the only available terapeutic option 
available (Cauchi et al., 2008). Keratoprosthesis can be used as an alternative to 
allogeneic transplantation to avoid immunosupression. Athough patient with 
keratoprosthesis show improved vision postoperatively they may develop glaucoma 
and retroprosthetic membranes (Kamyar et al., 2012).  
1.7.5 Surgical treatment of LSCD  
1.7.5.1 Conjuntival limbal autograft (CLAU) 
The pioneer work by Kenyon and Tseng in 1989 identified that the transplanted 
limbal tissue can rehabilitate the corneal surface. They showed that in cases of 
unilateral total LSCD a contralateral conjunctival limbal autograft harvested from the 
healthy fellow eye may be used to help recover dieased eye’s corneal surface 
(Kenyon and Tseng, 1989), but the procedure is linked with the risk of iatrogenic 
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LSCD development in the donor eye as this technique requires the removal of 
relatively large free conjuntival lenticule (Kenyon, 1989; Kenyon and Tseng, 1989).  
Iatrogenic LSCD in the healthy donor eye has been reported clinically (Jenkins et al., 
1993) and validated in experimental animal studies (Chen and Tseng, 1990; Chen 
and Tseng, 1991). The risk of iatrogenic LSCD is lower when fewer than four to six 
clock-hours of limbal tissue is transplanted (Dua et al., 2000), but the success rate 
decreased in these smaller grafts and complications were seen (Liang et al., 2009; 
Baradaran-Rafii et al., 2012). 
1.7.5.2 Allograft limbal transplant 
In total bilateral LSCD, allograft limbal transplantation is one of the approaches to 
reconstruct the ocular surface (Tsai and Tseng, 1994). Allogeneic limbal 
transplantation can be carried out as as living-related conjunctival allograft (LR-
CLAL), cadaveric keratolimbal allograft (KLAL), or the combination of LR-CLAL and 
KLAL (also referred to as the “Cincinnati Procedure”) (Holland, 2015; Haagdorens et 
al., 2016). Allograft limbal stem cell transplant can provide immediate postoperative 
epithelialization and rapid reconstruction of the ocular surface (Dong et al., 2018). 
However, in order to avoid rejection of the allograft, systemic immunosuppression is 
necessary. Adverse effects related to long-term immunosuppression including 
anemia, hyperglycemia, elevated creatinine, and elevated levels of liver function 
markers are commonly seen (Holland et al., 2012; Krakauer et al., 2012). 
Interestingly, a long-term study showed that eventually, only recipient DNAs were 
detectable in the regenerated epithelium of the majority of the successful cases. This 
finding suggests that the allografted limbal epithelium promotes regeneration of the 
corneal epithelium in patients with LSCD, at least in part, by activating residual stem 
cells and enhancing their self-renewal (Daya et al., 2005). One of the possible 
explanations is that allografted LSCs secrete factors necessary for maintaining stem 
cell homeostasis. It is important to further elucidate what exactly these factors are 
and whether their direct application onto the ocular surface could possibly restore the 
corneal epithelium (Dong et al., 2018). 
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1.7.5.3 Simple limbal epithelial transplantation (SLET) 
In 2012, Sangwan and colleagues introduced a novel technique called "simple limbal 
epithelial transplantation", that incudes direct transplantation of the 2 x 2 mm piece of 
healthy limbal tissue cut into pieces and secured on amniotic membrane using fibrin 
glue without ex vivo cultivation (Sangwan et al., 2012).  Promising results are 
reported after a multicenter study on 68 eyes from patients who underwent SLET for 
unilateral LSCD (Basu et al., 2012). Basu et al. reported that clinical success was 
achieved in 57 (84%) cases and the survival probability exceeded 80%, with a 
median follow-up of 12 months (Basu et al., 2012). In 2016, the same autors reported 
long-term clinical outcomes of a large cohort of patients (125 cases) with unilateral 
LSCD occurring after ocular burns with median postoperative follow-up of 1.5 years. 
They showed that 76% patients maintained a successful outcome and in addition to 
the ocular surface restoration, most patients showed a significant improvement in 
visual acuity (Basu et al., 2016).  
Gupta and coworkers reported that SLET showed a similar success rate to the 
traditional autologous limbal transplantation with an important advantage - 
autologous SLET requires only a tiny amount of limbal tissue from the unaffected eye 
therefore carrying a minimal risk to the donor eye (Gupta et al., 2018). 
 
1.7.6 LSCD cell-based therapies  
 
Cell therapy of LSCD involves tissue engineering techniques focused primarily on ex 
vivo expansion of the least amount of limbal tissue on different carrier scaffolds 
(substrates) and production of limbal epithelial sheets which will further be used to 
reconstruct severely damaged ocular surfaces by transplantation. Beside limbal 
epithelial cells, several studies focused on use of oral mucosal epithelial cells and 
mesenchymal stem cells (MSCs) in LSCD treatment.  
1.7.6.1 Cultivated limbal epithelial transplantation (CLET) 
A new chapter in the treatment of LSCD started with the laboratory expansion of 
limbal epithelial cells (LECs) when Pellegrini et al. first reported cultivating a small 
47 
 
limbal biopsy of the healthy eye of patients with severe alkali burn and successful 
restauration of the ocular surface by transplantation of the cultured cell sheet on the 
other eye (Pellegrini et al., 1997). Many studies published later confirmed that a small 
piece of limbal tissue, usually 2 x 2 mm, may be taken from the healty eye and 
transplanted following ex vivo cultivation of LECs, achieving excellent long term 
clinical outcome (Pellegrini et al., 1997; Kolli et al., 2010; Rama et al., 2010; Baylis et 
al., 2011). The limbal tissue can be harvested from the healthy fellow eye in unilateral 
LSCD, or living related donors or cadaveric eyes in bilateral cases. Cells can be 
cultured in either an explant or cell suspension system using various culture media 
and substrates (Shortt et al., 2007b; Ahmad et al., 2010; Shortt et al., 2010; Baylis et 
al., 2011). In the suspension technique, cells are separated by enzyme digestion 
from the limbal niche for culture while in the explant culture LSCs along with the 
entire limbal niche are placed in a culture (Ramachandran et al., 2014). In 
suspension culture, because cells are removed from their natural niche, additional 
support in the form of feeder cells is required to maintain stemness of LSC population 
(Ramachandran et al., 2014). 
The possibility to get enough cells for transplantation from a very small amount of 
starting material has made LSCD treatment simpler and safer. Also, it became 
possible to repeat CLET in cases in which the first CLET failed, without adversely 
affecting the health of the donor eye (Basu et al., 2012). It has been reported that by 
repeating CLET 3-12 months after the first CLET, a stable ocular surface could be 
generated in more than 66% of the failed cases (Basu et al., 2012).  
Rama et al. reported “permanent restoration of a transparent, renewing corneal 
epithelium” in 76.6% of eyes after CLET using autologous LSCs cultivated on fibrin to 
treat 112 patients with corneal damage, most with burn-dependent LSCD (Rama et 
al., 2010). Restored eyes remained stable over time, with up to 10 years of follow-up. 
Importantly, they also showed that successful outcome was associated with the 
percentage of p63-bright, holoclone-forming stem cells in culture. Namely, cultures 
with more than 3% of p63-bright cells were associated with successful 
transplantation in 78% of patients while, in contrast, cultures in which such cells 
made up 3% or less of the total number of cells were associated with successful 
transplantation in only 11% of patients (Rama et al., 2010). Moreover, they showed 
that graft failure was also associated with the type of initial ocular damage and 
postoperative complications (Rama et al., 2010). The next long-term multicentre 
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prospective study on 152 patients treated with autologous LSCs cultured on fibrin 
from the same research group, scored outcomes as full success, partial success and 
failure in 66.05%, 19.14% and 14.81% of eyes, respectively (Pellegrini et al., 2013). 
Although Pellegrini et al. initially recommended use of clinical-grade 3T3-J2 feeder 
cells as a substrate for LSCs cultivation, many research groups later tended to avoid 
the use of animal feeder cells in the process of cell product preparation for human 
administration. Kolli et al. for example, recommended use of HAM as a more suitable 
substrate for ex vivo LSCs expansion for clinical application (Kolli et al., 2010). 
Having in mind that HAM mimics the natural stem cell niche and has the potential to 
enhance the self-renewal of LSCs (Nakamura et al., 2006), it represents an ideal 
substrate for various transplantation procedures on the ocular surface (Sangwan et 
al., 2006). In their study, Kolli et al. reported treating of eight eyes of eight 
consecutive patients with unilateral total LSCD with ex vivo expanded autologous 
LSC transplant on HAM. After transplantation, successful ocular surface 
reconstruction with a stable corneal epithelium was obtained in all eyes (100%) with 
a mean follow-up of 19 months (Kolli et al., 2010). 
Over the past 22 years since the first CLET was performed, various modifications of 
the culture and transplantation techniques emerged. Consequently, due to variation 
within the studies and between the studies, it is often difficult to make an objective 
assessment. Outcomes of limbal epithelial therapy were reviewed by different 
research groups (Shortt et al., 2007b; Baylis et al., 2011; Holland, 2015; Fernandez-
Buenaga et al., 2018). Pooling the data of 13 studies with long-term outcomes, 
Holland analysed the long-term overall success rate (Holland, 2015). Overall, 720 
eyes were treated with either autologous (89%) or allogenic CLET (11%) and the 
single most common indication for the surgery was chemical/thermal injury (89%) 
(Holland, 2015). Using ocular surface reconstruction success and improvement in 
visual acuity as the main outcome measures, he reported the overall success rate of 
these 13 studies of 72% (Holland, 2015). 
 
1.7.6.2 Cultivated oral mucosal epithelial transplantation (COMET)  
As severe LSCD is mostly bilateral and allogeneic limbal transplant or CLET require 
intesive and prolonged postoperative immunosupressive therapy, scientists 
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worldwide become interested in an extraocular source of stem cells to avoid 
dependence on allogeneic LSCs. So far, oral mucosal epithelium and MSCs were 
used in regeneration of the corneal surface. It has been shown that COMET is a 
feasible substitute for allogenic CLET without the need for long-term systemic 
immunosuppression (Nakamura et al., 2004; Nakamura and Kinoshita, 2011; 
Nakamura et al., 2011; Eslani et al., 2012; Sotozono et al., 2013; Kolli et al., 2014; 
Sotozono et al., 2014; Prabhasawat et al., 2016).  
Gaddipati et al. reported that cultivated oral epithelial cells formed a stratified tissue 
and expressed proliferation and progenitor markers Ki67 and p63 in the basal layer 
of the cell sheets, suggesting that the epithelium had regenerative capacity 
(Gaddipati et al., 2014). Furthermore, the transplanted epithelium also expressed 
CK3, CK19, p75, and the cornea-specific PAX6 and CK12 (Gaddipati et al., 2014). 
This study confirms that the oral cells acquire some of the corneal epithelial-like 
characters at the ectopic site. However, although transplantation of ex vivo cultivated 
autologous oral mucosal epithelial cells in patients with bilateral total LSCD achieved 
success in stabilization of the ocular surface, the visual improvement was not as 
optimal (Nakamura and Kinoshita, 2003; Nakamura et al., 2004; Kolli et al., 2014). 
Moreover, compared with cultured LECs, oral epithelial cells have significantly higher 
angiogenic potential (Dong et al., 2018; Duan et al., 2019). Recently, Duan and 
colleagues suggested that this issue may be solved by using allogenic limbal niche 
cells instead of mouse-derived 3T3 cells as a feeder layer, as they reported that the 
cultivated oral mucosal epithelial cells obtained in this system are less likely to induce 
postsurgical neovascularization (Duan et al., 2019). 
Kolli et al. reported transplantation of autologous ex vivo expanded oral mucosa 
epithelium in two patients with bilateral total LSCD that resulted in successful 
reversal of LSCD in the treated eye up to 24 months (Kolli et al., 2014). In another 
study with mean follow up of 25.5 months in 40 eyes, corneal surface stability 
underwent an early decline in transplanted COMET over the first 6 months, 
remaining stable thereafter (1 year: 64.8%, 2 years: 59%, 3 years: 53.1%) (Satake et 
al., 2011). Fernandez-Buenaga et al. recently reported that COMET success rate 




1.7.6.3 Mesenchymal stem cell transplantation (MSCT) in LSCD treatment  
MSCs are relatively easy to obtain from a variety of tissues, including bone marrow, 
adipose tissue, umbilical cord, etc. Importantly, MSCs possess immunomodulatory 
and non‐immunogenic properties (Aggarwal and Pittenger, 2005), thereby removing 
the need for immunosuppression. There is plenty of evidence from both in vitro and 
in vivo studies regarding the potential use of bone marrow derived MSCs for ocular 
surface regeneration. All studies reported promising results in animal models and 
demonstrated significant corneal regeneration, improved corneal transparency, and 
rapid healing associated with the restoration of vision (Holan and Javorkova, 2013; 
Yao and Bai, 2013; Harkin et al., 2015). Another promising, easily accessible and 
abundant source of MSCs is adipose tissue (Strioga et al., 2012). Adipose tissue 
derived MSCs also show the beneficial role in corneal epithelial regeneration. Under 
basic culture conditions they express corneal epithelial markers, suggesting that 
these cells may have some inherent properties to regenerate the corneal epithelium 
(Nieto-Miguel et al., 2013). Moreover, several studies reported that in experimental 
models of LSCD, administration of adipose tissue derived MSCs either 
subconjunctivally (Lin et al., 2013a), topically (Lin et al., 2013b; Zeppieri et al., 2013; 
Almaliotis et al., 2015), or overlaid on scleral contact lenses or nanofiber 
scaffolds (Espandar et al., 2014; Holan et al., 2015) promoted regeneration of the 
corneal epithelium. A case report in which adipose tissue derived MSCs were applied 
topically to a patient with persistent sterile epithelial defects further supports the 
potential benefit of MSCs from this source (Agorogiannis et al., 2012). Furthermore, 
Galindo et al. showed that adipose tissue derived MSCs improved corneal and limbal 
epithelial phenotypes in animal LSCD models (Galindo et al., 2017). These cells 
transplanted in total LSCD models developed in rabbits were well tolerated, reduced 
inflammation, and restrained the evolution of corneal neovascularization and corneal 
opacity. The expression profile of the corneal epithelial cell markers CK3 and E‐
cadherin, and the limbal epithelial cell markers CK15 and p63 was lost in the LSCD 
models, but was partially recovered after human adipose tissue derived MSCT 
(Galindo et al., 2017).  
On the contrary, a study published by Holan and colleagues suggests superiority of 
bone marrow derived MSCs in comparison with adipose tissue derived MSCs (Holan 
et al., 2015). Clinical characterization of the healing process, evaluation of corneal 
thickness, re-epithelialization, neovascularization, and the suppression of a local 
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inflammatory reaction, were comparable in the bone marrow derived MSC and LSC-
treated eyes, but results were significantly better than in injured, untreated eyes or in 
eyes treated with adipose tissue derived MSCs (Holan et al., 2015). Due to these 
contradictory results it is still not clear whether or not one of these two MSC sources 
represent superior option for LSCD treatment. 
MSCs could also be used as a support to LSC transplantation. It’s been shown that 
co-transfer of murine LSCs with MSCs, which have immunosuppressive properties, 
significantly inhibited local inflammatory reactions and supported the healing process 
(Zajicova et al., 2010).  
Mittal et al. showed, using an in vivo mouse model of ocular injury, that MSCs 
possess the capacity to restore corneal transparency by secreting high levels of 
hepatocyte growth factor (HGF) and moreover that HGF alone can restore corneal 
transparency (Mittal et al., 2016). 
Recently, the first reported proof-of-concept clinical trial provided an evidence that 
allogeneic bone marrow-derived MSCT to the ocular surface is as safe and as 
effective as allogeneic CLET at facilitating recovery of LSCD (Calonge et al., 2019). 
They conducted a 6-12 month randomized, double-masked pilot trial to test whether 
allogeneic bone marrow-derived MSCT (performed in 17 patients with LSCD) was as 
safe and as equally efficient as allogeneic CLET (performed in 11 patients with 
LSCD), to improve corneal epithelial damage due to LSCD. Global success after 6-
12 months was 72.7% - 77.8% for CLET cases and 76.5% - 85.7% for MSCT cases, 
without any significant differences found. Since there were no adverse events related 
to cell products reported, their study showed that MSCs used in MSCT can safely 

































Chapter 2. Cultivation of LSCs under good manufacturing practice 
(GMP) conditions  
 
2.1 Introduction 
2.1.1 Regenerative medicine and cell therapy 
 
Regenerative medicine (RM) is an innovative, fast-moving field with the ultimate aim 
to return patient to full health. RM has been defined as the “process of replacing, 
engineering or regenerating human cells, tissue and organs to restore or establish 
normal function” (Mason and Dunnill, 2008). Stem cell research plays a central role in 
RM through translational research as stem cells can be used to repair or replace 
damaged or ageing cells in the human body by either promoting endogenous 
regenerative processes or directly replacing damaged tissues after cellular 
transplantation (Eming et al., 2014). 
There are a number of major medical conditions, such as heart failure, insulin-
dependent diabetes, spinal cord injury, Parkinson’s disease etc. which could be 
addressed via cell-based therapies. Stem cell derived β islet cells, for example, could 
potentially replace a patient’s requirement for insulin injections (Phillips et al., 2007).  
Cell manufacturing for clinical applications is a unique form of biological 
manufacturing that depends on maintenance of strict work practices invented to 
ensure product consistency and prevent contamination by either microorganisms or 
by another patient’s cells. For considerable period of time hematopoietic stem cell 
transplantation has been the principal cell therapy but since the adult stem cells were 
discovered cellular therapies evolved beyond. Limbal epithelial transplantation is a 
prime example of the cell-based therapy that has been used successfully in patients 
suffering from LSCD.  
The cell therapy market is one of the most emerging sectors of the global 
biopharmaceutical market with approximately $100 billion in revenues and very 
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promising compound annual growth rate predicted to reach at least 20% in the near 
future (Abbasalizadeh and Baharvand, 2013).  
In 2004, medicinal products for human use which are either based on gene therapy, 
somatic cell therapy (including stem cell therapy), tissue engineering or a 
combination of those are classified as “Advance Therapy Medicinal Products” 
(ATMPs) by European Commission (EC) (Hartmann-Fritsch et al., 2016). Recently, 
ATMPs have been regulated by pharmaceutical rules applying to this new area of 
medicine. Regarding their manufacturing and testing, the ATMP regulation EC 
1394/2007 defines the standard in Europe (Off J Eur Union, 2007). The regulation 
sets out tailor-made technical requirements and establishes new standards for 
clinical trials in the development of ATMPs. In enforcement of the European 
regulation 1394/2007, all ATMPs must be produced under conditions following the 
guidelines of Good Manufacturing Practice (GMP). The principles of GMP are 
described in the Commission Directive 2003/94/EC (Off J Eur Union, 2003). This 
directive is concerned with medicinal products of human use only.  
GMP is a quality assurance system which ensures the highest quality and safety of 
medicinal product. It ensures that products are manufactured consistently and to 
defined standards as well as that the end product meets preset specifications. It 
requires traceability of raw materials and production that follows validated standard 
operating procedures (SOPs) (Arjmand et al., 2012). The GMP regulations address 
also record keeping, personnel qualification, sanitation, cleanliness, equipment 
verification, the validation of the process and complaint handling (Skottman et al., 
2006). 
The translation of a successful research process into a process following GMP 
guidelines is a challenging procedure. The common misconception is that clinical-
grade cell lines may be produced only by transfer of current methodology into clean 
room facilities. These GMP facilities are indeed important in avoiding contamination 
of the product but equally important in implementing GMP standards is the 
development of validated SOPs for the entire process, from cell isolation to freezing 
and cell storage. Another important aspect is transfer of cell production to GMP 
grade standards is establishment of quality control methodology and release criteria 




2.1.2 Hurdles to produce ATMPs under GMP conditions 
 
The translation of a research process into a GMP process is a long and challenging 
procedure that requires many adaptations to be made at different levels (Hartmann-
Fritsch et al., 2016): 
1. Risk management   
A complex process such as ATMPs production should be divided into small 
achievable production steps, for example: starting materials, consumables, 
handling techniques, equipment used etc. Careful risk management ensures 
quality of the manufacturing process and ultimately safety of the patient 
(European Medicines Agency, 2015). General risk assessment includes 
assessment, control, communication and review of risks. Risk can affect any area 
of the process from: 
 materials - not all material required is available in GMP grade; 
 involved personnel - working with living tissues includes risk of transmitting 
pathogens to staff or cross-contamination with other batches/products; 
 patient – if the batch manufacturing has to be stopped due to 




Documentation is of crucial importance to GMP (EudraLex, 2010). It ensures 
the traceability in case of batch-specific problems, reduces the risk of mistakes 
by defining the complete process, assures reproducibility, and confirms 
responsibilities by signatures. A precise documentation system has to be 
established, describing the whole manufacturing process in details (EudraLex, 
2012). Besides manufacturing steps of the ATMP itself, this includes also 
preparation protocols for culture media, solutions and matrixes. In addition to 
these, all used materials including starting materials and consumables need to 





3. Starting materials 
 
Although over the past years GMP grade materials become more and more 
available or may be produced by some companies on customer request, 
majority of starting material is made for “research use only”. The use of these 
materials under GMP conditions may only be approved by authorities under 
special circumstances if no other option is available and on a risk-based 
assessment.  
Human tissue sample is a starting material of special interest. Before tissue 
removal minimally required laboratory analyses have to be performed (HIV1, 
HIV2, HBV, HCV and syphilis) together with additional tests depending on the 
type of tissue or donor. 
  
4. Consumables  
 
Single-use single-pack consumables are the first choice for manufacturing 
according to the GMP guidelines. For reusable materials efficient cleaning has 
to be performed and validated. 
 
5. In process controls (IPCs) 
 
IPCs have to be established for the complete manufacturing process. These 
controls are necessary in order to ensure the safety of the product and the 
quality of the product (EudraLex, 2014).  
IPCs of the first category ensure safety of the product, verifying for instance 
that a certain cell population used for the production of a tissue engineered 
product is free of endotoxins and mycoplasma. Sterility is of vital importance 
for the safety of the product and is broadly and carefully checked. Cell 
populations need to be tested on their identity and purity to assure that the 
appropriate cells are present in the final product in the defined number. 
Whenever possible objective controls with measurable outcome should be 
chosen, for example cell morphology identification using only microscopic 
assessment should be replaced by immunofluorescence analysis, using 




6. Release controls 
The use of reference standards and potency assays in the manufacture of ATMPs 
is recommended to ensure product safety and potency prior to transplantation. It’s 
crucial to ensure that final products are consistently manufactured and meet all 
necessary criteria in terms of viability, function, purity and sterility (Neofytou et al., 
2015). 
At the end of the process, the end product needs to be analyzed for safety and 
quality by a qualified person. The strategy regarding sterility of the final product 
requires particular attention. Widely used sterilization methods such as 
autoclaving, gamma ray and ethylene oxide sterilization are not applicable for 
living tissues. Since no final sterilization can be performed sterility of the product 
has to be ensured during manufacturing itself, all the way from starting materials 
to packing materials (EudraLex, 2008). Living ATMPs has relatively short shelf life 
and often clinical application of the batch takes place before final sterility results 
are available (sterility results available after approximately 14 days), which leads 
to so called conditional release of ATMP for transplantation. Other mandatory 
release controls regarding product safety involve analysis for mycoplasma and 
endotoxins. As a part of quality control, analysis regarding functionality and 
performance of the final product should also be included (the amount of living 
cells, the concentration of secreted factors etc.).  
For example, control measures and well defined release criteria should be 
employed for LSC cultures before they are used for human transplantation as for 
other stem cell products, to determine the quality of the final cell product (Daniels 
et al., 2006b). To release the epithelial cell graft for ocular surface reconstruction, 
critical quality parameters such as adherent and healthy epithelial cells with 
cobblestone morphology, integrity of the fibrin gel and no contamination must be 
met (Sheth-Shah et al., 2016). Pellegrini et al. proposed stringent quality criteria 
that should be adopted for LSC cultures in order to ensure that they contain a 
sufficient number of stem cells essential for long term epithelial survival (Pellegrini 
et al., 2011). According to the same research group, quality control should also 
include rigorous clonal analysis or the evaluation of cell doublings generated 
during serial cultivation of LSCs (Pellegrini et al., 2011). Another important 
analysis that has to be done before the LSC product is released for human 
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transplantation is evaluation of levels of contaminating murine fibroblasts in LSC 
cultures. It was previously estimated that more than 5% contamination was 
unsuitable for clinical use (Di Iorio et al., 2010). Ideally, the use of murine 3T3 
fibroblasts should be eliminated in the future and substrates more appropriate for 
clinical use such as HAM should be employed. Furthermore, mandatory microbial 
analyses of LSC cultures have to be conducted before these cells are applied to 
treat patients with LSDC proving that cultures are sterile and safe for human 
administration.  
Once all the required specifications are confirmed, certificates of analysis could 
be generated for all product lots to certify them for clinical use (Neofytou et al., 
2015). 
7. Training of staff 
The vital point for implementing a successful GMP practice and process is the 
staff (EudraLex, 2013). The level and quality of implementation of all 
documentation, protocols and controls by qualified staff define the quality of the 
end product.  
8. Approval by the Regulatory Authority 
The final step after successful establishment and validation of the entire GMP 
process is approval of the manufacturing process by the regulatory authority. The 
basis for approval is the investigational medicinal product dossier which structure 
is set out in “Guideline on the Requirements to the Chemical and Pharmaceutical 
Quality Documentation Concerning Investigational Medicinal Products in Clinical 
Trials” (European Medicines Agency, 2016). 
The use of defined cultured systems should be implemented with manufacturing 
clinical grade cell products. Using chemically undefined media or material of animal 
origin, such as fetal bovine serum and mouse embryonic fibroblasts, should be 
avoided if possible. The cultures should be animal substance free in order to exclude 
the risk of infections and immunogenity (Skottman et al., 2006; de Lazaro et al., 
2014). The use of xeno-free media for cell generation, maintenance and 
differentiation in culture is for these reasons one of the clinical grade requirements. 
The safety of the exposure to variety of growth factors and culture conditions also 
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has to be thoroughly investigated prior to any clinical application (de Lazaro et al., 
2014).  
 
2.1.3 Limbal stem cell therapy 
 
Therapeutic use of LSCs must be performed in compliance with GMP as a quality 
assurance system to ensure highest quality and safety of cell product for 
transplantation in accordance with the European Union, Regulation (EC) No 
1394/2007 of the European Parliament and of the Council, on ATMPs (Off J Eur 
Union, 2007). 
Replacement of a pathologically altered cornea with healthy corneal tissue from a 
suitable donor is among the most common and successful transplantation 
procedures in medicine. With a success rate of 90%, the outcome of cornea 
transplantation is very favorable. However, one global survey from 2016, that 
included 95% of the world’s population, quantified the considerable shortage of 
corneal graft tissue, with only 1 cornea available for 70 needed (Gain et al., 2016). In 
2017, NHS Blood and Transplant reveals that its eye banks are 21% below the level 
needed to supply hospitals (NHS Blood and Transplant, 2017). Having in mind the 
shortage of corneal tissue worldwide, innovative, cell-therapeutic approaches may 
open new, promising treatment perspectives. 
The patients with severe total LSCD have been successfully treated with autologous 
limbal tissue transplants taken from the healthy contralateral eye (unilateral cases) or 
allogeneic transplants obtained from living related or cadaveric donors (unilateral and 
bilateral cases) (Kenyon and Tseng, 1989), but this technique is connected with the 
risk of iatrogenic LSCD development in the living donor eye. Importantly, 
improvements in the ex vivo expansion of LSCs obtained from the culture of small 
limbal biopsies and the successful reversal of LSCD upon their transplantation has 
revolutionized the field and has reduced the risk to the donor eye, making this a 
widely used technique for treatment of LSCD in humans (Pellegrini et al., 1997). In 
2015, the European Commission granted marketing authorization to the first stem 
cell-based treatment in the European Union. The product named Holoclar® is an 
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ATMP for the treatment of moderate to severe LSCD due to physical and chemical 
burns in adults (Pellegrini et al., 2018). 
2.1.3.1 Sources of the LSCs for transplantation 
In clinical trials both autologous and allogeneic sources have been used. Autologous 
cells are however preferred, as their transplantation does not cause any 
immunoreactivity and therefore does not require systemic immunosuppression. 
However, this option is not possible in cases of bilateral disease when tissue 
donation from deceased person or living related or unrelated donor is the only option 
available (Behaegel et al., 2017).   
 
2.1.4 Basic concepts of epithelial cell culture 
 
Rheinwald and Green pioneering work made possible the cultivation of human 
keratinocytes using a feeder layer of lethally irradiated 3T3-J2 mouse embryonic 
fibroblasts (Rheinwald and Green, 1975). The same principle has been used to 
cultivate human limbal and epidermal keratinocytes for more than 3 decades (Gallico 
et al., 1984; Pellegrini et al., 1997; Pellegrini et al., 1999b; Ronfard et al., 2000; 
Pellegrini et al., 2013). Ex vivo expansion of limbal biopsies on HAM as a substrate is 
also a well-established technique which has been used successfully to cure patients 
with total LSCD (Kolli et al., 2010; Yu et al., 2016).  
Epithelial cells on a substrate grow optimally at 37C° in a humidified atmosphere with 
95% air and 5% carbon dioxide (Rheinwald, 1980; Kolli et al., 2010; Yu et al., 2016).  
Additionally, there are a certain number of nutritional requirements for successful 
epithelial cell culture: 
1. Dulbecco’s modification of Eagle’s medium (DMEM) – The basic nutritional 
requirements of epithelial cells in culture are fulfilled by DMEM (Rheinwald, 




2. HAM’s nutrient mixture F12 – Addition of HAM’s nutrient mixture F12 to DMEM 
at the ratio of 3:1 has been shown to improve epithelial cell culture (Allen-
Hoffmann and Rheinwald, 1984).  
 
3. Fetal bovine serum (FBS) – Addition of FBS is an essential requirement for 
successful epithelial cell culture (Maciag et al., 1981). It contains a mixture of 
growth factors, hormones and cytokines (some of them unknown) important 
for successful cell culture. All the attempts to eliminate it from epithelial cell 
culture, particularly limbal epithelial cultures, led to poor maintenance of stem 
cells in cultures (Kruse and Tseng, 1991).  
 
4. Hydrocortisone – Besides the presence of hydrocortisone in culture medium 
improves the growth and morphology of epithelial cells in culture (Rheinwald 
and Green, 1975), it also prevents deterioration of the 3T3 fibroblast feeder 
layer (Pera and Gorman, 1984). 
 
5. Insulin – Insulin stimulates glucose transport into cultured cells and it has an 
important role in glycogen synthesis within the cells (Hayashi et al., 1978). As 
it’s one of the most important hormonal constituents of FBS, its addition to the 
culture media has shown to reduce the FBS requirements (Hayashi et al., 
1978; Maciag et al., 1981). 
 
6. Triiodothyronine (T3) – Similarly to insulin, T3 is a hormone involved in cellular 
metabolic processes, and its addition to the culture medium also lowers the 
requirement for FBS (Hayashi et al., 1978). The addition of both insulin and T3 
together lowers the requirement of FBS in epithelial culture medium from 20% 
to 10%. 
 
7. Adenine – It was shown that addition of adenine to the culture medium 
improves the ability of epithelial cells to form colonies (Allen-Hoffmann and 
Rheinwald, 1984). 
 
8. Cholera toxin – The addition of cholera toxin to the culture medium stimulates 
DNA synthesis in cells by increasing levels of cyclic AMP (adenosine 
monophosphate) therefore promoting epithelial cell proliferation (Green, 
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1978). Importantly, its addition also opposes terminal differentiation of the 
epithelial cells (Sun and Green, 1976). 
 
9. Epidermal growth factor (EGF) – The addition of EGF has been shown to 
antagonize the differentiation of epithelial cells in culture, promoting 
undifferentiated state. It also promotes migration of growing epithelial cells 
therefore preventing crowding at the center of the colonies (Rheinwald and 
Green, 1977). 
 
2.1.4.1 Types of epithelial clones 
 
The proliferative compartment of human squamous epithelia contains three different 
types of clonogenic keratinocytes with different capacities for multiplication, named 
holoclones, meroclones and paraclones (Barrandon and Green, 1985; Barrandon 
and Green, 1987; Rochat et al., 1994; Pellegrini et al., 1999a; Pellegrini et al., 2014). 
The stem cell of all squamous epithelia is the holoclone forming cell (De Luca et al., 
2006). Meroclone and paraclone forming cells, on the other hand, have properties of 
progenitor cells also known as transient amplifying cells (Pellegrini et al., 2014). 
Holoclone forming cells have the greatest growth potential giving rise to meroclones, 
a clones of mixed composition, which further give rise to paraclones (Barrandon and 
Green, 1987). These transitions from holoclone to meroclone to paraclone are 
unidirectional and result in progressively restricted growth potential. 
In vitro holoclones give rise to large colonies with smooth circular perimeter (Figure 
2.1). Due to their greatest growth potential they can be sub-cultured for the longest 
time compared to meroclones and paraclones. When sub-cultured, holoclones give 













Figure 2.1 Phase contrast micrographs of typical holoclones showing closely 
packed, small cells that pile up around the edge of the colony. 
 
Meroclones in culture give rise to intermediate sized colonies with slightly irregular or 
wrinkled perimeter (Figure 2.2). When sub-cultured, meroclones give rise to 5-95% 










Figure 2.2 Phase contrast micrographs of typical meroclones with small cells 
around the edge of the colony and larger, flatter cells in the centre. 
 
Paraclones give rise to small colonies with highly irregular perimeter referred as 
terminal colonies due to their terminal looking appearance (Figure 2.3). Terminal 
colonies generated by paraclones cannot be effectively sub-cultured since they form 
over 95% of terminal differentiated colonies. 
The typical clonal hierarchy has also reported in limbal epithelium. Dziasko and co-
workers showed that limbal epithelial cells isolated from the limbal crypts were able to 
generate the highest proportion of holoclones while this ability was dramatically 
decreased when cells were isolated from the non-crypt-rich limbus, confirming the 













Figure 2.3 Phase contrast micrographs of typical paraclones, a small terminal-
looking colony with irregular borders.  
 
2.1.5 LSC culture techniques 
 
LSCs culture can follow either the explant or cell suspension method (Utheim et al., 
2018c). In the explant method, cells grow out from a small biopsy attached to the 
base of a culture dish or a substrate (Tsai et al., 2000; Kolli et al., 2008; Kolli et al., 
2010). In the cell suspension method cells are first enzymatically released from the 
tissue and seeded as single cells (Ahmad et al., 2007; Shortt et al., 2008). Once 
attached to the bottom of a culture dish or substrate the single cells divide, grow and 
form colonies until they merge and form a confluent layer. Some culture methods 
include so called “air-lifting” to promote differentiation of the superficial layer (Schwab 
et al., 2000; Nakamura et al., 2006).  
The use of irradiated or Mytomicin C growth arrested mouse embryonic fibroblasts 
was originally developed to enable culture of skin epidermal cells in vivo, now these 
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feeder cells are widely used for culture of all types of epithelial cells to supply 
cytokines and growth factors that promote their proliferation (Llames et al., 2015). 
Puck and Marcus reported for the first time in 1955 the use of feeder cells in cell 
culture (Puck and Marcus, 1955). Feeder layer cells usually consist of adherent 
growth-arrested, but viable and bioactive, cells. Beside feeder cells, LSC growth can 
be supported by different native and synthetic scaffolds. 
2.1.6 Scaffolds for LSC transplantation 
 
In vitro, cells are maintained in culture much more readily if they are supported by 
substrate components most closely resembling the extracellular matrix (ECM) in 
which they occurred in vivo (Kruk and Auersperg, 1994; Baharvand et al., 2005). The 
choice of culture substrate as the substitute for the in vivo niche is known to affect 
the phenotype of the cultured cells (Utheim et al., 2018c). A wide range of biological 
and synthetic materials have been identified as substrates for cultivation of limbal 
epithelial cells so far, each of them with own advantages and limitations (Nguyen et 
al., 2018). Among native scaffolds HAM is by far the best characterized. Seventy 
years after its first use in ophthalmology the HAM represents one of the major 
developments in ocular surface reconstruction (Eidet et al., 2012). Tsai et al. were 
the first to introduce the use of HAM to culture limbal epithelial cells (Tsai et al., 
2000). HAM is especially suited for clinical use thank to its effects on promoting 
epithelialization, reducing pain and decreasing inflammation (Tseng, 2001). HAM 
harbors a variety of endogenous signaling molecules (growth factors and 
cytokines)(Hao et al., 2000; Gicquel et al., 2009), most of which are associated with 
various stem cell activities, rendering HAM an excellent surface for maintaining 
stemness before, during and after grafting (Riau et al., 2010). Various culture 
techniques are used to culture LSCs on HAM which differ regarding the composition 
of HAM (with or without epithelium), air-lifting prior to transplantation and the use of 
an additional 3T3 feeder layer (Utheim et al., 2018c). Many studies have shown that 
limbal epithelial cells cultured on an intact HAM maintain a more stem cell-like 
phenotype compared to limbal epithelial cells cultivated on denuded HAM (Grueterich 
et al., 2002; Grueterich et al., 2003b; Sudha et al., 2008). The precise role of 
devitalized amniotic epithelium is not fully understood, however studies have shown 
that intact amniotic membrane (with the amniotic epithelium) exhibits higher levels of 
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growth factors compared with epithelially denuded HAM (Koizumi et al., 2000). 
Previously it was shown that self-renewal of LSCs, their migration and differentiation 
can be mimicked by ex vivo culture system on HAM where the outgrowth zone nearer 
to explant contains the highest proportion of stem/progenitor cells and as they move 
away from the explant they differentiate to acquire features typical of corneal 
epithelial cells (Kolli et al., 2008). 
2.1.7 Cultivation of LSCs under GMP conditions 
 
The therapeutic use of limbal epithelial cultures for the permanent regeneration of 
corneal epithelium in patients with LSCD has been reported in many studies. In 
accordance with GMP guidelines, strictly regulated procedures and stringent quality 
control tests are required to manipulate stem cells as "medicinal products" and make 
engraftment safer and eventually more successful. Accordingly, in order to be used 
for human transplantation, human limbal epithelial cells need to be propagated under 
GMP quality requirements in a validated GMP facility. However, the traditional culture 
media for ex vivo expansion of LSCs contains a number of ingredients derived from 
animal sources which may compromise its safety profile for human transplantation 
that ideally should be replaced with more safe alternatives (Yu et al., 2016).  
The ex vivo expansion of limbal epithelium prior to clinical transplantation is still a 
relatively new technique, and as such, optimization and constant evaluation of the 
culture medium components are required for minimizing any risk to patients (Yu et 
al., 2016). The traditional culture media for the ex vivo expansion of limbal biopsies 
on HAM used by our and other groups includes hydrocortisone, triiodothyronine, 
adenine and cholera toxin (Pellegrini et al., 1997; Tsai et al., 2000; Meller et al., 
2002; Kolli et al., 2008; Yu et al., 2016). Hydrocortisone is shown to be important for 
the maintenance of distinct epithelial colonies as well as keratinocyte proliferation 
(Rheinwald and Green, 1975). Triiodothyronine is a thyroid hormone which was 
reported to reduce the requirement for fetal calf serum in epithelial cultures to 
minimal levels (Hayashi et al., 1978). Cholera toxin (CT), a protein complex secreted 
by the bacterium Vibrio cholera, is responsible for the profuse, watery diarrhea 
characteristic of cholera infection. It has been reported that CT strongly stimulates 
colony growth from a small number of cultured human epidermal keratinocytes. The 
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effect of CT on proliferation of keratinocytes has been associated with increased 
intracellular cyclic AMP level (Okada et al., 1982), whilst the addition of adenine to 
the culture media improves the colony forming of epithelial cells (Flaxman and 
Harper, 1975; Allen-Hoffmann and Rheinwald, 1984). Their individual contribution for 
the expansion and differentiation of LSCs in this culture system was examined in 
detail by Yu, Bojic and co-workers (Yu et al., 2016).  
2.1.8 Aim of the study  
 
The aim of the study was a replacement of all research grade ingredients of 
traditional, research grade medium with GMP grade reagents wherever possible and 
consequent formulation of new GMP grade medium for cultivation and maintenance 
high percentages of LSCs in vitro. With this in mind Solu-Cortef® (hydrocortisone 
sodium succinate) was used as hydrocortisone replacement, Actrapid® (human 
insulin produced in Saccharomyces cerevisiae) as insulin replacement, Liothyronine 
(liothyronine sodium) as triiodothyronine replacement, Isoprenaline (L-isoproterenol) 
as cholera toxin replacement together with GMP grade EGF. 
 
 
2.2 Material and Methods  
2.2.1 Human donor tissue 
 
Cadaveric adult human limbal tissue was obtained from the corneo-scleral rings 
remaining (3 males and 1 female, average age 62, SEM 2.72, range from 55 - 68 
years), after removal of the central cornea for transplantation supplied by the NHS 
Blood and Transplant (NHSBT) Cornea Transplantation Service eye banks based in 
Manchester and Bristol, UK. Human amniotic membranes were provided as 
individual units of 3 x 3 cm2 mounted on nitrocellulose paper by NHSBT, Tissue 
Services. Human tissue was handled according to the tenets of the Declaration of 
Helsinki and informed consent was obtained for research use of all human tissue 
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from the next of kin of all deceased donors. The study was approved by the NRES 
Committee North East ‐ Newcastle & North Tyneside 1 (REC number: 11/NE/0236, 
protocol number 5466) on the 29th October 2013. 
2.2.2 Cell culture  
2.2.2.1 Traditional culture media and GMP grade media 
“Traditional” complete epithelial medium was prepared according to a previously 
validated composition (Kolli et al., 2010), containing low-glucose Dulbecco’s modified 
Eagle’s medium and HAM’s nutrient F12 mixture in 3:1 ratio (both Gibco, UK). This 
composition was further supplemented with FBS, penicillin/streptomycin (both Gibco, 
UK), hydrocortisone, insulin, triiodothyronine, adenine, cholera toxin and EGF (all 
Sigma-Aldrich, UK) (Table 2.1).  
Newly formulised, “GMP grade” complete medium contained DMEM and HAM's F12 
medium in the same 3:1 ratio, supplemented with human serum instead of FBS 
(SigmaAldrich, UK), penicillin/streptomycin (Gibco, UK), Solu-Cortef® as 
hydrocortisone replacement (Pharmacia Limited, UK), Actrapid® as insulin 
replacement (Novo Nordisk, Denmark), Liothyronine as triiodothyronine replacement 
(Mercury Pharmaceuticals Ltd., UK), Isoprenaline (South Devon Healthcare, UK) as 
cholera toxin replacement, adenine (Sigma-Aldrich, UK) and GMP-grade EGF 10 ng/ 
ml (Miltenyi Biotec, UK) (Table 2.1). Penicillin/streptomycin was removed from 
culture medium after the first 3 days of culture, as per our GMP protocol, in 
accordance with the Medicines and Healthcare products Regulatory Agency (MHRA). 
In addition to complete GMP grade media, four different complete media were 
prepared with replacement of just one ingredient in isolation (either Solu-Cortef®, 
Actrapid®, Liothyronine or Isoprenaline) to assess the impacts of individual 
replacements of GMP grade ingredients.  
The medium was changed on the third day and then every other day thereafter. All 
cultures were placed in a tissue culture incubator at 37°C with a humidified 





Table 2.1 Composition of traditional and GMP grade medium. 
Traditional medium GMP grade medium 
REAGENT COMPOSITION REAGENT COMPOSITION 
DMEM : F12 3:1 DMEM : F12 3:1 
FBS 10% Human serum 10% 
Pen/Strep 1% Pen/Strep* 1% 
Hydrocortisone 0.4 µg/ml Solu-Cortef® 0.4 µg/ml 
Insulin 5 µg/ml Actrapid® 5 µg/ml 
Triiodothyronine 1.4 ng/ml Liothyronine 1.4 ng/ml 
Cholera toxin 8.4 ng/ml Isoprenaline 2 mg/ml 
Adenine 24 mg/ml Adenine 24 mg/ml 
EGF 10 ng/ml GMP-grade EGF 10 ng/ ml 
 *removed from culture medium after the first three days of culture 
 
2.2.2.2 LSCs culture under GMP conditions 
 
Limbal explant culture was performed as previously described (Kolli et al., 2010). 
Briefly, the HAM was defrosted at room temperature in a class II laminar flow hood 
and washed twice with phosphate-buffered saline (PBS) (Gibco, UK) containing 1% 
penicillin/streptomycin, and once more with culture medium. After washing, HAM was 
trimmed and wrapped around a sterile 24 x 24 mm2 glass coverslip with the epithelial 
side facing up and the overhanging part being folded over the edges of the coverslip. 
The HAM and its associated coverslip were placed on the top of a second sterile 
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glass coverslip to lock the HAM in place. Finally the whole construction was placed in 
a 9.6 cm2 tissue culture well (well of a six well plate).  
Two limbal explants were prepared from each of four corneo-scleral rings, which had 
been stored in organ culture (supplied for corneal transplantation). The limbal 
explants were expanded in the GMP facility either in previously described traditional, 
non GMP grade complete medium described above (n=4) or newly formulised GMP 
grade complete medium (n=4) using HAM as a substrate. The stromal tissue and 
deeper layers of the corneo-scleral rings were dissected away together with excess 
sclera leaving a ring containing approximately 2 mm of peripheral cornea and 2 mm 
of adjacent sclera, thereby including all the corneo-scleral limbus. Each ring was then 
divided into separate 4 mm2 segments and one of each such segment was carefully 
placed at the centre of the prepared HAM with a slight pressure for a few second to 
facilitate adhesion. Complete epithelial medium were slowly added to ensure the 
explants were covered in medium without causing them to detach from the HAM 
(1.5ml of medium).  
The medium was changed on the third day and then every other day thereafter. All 
cultures were placed in a tissue culture incubator at 37°C with a humidified 
atmosphere containing 5% CO2.  
 
2.2.2.3 Measuring of explant outgrowth 
 
The expansion of each epithelial outgrowth was marked at every medium change for 









Figure 2.4 Examples of explant growth rate monitoring. (A) Macroscopic picture of 
limbal biopsy explant culture on HAM showing present outgrowth as the white ring 
pointed with red arrows (B) Every single line represents external border of a tissue 
outgrowth at the corresponding day of medium change.  
 
2.2.2.4 Division of outgrowths into three zones  
 
The cultures were terminated prior to the growth reaching the edge of the slides (at 
∼14 days), upon reaching 90% confluence. The epithelial outgrowth was divided into 
three equal zones depending on proximity to the explant (4.0 mm from the edge of 
the biopsy or the adjacent zone) as described by Kolli and co-workers (Kolli et al., 
2008): zone A indicating growth adjacent to the explant, zone B indicating 
intermediate outgrowth and zone C indicating the growth furthest away from the 
explant (Figure 2.5). At the end of the culture period, the epithelial cells from these 
zones were released and detached from the underlying HAM by 0.05% trypsin 
treatment for 10 min at 37°C. The cells from these three samples were further 
analysed for any differences in stem cell properties including colony-forming 











Figure 2.5 Schematic representation of an explant outgrowth and its different 
zones. The outgrowth zone nearest to explant contains the highest proportion of 
stem/progenitor cells (zone A) and the lowest proportion in the zone furthest from the 
explant (zone C). As cells grow and move further away from the explant they 
differentiate to acquire features typical of corneal epithelial cells (Kolli et al., 2008). 
 
2.2.2.5 Cell counting and viability 
 
20 µL of cells were transferred to a 1.5-mL clear Eppendorf tube and incubated for 3 
minutes at room temperature with an equal volume of 0.4% (w/v) trypan blue solution 
prepared in 0.81 % NaCl and 0.06 % (w/v) dibasic potassium phosphate. Cells were 
counted using a dual-chamber haemocytometer and a light microscope. Viable and 
nonviable cells were recorded and used for viability measurement. 
2.2.3 Colony forming efficiency (CFE) assay 
 
Colony-forming efficiency assay (CFE) assay is a method for determining the ability 
of the limbal epithelial progenitor cells to form colonies and assess their frequency. 
Mitotically inactivated 3T3-J2 mouse embryonic fibroblasts (Kerafast, USA) were 
suspended in complete medium containing: high-glucose DMEM (89%), FBS (10%) 
and penicillin/streptomycin (1%) and plated in a 9.6 cm2 tissue culture well at a final 
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density of 2.4×104 cells per cm2 and placed in a tissue culture incubator overnight to 
allow the establishment of a 3T3 feeder layer. The following day, 500 viable limbal 
cells from the limbal epithelial culture of interest were plated onto the prepared 3T3 
feeder cells together with 2 ml of epithelial medium. The CFE culture was then 
placed in the tissue culture incubator and the epithelial medium was changed on the 
third day and then every second day thereafter with regular microscopic examination 
(Eclipse TS100, Nikon, Japan) for the presence of LSC colonies. The CFE was 
measured on the 12th day of the culture. This was performed by removal of the 
epithelial medium followed by two brief washes with PBS. The culture was then fixed 
with 3.7% formaldehyde (VWR International, UK) in PBS for 10 minutes at room 
temperature. Next, the formaldehyde solution was removed and the culture was 
irrigated with PBS. The colonies were then stained by incubation with 1% Rhodamine 
B (Sigma-Aldrich) in methanol for 10 minutes at room temperature. Following 
staining, the colonies were counted under dissecting microscope (SMZ645, Nikon, 
Japan). The CFE was calculated using the formula: number of colonies 




Cells were prepared by cytospin using a cytocentrifuge obtained from Shandon 
Southern Instruments, Sewickley, USA, with centrifugation speed of 1000×g in order 
to provide a better cell distribution over the slides.  
2.2.4.2 Immunofluorescent staining and microscopy 
Immunocytochemistry was performed as previously described (Polak et al., 1975). In 
brief, cells were fixed with 4% paraformaldehyde, permeabilized with 0.25% Triton X-
100 (Sigma-Aldrich, UK), blocked with 5% BSA for 1 h, and incubated with primary 
antibodies including anti- ΔNp63 antibody, also known as p40 (NBP2-29467, Novus, 
USA), CK3 (08691431, MP Biomedicals, USA) and Connexin 43 (C6219, Sigma-
Aldrich, UK) in recommended dilutions overnight at 4 °C. Next day, the slides were 
washed three times with PBS for 5 min and then incubated with secondary antibody 
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conjugated with FITC for 30 min in the dark at room temperature. An isotype control 
was used as a negative control where the primary antibody was omitted. Following 
this, cells were washed and then mounted in Vectashield anti-fading media 
containing Hoechst (Vector Laboratories, UK). Images were obtained with Zeiss Axio 
Imager (Carl Zeiss Microscopy, Germany). The images were analyzed with ImageJ 
by marking and counting the immunostained cells as well as total cells separately. A 
minimum of 300 cells per treatment were counted and the percentages of 
immunostained cells was calculated. 
2.2.5 Statistical analysis  
 
For comparison of two groups Student T-test analysis was used whilst the growth 
rates were compared using one-way ANOVA analysis. Results were considered 
significant if p value was less than 0.05. 
 
2.3 Results 
Growth rate, cell number and viability, colony-forming efficiency together with 
expression of putative stem cell marker ΔNp63 and markers of corneal differentiation 
(cytokeratin 3 and Connexin 43) at the transcriptional and protein level were used to 
fully analyze the potential impacts of the newly formulized GMP media. 
2.3.1 Growth rate in limbal explant epithelial cells expanded in traditional and 
GMP grade medium 
 
Successful cultures for explant outgrowths and CFE assay were obtained using both 
non GMP and GMP grade media. 90% confluence was reached at day 13 in both 
groups. Growth rates, however, differed significantly between the groups at day 6 
(***p < 0.001) and day 13 (*p < 0.05) with limbal epithelial cultures showing earlier 
onset of cell growth and greater growth area at the end of culture for explants 





Figure 2.6 Schematic graph showing the area of explant outgrowth (mm2) on 
different days of culture for the explants cultivated in non GMP and GMP grade medium 
(n=4).  
 
2.3.2 Cell number and viability in limbal explant epithelial cells expanded in 
traditional and GMP grade medium 
 
Cell number in zone A was not significantly different whilst cell numbers in zones B 
and in zone C were significantly higher in the explants cultivated in non GMP grade 





































Figure 2.7 Cell numbers per zone of outgrowths cultivated in non GMP and GMP 
grade medium. Data are presented as mean ± SEM, * p < 0.05, ** p < 0.01. 
 
 
Figure 2.8 Cell viability per zone of outgrowths cultivated in non GMP and GMP 
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Cell viability did not differ over different zones between traditional and newly formulized 
GMP grade medium (Figure 2.8). 
2.3.3 Morphology of colonies derived by cells expanded in traditional and GMP 
grade medium 
 
Cells cultivated in the GMP grade medium formed colonies with more differentiated 
appearance compared with cells cultivated in the non GMP grade medium (Figure 










Figure 2.9 Appearance of colonies per zone of outgrowths cultivated in different 







2.3.4 CFE assay in limbal explant epithelial cells expanded in traditional and 
GMP grade medium 
 
Analysis of CFE didn't reveal any significant difference between the zones of 
outgrowths cultivated in non GMP and GMP grade medium (Figure 2.10) (Yu et al., 
2016). 
 
Figure 2.10 The colony forming efficiency of cells from different zones of 
outgrowths cultivated in non GMP or GMP grade medium. Data are presented as 
mean ± SEM. 
 
2.3.5 Expression of stem cell related and differentiation markers in limbal 
explant epithelial cells expanded in traditional and GMP grade medium 
 
The percentage of ΔNp63 positive cells (Figure 2.11A) didn't reveal any significant 
difference between the zones of outgrowths cultivated in non GMP and GMP grade 
medium (Yu et al., 2016). 
The percentage of cytokeratin 3 (Figure 2.11B) and Connexin 43 positive cells 
(Figure 2.11C) was significantly higher in zone A suggesting the presence of more 
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Figure 2.11 Expression of putative LSC and epithelial cell markers in non GMP 
and GMP grade media assessed by immunofluorescent microscopy. (A) 
Expression of ΔNp63 using the ΔNp63 antibody; (B) Expression of CK3; (C) 










2.3.6 Growth rate, CFE and expression of putative LSC and corneal epithelial 
cell markers in limbal explant epithelial cells expanded in different media 
 
In order to assess the impacts of individual replacements of GMP grade ingredients, 
four additional complete media were prepared with replacement of just one ingredient 
in isolation (either Solu-Cortef®, Actrapid®, Liothyronine or Isoprenaline). Successful 
cultures for explant outgrowths and CFE assay were obtained in all different media 
formulations (Figure 2.12) (Yu et al., 2016). Distribution of LSCs in non GMP 
medium followed a characteristic pattern, previously demonstrated by our group, with 
the highest percentage of progenitors in zone nearest to the explant (zone A) with 
successive decline in zones B and C which are situated further away from the 
explant, whilst distribution of progenitors in GMP grade medium did not follow this 
pattern (Figure 2.13A) (Yu et al., 2016). Unusually, the percentage of progenitor 
cells in different zones of explants cultured in GMP grade media was the highest in 
zone C. Analysis of every substituted component in isolation (Figure 2.13A-D) 
showed that Liothyronine may be responsible for the altered distribution of progenitor 
cells in zones A to C as the similar “inverted” pattern with the highest percentages of 
progenitor cells in the zone C furthest from the explant was only seen in explant 
cultures with addition of Liothyronine in isolation (Figure 2.13B) (Yu et al., 2016). 
Cultivation of explants in the presence of Liothyronine also led to different CFE per 
zone, where cells from zone C showed the highest CFE (Figure 2.13A) which is 
concordant with finding of the highest number of ΔNp63 positive cells in zone C using 
the same medium. Moreover, cells in zone A of the explants cultivated in 
Liothyronine medium showed higher expression of CK3 but not Connexin 43 
compared to zones B and C (Figure 2.13C-D) (Yu et al., 2016). Due to lack of HAM 
we were unable to repeat experiments with four additional media with replacement of 
only one ingredient in isolation (n=1) and no statistics has been done to further 






Figure 2.12 Schematic graph showing the area of explant outgrowth (mm2) on 
different days of culture for the explants cultivated in non GMP grade medium, GMP 
grade medium, medium with replacement of Liothyronine in isolation, medium with 
replacement of Solu-Cortef® in isolation, medium with replacement of Isoprenaline in 


















































































Figure 2.13 The colony forming efficiencies and expression of putative LSC and 
corneal epithelial cell markers of outgrowths cultivated in non GMP grade 
medium, GMP grade medium, medium with replacement of Liothyronine in 
isolation, medium with replacement of Solu-Cortef® in isolation, medium with 
replacement of Isoprenaline in isolation and medium with replacement of 
Actrapid® in isolation. (A) The colony forming efficiencies per zone of outgrowths 
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cultivated in different media; (B) Expression of ΔNp63 per zone of outgrowths 
cultivated in different media; (C) Expression of CK3 per zone of outgrowths cultivated 
in different media and (D) Expression of Connexin 43 per zone of outgrowths cultivated 
in different media (n=1). 
 
2.4 Discussion  
Limbal epithelial transplantation is a cell-based therapy with the goal to restore the 
limbal microenvironment enabling the cornea to regain a corneal epithelial 
phenotype. Since its introduction in 1997 by Pellegrini and coworkers the ex vivo 
expanded LSC transplantation has been successfully used to treat patients with 
LSCD. While it has numerous advantages, the ex vivo LSC culture protocol does 
introduce some risks related to the culture processing methods. This includes 
potential contamination with known and unknown infectious agents introduced by the 
use of human or animal tissue as well as the risk of immunogenic reactions. 
Moreover, GMP compliant cell production, careful and strict operative techniques and 
product traceability are further key elements that need to be considered when 
determining the safety of a stem cell and any other cell therapy. 
Although many of the published cell culture protocols depend on the support of a 3T3 
mouse cell feeder layer to nurture the graft there is still a risk of exposure to animal 
material during the culture period despite their inactivation. Therefore the use of 3T3 
cells carries a risk in terms of microchimerism, graft rejection or infection with viral or 
prion agents (Schwab et al., 2006; Lei et al., 2007; Llames et al., 2015). However, up 
to date such events have not been reported. Cells cultured under xeno-contaminated 
conditions can present a nonhuman sialic acid which has been reported as 
immunogenic to humans (Martin et al., 2005; Heiskanen et al., 2007). For all these 
reasons in our study we used HAM as a substrate for LSC cultivation, which acts as 
a surrogate environmental stem cell niche (Grueterich et al., 2003a). HAM is the 
innermost layer of the placenta that has been extensively used in a treatment of 
ocular surface pathologies (Rahman et al., 2009). The HAM exhibits several 
properties that make it suitable for use in tissue engineering (Niknejad et al., 2008). 
The membrane has an immunomodulatory effect which explains why tissue rejection 
is not observed after its clinical use (Ueta et al., 2002). Furthermore, cells in the 
epithelial layer of HAM have significant similarities to stem cells: expression of 
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pluripotent markers, ability to differentiate into all three germ layers and no need for 
feeder layer throughout their cultivation (Niknejad et al., 2008). Its low 
immunogenicity together with anti-tumorigenic, anti-fibrotic, anti-inflammatory, anti-
microbial, anti-scaring and useful mechanical properties make HAM suitable for use 
in tissue engineering (Niknejad et al., 2008). Despite many advantages, its clinical 
use also carries theoretical risk of disease transmission therefore in Western 
countries strict legislation stipulates HIV, hepatitis B and C and HTLV tests on donor 
serum at the time of procuring the HAM (Rahman et al., 2009). 
Adenine, hydrocortisone, triiodothyronine and cholera toxin have been traditionally 
used in the skin and limbal epithelial explant cultures and shown to promote the 
growth and morphology of keratinocytes (Rheinwald and Green, 1975), the colony-
forming ability of epithelial cells (Allen-Hoffmann and Rheinwald, 1984), proliferation 
of epithelial cells and the requirement for large amounts of fetal calf serum in the 
media (Allen-Hoffmann and Rheinwald, 1984) (Kolli et al., 2010). Limbal epithelial 
explants could grow in media lacking any of these four components; however 
triiodothyronine stood out for its impacts on cell survival and adenine for increased 
explant surface area (Yu et al., 2016). Our previous work has shown that self-
renewal of LSCs, their migration and differentiation can be mimicked by our ex vivo 
culture system where the outgrowth zone nearer to explant contains the highest 
proportion of progenitor cells and as they move away from the explant they 
differentiate to acquire features typical of corneal epithelial cells (Kolli et al., 2008). In 
accordance with this, removal of each of the four components reduced the self-
renewal of LSCs in the outgrowth nearest to the explant (Yu et al., 2016). 
Furthermore, the removal of adenine also led to increased percentage of 
differentiated cells in the zone closest to the explant as well as increased cell size 
showing that all four components are currently indispensable for the successful ex 
vivo expansion of limbal epithelial explants on HAM and for maintaining the highest 
number of proliferating LSCs. The balance between self-renewal and differentiation 
of LSCs is tightly regulated in vivo with LSCs moving centripetally towards the center 
of the cornea and differentiating to give rise to the corneal epithelial cells which are 
replaced approximately every 14 days (Thoft and Friend, 1983). At the same time, 
the limbal stem cell niche maintains the self-renewal of LSCs through uneven 
distribution of cell fate determinants across the corneal epithelium. ΔNp63a and 
C/EBPδ have been shown in asymmetric cell division and early cell fate decision of 
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human limbal stem cells (Mort et al., 2012). Increasing evidence supports the theory 
that p63 promotes the maintenance of LSCs and also is a determinant of their 
proliferative potential. Pellegrini et al. has reported that the number of p63 bright cells 
is an important prospective measure of determining the clinical success of LSC 
transplantation (Pellegrini et al., 2011). LSC culture system on HAM results in 
generation of a high percentage of p63 positive cells, namely: 78.1% in zone A, 
67.8% in zone B and 49.4% in zone C; however the number of p63 positive cells 
significantly decreased to nearly half of that from standard medium when treated with 
media lacking any one of the four components tested in this study, thus suggesting 
that removal of each of these four components may pose a risk for clinical 
translations (Yu et al., 2016). 
Therapeutic use of LSCs must be performed in compliance with Good Manufacturing 
Practice as a quality assurance system to ensure highest quality and safety of cell 
product for transplantation in accordance with the European Union, Regulation (EC) 
No 1394/ 2007 of the European Parliament and of the Council, on Advanced Therapy 
Medicinal Products. As part of our study, we aimed at replacing all ingredients that 
were not produced according to GMP guidelines with GMP grade products. This is a 
rather important safety aspect as it has been shown that animal-derived components 
can cause severe immunologic reactions and potential transmission of 
microorganisms (Erickson et al., 1991; Selvaggi et al., 1997; Chachques et al., 2004; 
Schwab et al., 2006). We chose widely used clinical grade products Solu-Cortef®, 
Actrapid®, Liothyronine or Isoprenaline to replace non GMP grade ingredients. 
Isoprenaline, β-adrenergic agonist, is commonly used for the treatment of 
bradycardia and is known to increase intracellular calcium concentration of bovine 
corneal epithelial cells by inducing stimulation of cyclic AMP and thus it represents a 
safe alternative to cholera toxin for LSC cultivation (Reinach et al., 1992; Akhtar and 
Choi, 1994). CT and L-isoproterenol are largely used to enhance cell proliferation 
(Ghoubay-Benallaoua et al., 2012). It was particularly important to replace cholera 
toxin since this is obtained from bacteria cultured on bovine brain broth and fetal calf 
serum. While no data have been published for Solu-Cortef® and Liothyronine, 
Actrapid® and Isoprenaline were previously used for LSC cultivation with success 
(Ghoubay-Benallaoua et al., 2012). These previous data indicated that isoprenaline-
supplemented medium (2 mg/ml) is more efficient than cholera toxin for enhancing 
cell growth and decreasing cell size in two-week cultures (Ghoubay-Benallaoua et 
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al., 2012). In accordance with this, we observed a slightly faster growth rate of 
explants in the GMP culture media and a larger growth area at the end of culture 
period. Although CFE per zone did not differ significantly between the groups, the 
morphology of colonies was different. Cells cultivated in the GMP grade medium 
formed colonies with more differentiated appearance compared with cells cultivated 
in the non GMP grade medium. While the percentage of progenitor cells per zone did 
not differ between groups, distribution of progenitor cells per zone compared with 
explants cultivated in non GMP grade medium was unexpectedly altered. 
Furthermore, it seems that cultivation in GMP grade medium promoted differentiation 
of cells in the zone nearest to the explant. Analysis of every substituted component in 
isolation showed that Liothyronine may be responsible for the altered distribution of 
progenitor cells in zones A to C and for promoting the differentiation of progenitor 
cells in zone A. Notwithstanding these differences, LSCs expanded in LSC media 
with GMP grade reagents have not been tested in vivo. With this in mind, it would be 
useful to test their potential to engraft and reverse LSCD in animal model settings (for 
example rabbit) to investigate whether the molecular differences we have observed 




Replacement of each of the research grade LSC media components with GMP grade 
reagents resulted in equal growth to non-GMP grade media; however an enhanced 
differentiation of progenitor cells in the outgrowth situated closest to the explant was 
observed, suggesting that additional combinations of GMP grade reagents need to 
be tested to achieve similar or better level of LSC maintenance in the same manner 
as the traditional LSC media. The research strategy of better refining the current 
stocks of materials and their possible replacement with GMP grade components 
provides a pathway that may be beneficial to other medicinal advanced cell therapy 
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Chapter 3. Transport  
 
3.1 Introduction 
Since 1997, when Pellegrini and colleagues first demonstrated transplantation of in 
vitro expanded limbal epithelium for treatment of LSCD from a small biopsy taken 
from the patient’s contralateral healthy eye (Pellegrini et al., 1997), transplantation of 
cultured limbal epithelial sheets has become the most successful alternative to 
corneal surface reconstruction in patients with unilateral LSCD (Burman and 
Sangwan, 2008). So far, more than 1000 transplantations have been performed 
worldwide (Utheim et al., 2018a) with approximately 75% overall success rate 
(Utheim, 2013). In patients with LSCD, stem cell graft is required to replenish LSC 
reservoir, which is ultimately responsible for regeneration of the corneal epithelium. 
Current treatment options utilize limbal tissue biopsies that harbour LSCs as well as 
tissue culture expanded cells. The tissue is usually placed on a scaffold that supports 
the formation of so called “limbal epithelial cell sheets” which are then transferred 
and transplanted to diseased eye. A numerous biological and synthetic materials 
have been reported as carrier substrates for LSCs, some of which have been used in 
the clinic, including HAM, fibrin and silicone hydrogel contact lenses (Nguyen et al., 
2018). 
Although a variety of expansion protocols for LSC culture showed good clinical 
outcomes, LSC-based therapy still faces challenges regarding tissue safety and 
sterility, tissue transportation, surgery logistics and availability of cultured tissue 
(Raeder et al., 2007). As the European Union classified stem cell-based therapies as 
“medicinal products”, their manipulation is strictly regulated and has to follow defined 
conditions of good manufacturing practice. The production of stem cell therapeutics 
is therefore limited exclusively to accredited production sites authorized by the 
national regulatory agencies (Di Iorio et al., 2010; Massie et al., 2014). The strict 
production requirements represent a barrier to a widespread use of stem cell-based 
therapies, despite the fact that demand is anticipated to increase due to successful 
clinical outcomes. For this reason, the need for safe, validated and reproducible 
techniques for ex vivo cultured tissue distribution and preservation are coming to the 
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forefront of research. Numerous new challenges for bio-banking industry such as 
retention of viability, sterility issues and good functionality of stem cells in the end 
product are still waiting to be fully scientifically addressed.  
The cell-processing centre (CPC) is a clean room that serves as an essential area for 
aseptic culturing or processing of human cells for regenerative medicine (Oie et al., 
2014). Although many hospitals require tissue-engineered epithelial cell sheets for 
treatment, due to the high expense of a CPC, many hospitals need to share one CPC 
to standardize and spread regenerative therapy. Development of an efficient cell 
transportation technique is therefore vital for bridging many hospitals and CPCs 
(Figure 3.1).  
 
 
Figure 3.1 Simplified scheme of multi-centre study organisation. Limbal tissue 
biopsy and transplantation of cultured LECs on HAM are performed in a hospital, 
explant culture of limbal biopsies and preparation of limbal epithelial cell sheets in a 
CPC.  
 
Connecting cell laboratories and eye banks is likely to increase the availability of 
regenerative medicine (Utheim, 2013). Growing interest in cultured limbal epithelial 
cells (LECs) is evident from the literature (Schwab et al., 2000; Rama et al., 2001; 
Kito et al., 2005; Oh et al., 2007; Raeder et al., 2007; Utheim et al., 2007; Yeh et al., 
91 
 
2008; Utheim et al., 2009; Raeder et al., 2010; Rama et al., 2010; Utheim et al., 
2015; Jackson et al., 2016; Utheim et al., 2018a). In a review on LSC therapy, 
Ahmad et al. suggested that the production of cultured limbal epithelial sheets for 
transplantation should be centralized for the following reasons: (a) strict regulatory 
demands make this kind of laboratories extremely costly and (b) requirement of 
expertise in culturing limbal tissue is of vital importance (Ahmad et al., 2010). Due to 
the strict regulations of cell therapy, the number of small units producing tissue for 
clinical use will decrease (Daniels et al., 2006b), therefore forcing centralization and 
forming of larger centres, which necessitate effective transportation strategies 
(Ahmad et al., 2010).  
Due to the limited insights into the LSC-based product’s safety and stability after 
preservation, most of the clinical studies on LSC transplantation reported so far used 
non-preserved terminal products (fresh cultured LSC epithelial grafts on a carrier 
scaffold) applied directly to LSCD patients (Grueterich et al., 2003a; Ti et al., 2004). 
Without a reliable method of limbal epithelial sheets storage challenges regarding 
sterility, transportation, surgery logistic and availability of tissue cannot be overcome.  
It is mandatory that the final products recovered from storage are physiologically and 
biochemically identical to its pre-preservation state, retaining high viability, good 
functionality and tissue morphology (Massie et al., 2014). For example, retention of 
undifferentiated cell phenotype in cultured and stored cultured epidermal cell sheets 
is important for the treatment of patients with burns (De Luca et al., 2006). Moreover, 
retention of a high percentage of progenitor cells within transplanted cultured limbal 
epithelial sheets in the treatment of LSCD results in a higher rate of clinical success 
(Rama et al., 2010).  
However, the current preservation methods still leave open fundamental questions 
regarding the optimal storage temperature and storage media formulations (short or 
long term) not only for single LSC suspensions but also for the final products 
(cultured epithelial sheets on different scaffolds). Thus, storage methods and 
preservation techniques for LSC delivery have recently been under investigation at 
an accelerated rate (Luznik et al., 2016a). 
To address these problems, Utheim et al. developed a method for short-term storage 
of cultured LSCs improving surgery logistics and enabling transportation and 
microbiological assessment using a closed container (Raeder et al., 2007) whilst Oie 
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et al. designed a transport container for cell sheets with three basic functions: 
maintaining a constant interior temperature, air pressure and sterility (Oie et al., 
2014). Raeder et al. reported that organ culture storage of cultured human LECs in a 
closed container for 1 week at ambient temperature is superior to both organ culture 
storage at 31°C and Optisol-GS storage at 5°C (Raeder et al., 2007). Oie et al. 
suggested that during 24 hour long transportation via an airplane, the temperature 
inside the container should be maintained above 32°C. They tested four kinds of 
transportation liquids (keratinocyte culture medium - KCM, KCM minus FBS and 
EGF, DMEM/F12 in 3:1 ration and HBSS) and concluded that HBSS was the best 
choice of transportation media (Oie et al., 2014). 
Appropriate tissue storage methods (both short and long term) would allow cultured 
tissue transportation from centralized laboratories to the operating theatre as well as 
between eye banks, offering the logistic flexibility in scheduling transplantation 
surgery (Raeder et al., 2007). As cell cultures may fail at any time during cultivation, 
the planning of surgery becomes cumbersome without efficient storage technology 
(Utheim, 2013). 
Importantly, tissue storage would increase the time for quality control of LEC cultures 
(microbiological testing, stem cell identification etc.) (Jackson et al., 2014). Daniels 
and colleagues proposed that control measures should be employed, whenever 
possible, to determine the quality of the final cell product (Daniels et al., 2006b). 
Microbial analyses of LECs cultures are mandatory part of the quality control 
measures conducted before these cells are applied to treat patients with LSDC. 
Bacterial infection of LEC cultures may be avoided by using a hermetically sealed 
container for storage prior to clinical use (Utheim et al., 2009). Long term corneal 
epithelium renewal after ex vivo cultured limbal epithelial transplantation depends 
mainly on the sufficient number of LSCs transferred in the cultured epithelial sheets 
(Rama et al., 2001). To date, transcriptional factor ΔNp63α is the commonly used 
putative marker for determination of percentage of stem cells in limbal epithelial 
cultures, as a positive clinical correlation was already reported between ΔNp63α 
expression and clinical success rate (Pellegrini et al., 1999a; Di Iorio et al., 2010). 
Pellegrini et al. suggested that stringent quality criteria should be adopted for LEC 
cultures to ensure that they contain a sufficient number of stem cells vital for long 
term epithelial survival (Pellegrini et al., 2011). Quality control should include rigorous 
clonal analysis or the evaluation of cell doublings generated during serial cultivation 
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of LECs (Pellegrini et al., 2011). Another important measure for ensuring quality of 
cultivated cells is regulating levels of contaminating fibroblasts in LEC cultures. Di Iori 
and colleagues evaluated the percentage of contamination of murine fibroblasts in 
cultured LECs and estimated that >5% contamination was unsuitable for clinical use 
(Di Iorio et al., 2010). Proulx et al. emphasized the importance of viability assessment 
of LECs prior to clinical use (Di Iorio et al., 2010) while other authors highlighted the 
need for standardization and validation of LEC cultures for clinical use (Higa and 
Shimazaki, 2008; Hayashi et al., 2010).  
Additionally to short-term preservation, efficient long-term cryopreservation of surplus 
cultured tissue could enable consecutive surgeries in case of unsuccessful primary 
treatment (Mohamed-Noriega et al., 2011).  
For all these reasons accredited centres for LSC culture are challenged to further 
develop efficient, standardized and validated transport and preservation methods. 
 
3.1.1 Current preservation strategies in different stages of the production 
process of bio-engineered limbal epithelial sheets  
 
Current preservation methods fall into two main categories: preservation of LSCs 
before in vitro limbal tissue generation (e.g. preservation of donor corneas, 
cryopreservation of suspended amplified LSCs after several passages) or 
preservation of limbal bio-engineered sheets on different scaffolds.  
3.1.1.1 Preservation of donor corneas and single LSCs 
Most of the tissue used for penetrating keratoplasty is issued through eye banks that 
store the corneo-scleral button either in organ culture at 31-37ºC introduced in 1976 
or in hypothermic storage at 2-6ºC introduced in 1974 (Pels et al., 2008).  
The two preservation techniques differ in technical aspects, tissue evaluation 
methods, storage time and microbial safety. Hypothermic storage is a simple 
technique that allow storage for up to 7-10 days whilst organ culture is a relatively 
complicated technique but allow storage for longer period of time, up to 4 weeks. 
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Both preservation techniques seem to result in similar graft survival. Organ culture, 
although it originates from United States (Doughman et al., 1976; Doughman, 1980), 
is now widely applied only in Western Europe but not commonly used elsewhere 
(Pels et al., 2008).  
A longer storage time permits a greater flexibility in the use of donor tissue and 
prevents wastage. Currently, only cryopreservation methods offer truly long-term 
storage of living cells and tissues (Woods et al., 2004; Armitage, 2009). Long-term 
preservation is especially important for preventing the loss of outdated material 
(Corydon et al., 2009), particularly in countries where shortage of donor corneas 
exists. However, bio-banking of donor corneas by cryopreservation is technically 
challenging and still in experimental phase. It’s been shown that only corneas 
obtained immediately after death from young donors were suitable for 
cryopreservation (Corydon et al., 2009) as freezing led to damage of the corneal 
endothelial cells (Armitage, 2009). On the other hand, cryopreserved whole donor 
corneas could be potential source of LSCs (Mohamed-Noriega et al., 2011). 
Bratanov and colleagues successfully cultured limbal explants from cryopreserved 
corneas (Bratanov et al., 2009). Albeit the limbal tissue was subjected to long lasting 
storage in liquid nitrogen, it enabled proliferation of epithelial cells with phenotypically 
identified LSCs (p63 positive cells) present in culture. However, no further functional 
test for LSCs identification was performed and a different growing pattern of 
expanded cells from the cryopreserved limbal explants was reported, most likely due 
to destabilization of the extracellular matrix during freezing-thawing procedures 
(Bratanov et al., 2009). 
Another possible strategy of long-term LSCs preservation is cryopreservation after in 
vitro expansion. Several studies reported cryopreservation of the suspension LSC 
culture (Corradini et al., 2012; Pellegrini et al., 2014). Schrader and colleagues 
reported that conjunctival epithelial cells could be efficiently cryopreserved with 
successful maintenance of progenitor cell-like characteristics and function in vitro 
over several culture passages (Schrader et al., 2009). Importantly, cryopreservation 
of suspended LSCs after in vitro expansion showed a non-immunogenic nature of 
defrosted limbal cells (Vasania et al., 2011). After thawing, human LSC cultures 
retained the expression of LSC markers but no HLA-DR gene expression was 
observed (Vasania et al., 2011). Moreover, cultured LSCs were also unable to 
stimulate allogenic T cell proliferation in vitro, even in the presence of pro-
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inflammatory cytokines (Vasania et al., 2011). Thus, cryopreserved LSC cultures 
could express negative immunoregulatory molecules, which may be critical for their 
survival in an allogenic environment and would enable better allograft survival 
(Vasania et al., 2011). 
However, the exact cryopreservation details are often not explicitly reported in clinical 
case publications and further evaluation of the impact of freezing/thawing procedures 
is often missing (Luznik et al., 2016a). Therefore, further experimental studies are 
needed to elucidate this important issue.  
So far, only one experimental study reported successful reconstruction of corneal 
epithelium using cultured epithelial grafts generated from long-term cryopreserved 
LSCs in a goat model of LSCD (Mi et al., 2008). However, it is yet not proven how 
stable these limbal epithelial sheets will be over time.  
 
 
3.1.1.2 Preservation of bio-engineered limbal epithelial sheets on different 
scaffolds 
 
Optimal physiological approach to preserve cultured limbal epithelial sheets at the 
genomic, proteomic, structural and functional levels is still under active investigation. 
Before widespread clinical use there are several issues to be solved regarding the 
optimal preservation temperature and storage media composition.  
Recent studies were focusing on the optimal temperature for efficient preservation of 
limbal epithelial cell sheets (Jackson et al., 2014; Eidet et al., 2015; Jackson et al., 
2016; Jackson et al., 2017). 
Utheim and colleagues first reported a method for short-term storage of cultured 
corneal sheets (Raeder et al., 2007; Utheim et al., 2007). They showed successful 
maintenance of the original multi-layered structure and undifferentiated phenotype 
after 1 week in organ culture at 23ºC of limbal epithelial sheets obtained from explant 
culture on intact HAM (Raeder et al., 2007; Utheim et al., 2007). Raeder et al. 
showed morphological corneal epithelial changes such as epithelial detaching and 
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intracellular vacuoles after 1 week of organ culture preservation of cultured corneal 
epithelium at 31ºC. On the other side, hypothermic storage of corneas at 5ºC in 
Optisol-GS also showed separation of cells below the superficial epithelial layer and 
pronounced intracellular oedema (Raeder et al., 2007). Taken together, their data 
indicated that storage of cultured limbal epithelial cells on HAM at ambient 
temperature is superior to organ culture storage at 31ºC and Optisol-GS storage at 
5ºC, with minimal apoptosis after storage (Raeder et al., 2007; Utheim et al., 2007). 
Later studies from the same research group showed successful storage of cultured 
human conjunctival epithelial sheets on HAM for at least 4 days under serum free 
conditions (Eidet et al., 2012).  
For long-term preservation of the end cell product, as previously mentioned, the only 
effective method is cryopreservation. However, cryopreservation of adherent fully 
stratified ocular epithelium has been shown more challenging compared to 
cryopreservation of suspended cells. Up to date, there is no consensus regarding the 
functional and morphological outcomes after cryopreservation of cultured limbal 
epithelial sheets based on previous in vitro studies (Luznik et al., 2016a).  
Kito et al. reported that rabbit limbal epithelial cells stored at a lower storage 
temperature (-196ºC) showed an improved survival compared with samples stored at 
a higher temperature (-80ºC) (Kito et al., 2005). Although the structural integrity of the 
cultured limbal epithelial sheets was destroyed in all tested cryopreservation 
protocols, cell viability was reported to be up to 70% and the remained cells were 
able to regenerate a new cell sheet (Kito et al., 2005). Yeh and colleagues reported 
successful 8 weeks long cryopreservation of limbal explant cultures expanded on 
HAM (Yeh et al., 2008). Using their method, cell viability was reported to be around 
50% and good growth ability of remained cells was proven (Yeh et al., 2008). Oh and 
colleagues cryopreserved human limbal and rabbit conjunctival cultured epithelial 






3.1.2 Aims of the study 
 
As strict regulations for cell therapy promote centralization of culture units (Daniels et 
al., 2006b), the treatment remains limited to a few centres of expertise (Utheim et al., 
2015). For this reason, definition of reliable and practical transportation strategies is 
vitally important. This study aims to optimize a transport conditions of the starting 
material (limbal biopsies - LBs) as well as the conditions of transport and storage of 
the final cell product (cultured LECs on HAM - limbal epithelial sheets), which have 
not been precisely define yet, for their widespread distribution and use in 
regenerative medicine. 
To access the best transport conditions for the starting material, short (30 minutes) and 
prolonged (24 hours) transport at both room temperature (RT) and 4°C will be 
compared, whilst the best transport and storage conditions of the final cell product will 
be accessed by comparison of 24h transport in culture media and prolonged 4 days 
and 7 days transport in serum-free storage media. The best transport conditions will 
be defined by comparison of explants growth rates, morphology, phenotype, and 
viability of cultured human LECs (Figure 3.2). 
 
 
Figure 3.2 Experimental design. 
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3.2 Material and Methods 
3.2.1 Human donor tissue 
 
Cadaveric adult human limbal tissue was obtained from the corneo-scleral rings 
remaining (2 males and 1 female, average age 62, SEM 3.84, range from 55 - 68 
years), after removal of the central cornea for transplantation supplied by the NHS 
Blood and Transplant (NHSBT) Cornea Transplantation Service eye banks based in 
Manchester and Bristol, UK. Human amniotic membranes were provided as 
individual units of 3 x 3 cm2 mounted on nitrocellulose paper by NHSBT, Tissue 
Services. Human tissue was handled according to the tenets of the Declaration of 
Helsinki and informed consent was obtained for research use of all human tissue 
from the next of kin of all deceased donors, with approval from the local Research 
Ethics Committee. The study was approved by the NRES Committee North East ‐ 
Newcastle & North Tyneside 1 (REC number: 11/NE/0236, protocol number 5466) on 
the 29th October 2013. 
3.2.2 Transport of the starting material: limbal biopsies’ transport simulation 
 
Having in mind that actual LBs represent a very precious tissue taken only in very 
special cases (such as a need for limbal epithelial cell transplantation) we used 4 
mm2 segments of cadaveric corneo-scleral tissue as their alternative (tissue from 
three different donors, n=3). Segments of cadaveric corneo-scleral tissue were 
prepared as previously described in Chapter 2. Four different transport conditions 
were compared: the first segment of each corneo-scleral ring was kept in a traditional 
LSC culture medium filled tube for 30 minutes at RT, the second segment of each 
ring for 30 minutes at 4ºC, third segment for 24 hours at RT and finally fourth 
segment of each ring for 24 hours at 4ºC. After transport simulation all the segments 
were cultivated on HAMs as described in Chapter 2 (using “LSC explant culture”) 
until they’ve reached 90% confluence. The epithelial outgrowths were then divided 
into three equal zones depending on proximity to the explant (A, B and C zone) as 
previously described and used for further analyses. 
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3.2.3 Transport of the final cell product: limbal epithelial sheets’ transport 
simulation 
 
Following LSC explant culture four different dishes containing a cultured limbal 
epithelial cell sheet at 90% confluence from each of three donors were randomly 
selected for transport and storage simulation (three LSC explant cultures from each 
donor) or used as a non-stored control (one LSC explant culture from each donor). 
All experimental groups contained identically cultivated cell sheets at the start of 
storage. Control cultured limbal epithelial sheets from each of three donors were 
processed immediately after reaching 90% confluence while the rest of cultured 
limbal epithelial sheets were stored in dishes sealed by parafilm for 24 hours, 4 days 
and 7 days at 23ºC. 
Cultured LECs on HAM were shaken at 200 orbital rotations per minute (rpm) on 
Titramax 100 (Heidolph Instruments, Germany), multi-purpose mixer shaker, for 2 
hours before they were stored for 24 hours, 4 and 7 days in order to expose the 
tissue to transport simulation.  
Limbal epithelial sheets were stored in either traditional LSC culture medium (for the 
simulation of short 24 hour transport) or in serum-free storage medium (for long term 
4 and 7 days transport simulation).  
3.2.4 Tissue analysis after transport simulations  
 
All other techniques including monitoring of explant outgrowth, cell counting and 
viability, CFE and immunofluorescent staining of putative stem cell marker ΔNp63 
and markers of corneal differentiation CK3 and Connexin 43 are described in details 
in Chapter 2. 
3.2.5 Statistical analysis 
 
Data are presented as mean ± SEM. All experiments were performed in biological 
replicates of three or more. To access the difference between the groups, one-way 
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analysis of variance (ANOVA) were performed. A significance level of p < 0.05 was 
used throughout the study. GraphPadPrism 7.0 (San Diego, CA, 





3.3.1 Limbal explant growth rate, cell number, viability and CFE after LBs 
transport simulation  
 
Successful explant cultures were obtained after all four LBs transport condition 
simulations (Figure 3.3). A trend of earlier onset of cell growth, faster growth 
throughout the culture and earlier confluence reach were observed in RT groups 
compared to 4ºC groups in all three donors. No difference in growth rates between 
short 30 min and prolonged 24h transport was present at RT. On the other hand, 
there was a visible difference in growth rates between short and prolonged LBs 
transport at 4ºC across all three donors, with 24h transport at 4ºC showing the latest 











Figure 3.3 Limbal epithelial cell growth across different LBs transport condition 
groups. Schematic graphs are showing the area of explant outgrowth (mm2) on 





Figure 3.4 Number of cells and cell viability per zone of limbal outgrowths after 
limbal biopsies transport simulation. Data are presented as mean ± SEM, ** p < 
0.01, *** p < 0.001 (n=3).  
 
In terms of cell number per zone, no significant differences were found with the 
exception of zone C which contained higher number of cells in RT groups compared 
to 4°C groups (Figure 3.4). This difference was significant between 30min RT and 
both 30min 4°C and 24h 4°C groups (p<0.01 and p<0.001 respectively). A similar 
trend was observed in 24h RT compared to both 4°C transport groups but without 
any significance found (p>0.05).  
Cell viability was well preserved and there were no significant differences between 
the groups in any of the zones (Figure 3.4).  
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CFE was significantly higher in zone B and zone C of limbal outgrowths grown from 
LBs transported over 30min at RT compared to LBs transported over 24h at 4°C 
(p<0.05). An overall trend of higher CFEs in RT compared to 4°C groups was 
present. No differences were found between short and prolonged transport between 





Figure 3.5 Colony forming efficiencies per zone of limbal outgrowths after limbal 




3.3.2 Limbal epithelial cell marker expression after LBs transport simulation  
 
Expression of putative limbal stem cell marker ΔNp63 in zone A of explant 
outgrowths is significantly higher in both 30min and 24h RT groups compared to 24h 
4°C group (p<0.01 and p<0.05 respectively). 24h RT group show also significantly 
higher expression of ΔNp63 in zone A compared to 24h 4°C transport group (Figure 
3.6).  
In terms of ΔNp63 expression in zones C and B, similar pattern of differences 
between the groups was observed. Prolonged 24h transport on 4°C showed 
significantly lower expression of ΔNp63 compared to 30min RT, 24h RT and 30 min 
4°C groups (p<0.05 in all three cases in zone B; p<0.001; p<0.001 and p<0.05 in 











Figure 3.6 Expression of putative limbal stem cell marker ΔNp63 per zone of 
limbal outgrowths after limbal biopsies transport simulation. Data are presented 




Differentiation marker CK3 differs significantly between the groups across all the 
zones (Figure 3.7), while there were no significant differences or trends observed in 
expression of the other corneal differentiation marker, Connexin 43 (Figure 3.8). 
In zone A, CK3 expression was the lowest in 30min RT group. 24h RT, 30min 4°C 
and 24h 4°C group all showed higher CK3 expression compared to 30min RT 
(p<0.05; p<0.05 and p<0.01 respectively). Moreover, both 30 min and 24h 4°C 
groups also showed higher expression of CK3 in zone A from 24h RT transport group 
(Figure 3.7). Similarly, in zone B and zone C, 4°C transport led to higher CK3 
expression in comparison with RT conditions. In zone B, 30min 4°C transport showed 
higher expression of CK3 than 30min and 24h RT group (p<0.001) and the difference 
between 24h 4°C and both RT groups was even more significant (p<0.0001). Finally 
in zone C, CK3 expression was significantly higher in 30min 4°C and 24h 4°C 







Figure 3.7 Expression of corneal differentiation marker Cytokeratin 3 per zone 
of limbal outgrowths after limbal biopsies transport simulation. Data are 





Figure 3.8 Expression of corneal differentiation marker Connexin 43 per zone of 
limbal outgrowths after limbal biopsies transport simulation. Data are presented 
as mean ± SEM (n=3). 
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3.3.3 Limbal explant growth rate, cell number, viability and colony forming 
efficiency after final product transport simulation  
 
After successful explant cultures were obtained from all limbal biopsies (Figure 3.9), 
expanded limbal epithelial cells on HAM were used for final product transport 
simulation. All visible differences in growth rate were non-significant, most likely 
depending on the number of stem cells in the particular piece of cadaveric limbal 















Figure 3.9 Limbal epithelial cell growth across different final product transport 
condition groups. Schematic graphs are showing the area of explant outgrowth 




With regard of number of cells per zone, control had significantly higher number cells 
in zone A and zone C compared to 4 days transport group (p<0.05 and p<0.001 
respectively) and in zone B and zone C compared to 7 days transport group (p<0.05 
and p<0.0001 respectively). There was no significant difference between cell 
numbers between control and 24h transport group in any of the zones. 4 days 
compared to 7 days transport group showed higher number of cells in zone B 
(p<0.01) (Figure 3.10). 
Cell viability was significantly lower in 4 and 7 days transport groups compared to 
control across all the zones (p<0.05) whilst viability in 24h transport group was 
affected only in zone A compared to control (p<0.05). However, viability in zone A of 








Figure 3.10 Number of cells and cell viability per zone of limbal outgrowths after 
final product transport simulation. Data are presented as mean ± SEM, * p < 0.05, 
** p < 0.01, *** p < 0.001, **** p < 0.0001 (n=3).  
 
Interestingly, CFE was higher in 4 and 7 days transport groups in all the zones 
compared to control and 24h transport, with the highest CFE showed after 7 days of 
transport simulation. The difference was significant between 7 days and 24h 
transport in all three zones (p<0.05) and 4 days and 24h transport in zones A and B 
(p<0.05). 24h transport group had the lowest CFE, significantly lower not only from 4 
and 7 days transport groups but also lower than control especially in zone B where 




Figure 3.11 Colony forming efficiencies per zone of limbal outgrowths after final 




3.3.4 Limbal epithelial cell marker expression after final product transport 
simulation  
 
Several significant differences were found between the groups related to marker 
expression but scattered throughout zones and not logically correlated. For example 
significantly higher expression of limbal stem cell marker ΔNp63 was found in control 
compared to 24h transport group (p<0.05) but on the same time expression of 
Connexin 43 which is a marker of corneal differentiation was also significantly higher 
in control compared to 24h transport group (p<0.01) (Figure 3.12 and 3.13). Other 
differences found for the expression of putative stem cell marker ΔNp63 (Figure 
3.12) and corneal differentiation markers CK3 (Figure 3.13) and Connexin 43 
(Figure 3.14) were also inconsistent and for that reason they will not be commented 




Figure 3.12 Expression of putative limbal stem cell marker ΔNp63 per zone of 
limbal outgrowths after final product transport simulation. Data are presented as 





Figure 3.13 Expression of corneal differentiation marker Cytokeratin 3 per zone 
of limbal outgrowths after final product transport simulation. Data are presented 





Figure 3.14 Expression of corneal differentiation marker Connexin 43 per zone 
of limbal outgrowths after final product transport simulation. Data are presented 




3.4 Discussion  
LSC transplantation has been shown to reverse the signs of deficiency of these cells 
by restoring a corneal epithelial phenotype. Unilateral LSCD can be treated with 
autologous LSC transplantation, but in case of bilateral LSCD, only allogeneic 
transplantation is possible and the donor limbal tissue must be taken from a living 
relative or a cadaver (Tan et al., 1996; Djalilian et al., 2005; Fernandez-Buenaga et 
al., 2018). In our study we used human cadaveric limbal tissue as an alternative to 
real LBs obtained from living donors, which are taken only in strictly indicated 
occasions.  
The two basic approaches to store whole corneas for grafting are hypothermia and 
organ culture. Procedural simplicity and the immediate availability of tissue for 
transplantation make hypothermia the most widely used method (Pels et al., 2008). 
The recommended maximum storage time under hypothermic conditions (2–6°C) is 
up to 14 days. Organ culture storage is used in about 65% of European eye banks 
because of the possibility of performing a detailed assessment of the corneal 
endothelium and extending storage time up to 4–5 weeks (Pels et al., 2008).  
The effect of different storage temperatures on the maintenance of LEC phenotype 
and function was studied by Raeder et al. The research group evaluated effects of 1 
week storage of human limbal epithelial cultures in conventional organ culture (at 
31°C or 23°C) and hypothermic storage (at 5°C) in Optisol-GS (Raeder et al., 2007). 
They reported that although cultured human LECs remained undifferentiated in all 
storage conditions, the ultrastructure was better preserved at 23°C, while storage at 
31°C and 5°C was associated with enlarged intercellular spaces, separation of 
desmosomes, and detachment of epithelial cells (Raeder et al., 2007). After they 
identified the temperature of 23ºC as an optimal for LECs storage they evaluated 
viability, morphology and phenotype of cultured human LECs on HAM following 2 
and 3 weeks of organ culture storage (Utheim et al., 2009). Although a less 
differentiated phenotype was maintained, the multi-layered structure was lost after 3 
weeks whilst preserved in around 70% of cultures following 3 week storage along 
(Utheim et al., 2009). They concluded that even with a slight decrease in viability the 
human LEC sheets remain acceptable, which was not the case with 3 week storage 
which results was unsatisfactory (Utheim et al., 2009). Furthermore, they reported 
that the storage conditions with 23ºC temperature in either serum-free medium 
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(Quantum 286) or xenobiotic-free medium (Minimal Essential Medium-MEM) 
protected against cell death, loss of ultrastructure and differentiation of cells for 4-7 
days period (Utheim et al., 2015).  
The same group also studied effect of different storage temperatures on cultured 
human conjunctival (Eidet et al., 2012; Eidet et al., 2015) and epidermal cell sheets 
(Jackson et al., 2014; Jackson et al., 2016; Jackson et al., 2017). They reported that 
human conjunctival epithelial cells may be stored for at least 4 days in serum free 
conditions at 23ºC while maintaining the cell phenotype and viability (Eidet et al., 
2012). Furthermore, they later evaluated effect of nine different storage temperatures 
between 4ºC and 37ºC for 4 days and 7 days storage of cultured human conjunctival 
epithelium (Eidet et al., 2015) and cultured epidermal cell sheets (Jackson et al., 
2014). Storage at 12ºC appeared to be optimal for preserving the morphology, 
viability and total cell number of cultured human conjunctival epithelium. These 
superior cell preservation on 12ºC may be related to temperature associated effects 
on cell metabolism (Eidet et al., 2015). In terms of preservation of cultured epidermal 
cell sheets their initial results indicated that 12ºC and 24ºC storage temperature 
represent the prospective optimum temperature for short term storage of these cell 
sheets (Jackson et al., 2014). 24ºC temperature showed the clear advantage on cell 
viability whilst 12ºC were particularly favourable in terms of maintenance of 
proliferative capacity and morphology of cultured cells after storage (Jackson et al., 
2014). In their next study, they further reported that lower storage temperatures, in 
particular 12ºC, showed to be superior in terms the maintenance of the original 
phenotype of cultured epidermal cells (Jackson et al., 2014). Their third study of 
different storage temperatures from 2017 reported retention of undifferentiated cell 
phenotype on 12ºC, transition to differentiation at 16ºC and increased differentiation 
at 24ºC and confirmed that 12ºC temperature may be ideal for storage of cultivated 
epidermal cell sheets (Jackson et al., 2017). 
These studies clearly show that the choice of storage temperature has an important 
role in preservation of epithelial morphology on cultivated epithelial cells. In our 
study, we were interested in effect of the choice of different temperatures even 
before LEC cultivation, during transportation of LBs. As most eye banks in the world 
use either hypothermic storage (2-6ºC) or organ culture storage (31-37ºC) we 
decided to compare two different temperatures for LBs transportation, 4ºC and room 
temperature, similarly to storage temperatures in the two main approaches of the 
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corneal storage. The reason behind choosing RT instead of 31ºC was the fact that in 
2007 two studies reported that organ culture storage of cultured LECs on HAM at 
ambient temperature is superior to organ culture storage at 31ºC with minimal 
apoptosis after storage (Raeder et al., 2007; Utheim et al., 2007). We compared 
effects of these temperatures during short (30 minutes) transport and prolonged (24 
hours) transport of LBs.  
We demonstrated that cultivation of LBs transported at either RT or 4ºC will results in 
their successful growth on HAM after both short and long term transportation with no 
difference in regard of cell viability of the outgrowths. However, RT transport proved 
to be superior compared to 4ºC transport in terms of growth rate and preservation of 
undifferentiated cell phenotype. Besides better CFEs, LBs transported at RT showed 
presence of higher percentage of putative stem cells (higher expression of ΔNp63) 
and lower percentage of differentiated cells (lower CK3 expression) in comparison 
with LBs transported at 4ºC. Short and long transportation at RT proved to be equally 
efficient, whilst between short and long transportation at 4ºC there was a significant 
difference in expression of ΔNp63 suggesting that long 4ºC transportation is the least 
convenient option for preservation of LSCs within LBs.  
Our results are in accordance with a study that showed retention of proliferative 
function at 4ºC but also showed low cell viability, as well as cell-cell contact 
disruption and cell shrinkage, indicative to apoptosis (Jackson et al., 2014). Thus, 
possible explanation for slower growth in 4ºC transport groups, especially in 24 hours 
transportation group, may be the lower number of LSCs in LBs transported at low 
temperature due to increased apoptosis. We could further hypothesize that increased 
differentiation also may be the result of lower number of LSC in LBs after 
transportation but this needs to be further investigated.  
Further study from the same research group investigated the molecular mechanisms 
underlying activation of cell death pathways using genome-wide transcriptional 
analysis in human LECs following 2, 4 and 7 days storage at 4ºC (Utheim et al., 
2016). The most upregulated genes after 4 and 7 days hypothermic storage were the 
histone coding genes HIST1H3A and HIST4H4, involved in a functional network 
highly associated with cell death, necrosis, and transcription of RNA. The most down 
regulated gene, HDAC1, encoding histone deacetylase 1, is involved in a regulating 
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network associated with cellular function and maintenance, differentiation of cells and 
DNA repair (Utheim et al., 2016). 
Additionally, together with the choice of storage temperature, the choice of storage 
media also plays a role in the preservation of epithelia. For example, Utheim at al. 
showed that storage in MEM, simple storage medium preserve immature phenotype 
better than more complex Quantum 286. The possible reason might be the fact that 
simple media reduces metabolism and therefore potentially decreases differentiation 
during storage to a higher extent than media with added growth factors, such as 
Quantum 286 (Utheim et al., 2015). Their findings are in accordance with the other 
study demonstrating stimulated differentiation of cultured human LECs over time 
using a complex culture medium (Ghoubay-Benallaoua et al., 2013). Similarly, Oie et 
al. used Hanks' Balanced Salt Solutions (HBSS) as the transportation liquid for 
human and rabbit cell epithelial sheets air transportation using their special 
transportation container (Oie et al., 2014). HBSS is a relatively simple buffered 
solution that does not contain any growth factors but provides cells with water and 
certain bulk inorganic ions as well as the carbohydrates and glucose essential for cell 
metabolism. 
Development of efficient short-term storage can expand the utility of cultured limbal 
epithelial sheets by providing an extended window for quality control and sterility 
testing in centralized culture facilities, wider distribution, flexibility in timing of 
transplantation surgeries and back-up sheets for repeated operations. 
In our study we compared short one day (24 hours) storage in traditional LSC culture 
medium, with FBS and growth factors added, with prolonged 4 and 7 days storage in 
simple MEM medium without serum and growth factors.   
Cell number and viability of LECs in our study did not differ significantly between 24 
hours and 4 and 7 days storage, but the trend of increased cell death with longer 
storage was observed. Previously it has been shown that both apoptosis and 
necrosis occur in cells during corneal storage, with apoptosis appearing to 
predominate (Komuro et al., 1999). The viability of LECs stored for 4 and 7 days was 
significantly lower in comparison with non-stored controls in all the zones, but still 
around 80%. Similarly to our findings, Utheim and al. reported that viability of cells 
after 4 days serum free storage was 97% (Utheim et al., 2015).  
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Beside the maintenance of cell viability as the first general priority in storage of cells, 
maintenance of stemness is equally important during cultivated limbal epithelium 
storage and transportation.  
Highly proliferative cycling epidermal progenitor cells are the first to contribute to 
regeneration following transplantation, while quiescent stem cells provide long-term 
renewal (Schluter et al., 2011). As the same principle applies to the limbal epithelium, 
our objective was to maintain an undifferentiated cell phenotype and proliferative 
capacity within limbal epithelial cell sheets during storage. 
In terms of expression of putative stem cell markers and markers of corneal 
differentiation we didn’t find any consistent difference between three different storage 
groups and control. It seems that all storage conditions preserved stemness in a 
similar manner.  
In terms of colony forming ability, another important aspect of LSCs present in limbal 
epithelial sheets, the trend of lower CFE was obvious in cells stored for 24 hours in 
culture media compared to non-stored control cells, with significant difference in zone 
B. Surprisingly both 4 days and 7 days storage groups showed significantly higher 
CFE than 24 hours storage group in all three outgrowth zones. These phenomenon 
may be explained by serum starvation of stored LECs on HAM in serum free media 
for 4 and 7 days and their consequential arrest in the G1 phase of the cell cycle 
which was reversed upon returning into FBS supplemented culture media. Currently, 
this is hypothesis that needs to be verified experimentally.  
Multiple studies have been published on the various aspects of storage of cultured 
LECs (Kito et al., 2005; Oh et al., 2007; Raeder et al., 2007; Utheim et al., 2007; Yeh 
et al., 2008; Utheim et al., 2009; Wright et al., 2012; Utheim et al., 2015) while 
transportation of epithelial sheets for ocular surface reconstruction has been studies 
to a limited extent. Transport is different from storage in the sense that the tissue is 
exposed to movement that unlike other environmental factors cannot be eliminated 
by a sealed transport container (Utheim et al., 2018b). Vasania et al. tested in-house 
designed transportation container for cultured conjunctival epithelial cell sheets on 
HAM (Vasania et al., 2014). They reported presence of viable, intact epithelial sheets 
upon arrival and good post-operative outcome for pterygium surgery (Vasania et al., 
2014). Oie et al. developed a transportation container with three basic functions: the 
maintenance of interior temperature, air pressure and sterility (Oie et al., 2014). 
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Cultured human oral mucosa and rabbit LECs were successfully transported in the 
container for 5 hours in the airplane. After the transport, lower expression of zonula 
occludens-1 (ZO-1) was observed, suggesting that transportation may cause a 
reduction in intercellular adherence and barrier function (Oie et al., 2014). Utheim et 
al. simulated extreme transport conditions followed by a storage period and found 
that transport simulation of up to 36 hours appeared not to be critical to the viability, 
ultrastructure and phenotype of human LECs with a completely filled transportation 
container (Utheim et al., 2018b).  
 
3.5 Conclusion 
The choice of transportation temperature has an important role in preservation of 
LECs proliferation and phenotype. Here we demonstrated that LBs, as a starting 
material for limbal epithelial sheets production, may be efficiently transported within 
24 hours at room temperature from hospital where the biopsy was taken to CPC 
facility for further cultivation.  
Additionally, we showed that the final product, limbal epithelial sheets, may be stored 
up to 7 days in simple serum free medium without significant decrease in cell viability 













Chapter 4. Towards identification of novel limbal epithelial stem cell 
surface markers 
 
4.1 Introduction  
4.1.1 Challenges in LSC therapy 
 
As discussed in previous chapters, transplantation of autologous ex vivo expanded 
LSCs is an established and European Medicines Agency authorised treatment for 
patients with total/severe unilateral LSCD due to ocular surface burns. Currently 
however, ex vivo expansion strategies of limbal and other autologous epithelial stem 
cell are labour intensive and often lack standardization, largely because it is currently 
impossible to prospectively isolate pure populations of these cells for research or 
clinical use. Until this occurs, different centres will likely use specific techniques for 
isolation and ex vivo culture of LSCs in their respective institutions that have been 
developed and investigated in their individual basic laboratories, rendering it 
impossible to compare clinical success rates between clinical trials performed in 
different centres around the world. 
 
4.1.1.1 Identification of LSCs  
A major challenge in corneal stem cell biology is the ability to identify stem cells in 
vitro and in situ and one of the main controversies in the field relates to the issue of 
reliable stem cell markers. The ideal LSC marker should not only be able to pinpoint 
the location of LSC within the epithelium but should also allow isolation, enrichment 
and molecular characterisation of viable LSC.  
LSCs play the vital role in the regeneration of damaged corneal tissue, as discussed 
in details in Chapter 1. Due to the limited options available to treat corneal scars, 
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their isolation and identification received much attention as they have potential for 
autologous, cell-based approaches for treatment of damaged cornea. In the last 
decade LSCs transplantation has been successfully applied in the clinic. The LSC 
frequency significantly influences the outcome of corneal transplantation (Rama et 
al., 2010). The study by Rama et al. showed that more than 3% of p63 positive cells 
out of the total number of transplanted cells led to a successful rate of 78%. Less 
than 3% of p63 positive cells, on the other hand, led to a much lower successful rate 
of only 11% (Rama et al., 2010). The accuracy of LSC identification is therefore 
urgent for successful corneal transplantation. Up to date many putative LSC markers 
have been reported in the literature (page 33, Table 1.1), including cytoskeletal 
proteins, cell adhesion molecules, cell cycle regulators, enzymes, growth factors and 
their receptors, ATP-binding cassette transporters and differentiation associated 
markers (Chen et al., 2004; Schlotzer-Schrehardt and Kruse, 2005). However, there 
are still no LSC reliable specific biomarkers reported for accurate identification yet.  
LSC identification is usually based on the following methods: 
 Co-expression of putative positive LSC markers (such as p63, ABCG2, 
ABCB5, integrin α9, vimentin etc.) and negative LSC markers (Connexin 43, 
CK3, CK12, involucrin etc.); 
 Morphologic criteria (cell size and nucleocytoplasmic ratio (N/C) ≥ 0.7): As 
shown by flow cytometry and confocal microscopy, the smallest cells are 
located in the limbal basal epithelium compared to the basal corneal 
epithelium (10.1±0.8 vs. 17.1±0.8 µm) (Romano et al., 2003). Similarly, it has 
been shown that N/C ratio of LSCs lying on the basal membrane was higher 
than N/C ratio of TACs and corneal epithelial cells (Schlotzer-Schrehardt and 
Kruse, 2005). Moreover, LSCs were successfully identified and quantified 
based on ABCG2 expression and N/C ≥ 0.7 (Priya et al., 2013). Additionally 
using the same principle, Kasinathan et al. established a two-step protocol for 
LSC enrichment by combining basal cell isolation and laser capture 
microdissection of small cells with N/C ≥ 0.7. Using the protocol they achieved 
76-78% enrichment of LSCs from 2% LSCs in total limbal epithelial cells 
(Kasinathan et al., 2016); 
 Label retaining property: The BrdU-based “pulse-chase” experiment has been 
widely used for stem cell identification. Using the fact that BrdU can be 
incorporated into newly synthetized DNA molecule instead of thymidine, after 
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a period of BrdU pulse all cells with different degree of differentiation can be 
labelled by BrdU. As a result of slow cell cycling of stem cells, fewer divisions 
of labelled LSCs compared to differentiated cells will happen in the same time. 
Hence, after a period of BrdU chase, the BrdU retaining cells can be 
considered as LSCs (Arpitha et al., 2008). From the percentage of 
radiolabelled thymidine retaining cells present in the limbal zone, it has been 
concluded that stem cells may represent less than 10% of the total limbal 
basal cell population (Lavker et al., 1991). In 1998 Lehrer et al. showed that 
the limbal basal epithelium contains both slow-cycling stem cells and early 
TACs; 
 Side population (SP) phenotype: Most cells accumulate fluorescent dyes such 
as Hoechst 33342, but a subset of “dull cells” is often found and termed the 
“side population”. The SP cells are identified according to their ability to efflux 
the Hoechst dye at a higher pace than the remaining cells termed the main 
population (non-SP). The Hoechst 33342 efflux activity results from the 
specific stem cell protein expression, such as ATP binding cassette 
transporters expression (Goodell, 2005). The SP assay has emerged as a 
promising method for identifying stem cell and progenitor populations in 
different tissues, particularly in the absence of specific cell-surface markers 
(Golebiewska et al., 2011). Goodell et al. successfully isolated mice bone 
marrow stem cells using FACS based on Hoechst-SP method (Goodell, 2005) 
while Shaharuddin et al. successfully isolated LSCs (Shaharuddin et al., 
2014).  
 
4.1.1.2 Difficulties in the discovery of specific LSC biomarkers 
 
4.1.1.2.1 Particularity of limbal structure and phenotype 
 
Limbus represents the narrow band of tissue with unclear boundaries with to cornea 
and conjunctiva. Although there are some histological differences between the 
cornea and limbus, such as the presence of palisades of Vogt in limbal epithelium 
and more layers of epithelial cells compared to cornea (Mariappan et al., 2010),  it is 
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still difficult to distinguish corneal epithelium from limbal epithelium. Moreover, limbal 
epithelial cells share some molecular markers with both corneal and conjunctival 
epithelial cells that together with many controversial reports in the literature make 
their identification a very difficult task. For example, as reported by different authors 
CK19 and CK13 can serve as markers of conjunctival epithelial cells (Donisi et al., 
2003; Poli et al., 2015), but other author showed that CK19 expression was also 
detected both in limbal and corneal epithelial cells (Chen et al., 2004). Similarly, 
although Ramirez-Miranda et al. showed that CK13 was more specific than CK19 in 
terms of identification of conjunctival epithelial cells (Ramirez-Miranda et al., 2011), 
Poli et al. showed that CK13 was expressed in both the conjunctival epithelium and 
the suprabasal and superficial layers of the limbal epithelium (Poli et al., 2015). 
Although limbus could be distinguished from conjunctiva based on the presence of 
goblet cells, which are used to diagnose LSCD (Puangsricharern and Tseng, 1995), 
some conditions such as Stevens-Johnsons syndrome and long-term administration 
of glaucoma drugs could lead to LSCD with no goblet cell invasion (Poli et al., 2015). 
While CK12 is expressed in corneal but not in conjunctival epithelium (Chen et al., 
1994) and may be used to distinguish them, it is not clear if its expression is limited to 
central corneal epithelium or presents also in the limbal epithelium. Namely, Latta et 
al. showed that CK12 was specifically expressed in corneal epithelial cells but not in 
limbal epithelial cells (Latta et al., 2018) but, on the other hand, Ramirez-Miranda et 
al. reported that CK12 was not only expressed in corneal epithelial cells but also in 
limbal epithelial cells except in the basal layer (Ramirez-Miranda et al., 2011).  
 
4.1.1.2.2 Enzyme digestion impact 
 
The limbal epithelial suspension used for the isolation of LSCs is usually prepared 
from whole mass limbal tissue by enzymatic digestion using either dispase II, 
collagenase A or trypsin (Espana et al., 2003; Chen et al., 2011; Tovell et al., 2015; 
Shirzadeh and Heidari Keshel, 2018). Dispase II separates the limbal epithelium from 
the stroma by destruction of the BM, collagenase A disrupts the cellular connection in 
a limbal niche by digestion of extracellular matrix while trypsin separates a cells mass 
into a single cell suspension. Enzyme treatment may significantly influences gene 
and protein expression profile of LSC. Optimization of digest conditions including 
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digestion time and concentration of enzymes to avoid enzyme-induced destruction of 
the LSC integrity has been reported in many studies (Stasi et al., 2014; Lopez-
Paniagua et al., 2016).  
 
4.1.1.2.3 Stem cell heterogeneity  
 
Heterogeneity has been reported in different type of stem cells, such as embryonic 
stem cells (Luo et al., 2018), mesenchymal stem cells (Du et al., 2016) but also LSCs 
(Hayashida et al., 2010). An obvious problem with current LSC clinical treatments is 
that transplanted cells are a heterogeneous cell population containing many cell 
types in addition to LSCs (ranging from epithelial, stromal stem and progenitor cells, 
conjunctival and corneal epithelial cells and blood or vascular cells) that significantly 
affect safety and efficiency of treatment. This was best highlighted by a landmark 
study published by Rama et al. who showed that successful corneal regeneration 
was strongly correlated with the presence of more than 3% holoclone-forming 
(ΔNp63α-bright) cells in ex vivo expanded cultures used for grafting of patients with 
LSCD (Rama et al., 2010). Various studies have described morphological 
characteristics of LSCs (i.e. small cell size, pigmentation and high nuclear to 
cytoplasmic ratio) (Chen et al., 2004), their slow cycling nature and location within 
clusters at palisades of Vogt (Dua et al., 2005); however these factors have not been 
linked with LSC function and outcome of transplantation; hence harvesting a specific 
and purified sub-population of these cells remains a major challenge. Several key 
putative markers have already been identified including ΔNp63α, ABCG2, ABCB5, 
C/EBPδ, Bmi1 and Notch-1 among others (Pellegrini et al., 2001; Schlotzer-
Schrehardt and Kruse, 2005; Joe and Yeung, 2014; Ksander et al., 2014); however it 
is unclear whether these proteins are expressed by different LSC sub-populations or 
different LSC subsets within each population marked by a single putative marker. 
Stem cell heterogeneity has been well described in various stem cell compartments 
including blood, skin and intestinal epithelium pointing to the concomitant existence 
of multiple types of stem cells with distinct everyday roles (Goodell et al., 2015). From 
these studies it has also emerged that these different stem cell types are more 
adaptable than previously thought, in that they have a 'default' role under normal 
conditions, however following perturbation, such as stimulation by injury, they can 
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fulfil distinct functions when required (Goodell et al., 2015). Some tissues may 
contain rapidly-cycling, committed progenitors which are responsible for the majority 
of tissue maintenance, as well as a population of slow-cycling stem cells which 
maintain a higher degree of stemness and can act as alternative source of stem cells 
in response to injury and stress (Li and Clevers, 2010). To date, it is not yet known 
whether corneal epithelium is also maintained by a combination of such quiescent 
and cycling progenitors, however it is interesting to note that in the human cornea 
two different sub-populations have been identified: (1) Bmi1+, C/EBPδ+ and ΔNp63α+ 
mitotically quiescent LSCs which generate holoclones in culture and (2) Bmi1-, 
C/EBPδ- and ΔNp63α+ population which respond to injury (Barbaro et al., 2007). It is 
not known whether LSC heterogeneity extends beyond the presence of these two 
LSC sub-populations and whether cell surface markers to distinguish between these 
two subpopulations can be identified.   
 
 
4.1.1.2.4 Lack of robust LSC isolation technology  
 
Among the total number of limbal epithelial cells there is a small amount of LSCs 
present, accounting only 0.5 to 10% of cells according to Latta et al. (Latta et al., 
2018). Existence of such a complex limbal epithelial suspension makes isolation of 
LSCs in low frequency very complicated task. Some traditional methods of LSCs 
isolation were previously published, such as FACS (Shaharuddin et al., 2017), 
magnetic-activated cell sorting (Polisetti et al., 2016) and gradient centrifugation 
(Krulova et al., 2008). However, all of these methods include enzyme digestion which 
may influence changes in gene expression patterns and protein profile of LSCs and 
increase the risk of suspension contamination due to complicated process involved 
(Emmert-Buck et al., 1996; Espina et al., 2006; Espina et al., 2007). 
Isolation of target cells from complex and heterogeneous tissues became possible 
with a discovery of the laser capture microdissection (LCM) technique by Emmert-
Buck et al. (Emmert-Buck et al., 1996). Furthermore, a combination of LCM with next 
generation sequencing (NGS) has become a hot topic of heterogeneity and specific 
biomarker research (Guo and Zhang, 2018). Bath et al. collected cells for NGS from 
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four different human limbal compartments using LCM providing plentiful information 
for the study of LSC markers (Bath et al., 2013). Using the same technique Polisetti 
et al. proved the connection between LSC niche cells and cell adhesion molecules 
(Polisetti et al., 2016). However, LCM poses also some limitations. As thin sections 
(5-15 µm) cut the cell into several parts resulting in incomplete RNA information that 
cannot represent a full cell, large number of sections is needed to obtain enough 
RNA for future studies (Fend et al., 1999; Datta et al., 2015). Moreover, pre-
treatment of sections including fixation, dehydration and staining can significantly 
influence the quality of RNA (Fend et al., 1999) reducing efficiency for subsequent 
experiments such as NGS or microarray analysis (Gautam et al., 2016). 
 
4.1.1.3 Prospective in LSC biomarker identification 
 
Recently, many reports have demonstrated new biomarkers at the RNA level. 
Techniques such as NGS opened possibility to obtain mRNA and microRNA 
information enabling development of mRNA or micro RNA based biomarkers (Guo 
and Zhang, 2018), providing a new direction for LSC specific biomarkers study.  
Previously, the in situ hybridization has been used to localize LSCs (Chen et al., 
2004). In 2013 Ke et al. developed a new technique for RNA analysis known as in 
situ sequencing (Ke et al., 2013) which enables gaining of target RNA sequence with 
the information of original morphology and location of its hosting cells. Therefore this 
technology may be used to solve the LSC location and heterogeneity issues. 
Process of LSC isolation may destroy LSC niche that plays the vital role in 
maintaining LSC stemness. Study of LSCs in the transgenic animal system 
represents the excellent method to avoid LSC niche and specific microenvironment 
destruction. For example, Sartaj et al. developed a tetracycline-inducible (tet-off) 
double transgenic “pulse-chase” mouse system that accurately identified LSCs, and 
then used isolated LSCs in combination with NGS technology to analyse the 
expression profile of candidate LSC biomarkers (Sartaj et al., 2017). Similar 
transgenic mouse system has also been reported to demonstrate the mechanism of 
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LSC-promoted wound healing (Kasetti et al., 2016) (Nasser et al., 2018) and the 
homeostasis of corneal epithelium (Richardson et al., 2017). 
Combination of traditional biotechnologies with the virtual simulation technology 
represents also an useful tool for the study of LSCs. Molvaer et al. simulated the 3D 
computer model of the human corneo-limbal region by 3D visualization software 
based on series hematoxylin and eosin (HE) stained paraffin sections (Molvaer et al., 
2013). Using the technique, they successfully identified three niche types of LSCs 
(limbal epithelial crypts, limbal crypts and focal stromal projections), and their 
distribution in superior, inferior, nasal, and temporal regions. Furthermore, Lobo et al. 
successfully demonstrated the mechanism of self-organization centripetal migration 
of LSCs to repair the wounded corneal epithelium without external cues by using the 
virtual digital model (Lobo et al., 2016). 
Importantly, virtual simulation technology may lead to reduction of the amount of 
animals used in experiments. Moreover, the computer systems provide advantages 




4.2 Material and methods 
4.2.1 Corneal tissue  
 
Cadaveric adult human limbal tissue was obtained from the corneo-scleral rings 
remaining (9 females, 15 males, average age 69.42 years, SEM 2.99, range 28 - 83 
years) after removal of the central cornea for transplantation supplied by the NHS 
Blood and Transplant (NHSBT) Cornea Transplantation Service eye bank in 
Manchester and Bristol, UK. Average time from death to retrieval of corneo-scleral 
tissue was 16.1 ± 1.99 hours (mean±SEM). Average time tissue spent in organ 
culture was 36.55 ± 7.8 days (mean±SEM).  Human tissue was handled according to 
the tenets of the Declaration of Helsinki and informed consent was obtained for 
research use of all human tissue from the next of kin of all deceased donors. The 
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study was approved by the NRES Committee North East - Newcastle & North 
Tyneside 1 (REC number: 11/NE/0236, protocol number 5466) on the 29th October 
2013.  
Animal care and use conformed to the ARVO Statement for the Use of Animals in 
Ophthalmic and Vision Research.  
 
4.2.2 Single cell culture of human limbal epithelium on 3T3-J2 feeder layers 
 
Twenty four hours before limbal epithelial cell isolation from corneo-scleral tissue, 
mitotically inactivated J2–3T3 mouse fibroblasts were suspended in high-glucose 
DMEM supplemented with bovine calf serum (10%) (Hyclone, USA) and 
penicillin/streptomycin (1%) (Thermo Fisher Scientific, USA) and plated in a 9.6 cm2 
tissue culture well at the final density of 2.4×104 cells per cm2 as previously described 
(Yu et al., 2016). The use of bovine calf serum instead of fetal calf serum was 
recommended by the manufacturer of the 3T3-J2 cell line (Karafast, USA). The 3T3 
cell suspension was placed in a tissue culture incubator at 37°C overnight to allow 
the establishment of a 3T3 feeder layer. On the following day, limbal stem cells were 
harvested from cadaveric corneo-scleral rims as previously described (Ahmad et al., 
2007) (Figure 4.1). The deeper layers of the corneo-scleral rings were dissected 
away together with excess sclera leaving a ring containing approximately 2 mm of 
peripheral cornea and 2 mm of adjacent sclera. The remaining tissue containing 
limbal epithelium was then cut into smaller 1 mm2 pieces. The limbal epithelial cells 
were isolated from these pieces using serial trypsinization with 0.05% trypsin-EDTA 
solution (Thermo Fisher Scientific, USA). After 20 minutes incubation in a tissue 
culture incubator, the resulting cell suspension was removed from the limbal pieces 
and epithelial medium was added to this suspension. After the cell suspension was 
centrifuged for 3 minutes at 1000 rpm in Heraeus Megafuge 16R Centrifuge (Thermo 
Fisher Scientific, USA), the supernatant was removed and the remaining cell pellet 
was re-suspended in epithelial medium containing 3:1 mixture of low-glucose 
DMEM:F12 supplemented with fetal calf serum 10%, penicillin/streptomycin 1% (all 
Thermo Fisher Scientific, USA), hydrocortisone 0.4 µg/ml, insulin 5µg/ml, 
triiodothyronine 1.4 ng/ml, adenine 24 µg/ml, cholera toxin 8.4 ng/ml and EGF 10 
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ng/ml (all Sigma-Aldrich, UK). The trypsinization and centrifugation process was 
repeated a further three times using the same limbal tissue and the same centrifuge 
and settings. The resulting cell suspensions were pooled together. After counting, 
30,000 of viable limbal epithelial cells (trypan blue exclusion test) in epithelial 
medium were added to one 9.6 cm2 tissue culture well containing the growth arrested 
3T3 fibroblast and placed in a tissue culture incubator at 37°C with a humidified 
atmosphere containing 5% CO2. The medium was exchanged on the third culture day 
and every other day thereafter. Several days after, LSC colonies with typical 
morphology started to appear (Figure 4.2) and were cultured until became sub-
confluent. After 3T3 feeder cells were detached and removed using 0.02% EDTA 
(Lonza, Switzerland), sub-confluent primary cultures were dissociated with 0.5% 
trypsin-EDTA (Santa Cruz, USA) to single cell suspension and passaged at a density 
of 6 × 103 cells/cm2. For serial propagation, cells were passaged and cultured as 





Figure 4.1 Schematic representation of LSC isolation process. The corneo-scleral 
rings were cut into 1 mm2 pieces, trypsinized, centrifuged and obtained cells seeded 







Figure 4.2 Microphotograph of human LSC colonies surrounded by 3T3 mouse 
feeder cells. Characteristic appearance of LSC colonies with well-defined edges and 
cobblestone-like epithelium. 
 
4.2.3 Limbal epithelial cell surface marker screening  
 
Limbal epithelial cell cultures (passage 1) were dissociated as described above to a 
single cell suspension. Limbal epithelial cells were stained with 361 different 
phycoerythrin (PE) labelled antibodies and 10 immunoglobulin (Ig) isotype controls 
using the LEGEND Screen™ Lyophilized Antibody Panel Human Cell Screening (PE) 
Kit (700007, BioLegend, USA) (Figure 4.3). After the staining, cells were washed 
and analysed by LSR Fortessa (BD, USA) flow cytometer. Data were analysed with 
FCS Express 6 Flow Cytometry Software (De Novo Software, USA). The screening 
was repeated three times, for each experiment corneo-scleral rings from seven 
donors were pooled (21 donors in total; 8 females, 13 males, average age 70.50 




Figure 4.3 LEGEND Screen™ Lyophilized Antibody Panel Human Cell Screening 
Kit and schematic representation of a 96 well plate with different surface 
antibody in each well. 
 
After we identified candidate markers using LEGEND Screen™ Lyophilized Antibody 
Panel Human Cell Screening Kit we further investigated these markers by flow 
cytometry (after passage induced and calcium induced differentiation) and 
immunohistochemistry in order to perform further selection. Only the final two 
candidate markers were sorted using fluorescence-activated cell sorting (FACS) and 
positive and negative populations were investigated by qRT-PCR, clonal assay, 






Figure 4.4 Schematic representation of the study research design. The aim of the 
study was to discover the best candidate marker through multi-step examination. 
Firstly, potential candidate’s expression should decrease through differentiation 
process, secondly it should be expressed exclusively by epithelial cells in the basal 
layer of the limbus and thirdly sorted positive cell population for the given marker 
should be able to form holoclones. If all the conditions were fulfilled further analysis 
such as qRT-PCR and proliferation assay were performed. Abbreviations: H-
holoclones, M-meroclones, P-paraclones. 
 
4.2.4 Calcium induced differentiation 
 
Limbal epithelial cells from three different donors (n=3, passage 1) were plated at a 
density of 200,000 cells per well in a 6 well plate and cultured in EpiGRO™ Human 
Ocular Epithelia Complete Media Kit (SCMC001, Merck Millipore, USA) without 3T3-
J2 feeders or any plate coating. The medium contained basal medium, supplements 
mix (L-Glutamine 6 mM, Epinephrine 1.0 μM, Insulin 5 μg/mL, Apo-Transferrin 5 
μg/mL, Hydrocortisone 100 ng/mL, EpiFactor O proprietary and EpiFactor P 0.4%), 
150µM calcium and 1% penicillin/streptomycin. When the cells reached 80% 
confluence, calcium was added to a final concentration of 1.2mM, for the induction of 
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differentiation. Cells were differentiated for up to 1 week and collected for flow 
cytometry analysis.  
 
4.2.5 Flow cytometry analysis and FACS 
 
The expression of selected markers in limbal epithelial cell cultures was monitored 
through subsequent passages, from passage one to passage four, and during 
calcium induced differentiation using cells from three different donors (n=3) to provide 
biological triplicates. After trypsin dissociation, limbal epithelial cells re-suspended in 
flow buffer (1% Bovine Serum Albumin in PBS) were stained for 20 minutes with 
different selected antibodies on ice and analysed by flow cytometry (FACSCanto II, 
BD, USA). A minimum of 10,000 events were recorded for each sample. Antibodies 
used for FACS were PE-conjugated anti-human CD200 (329205, BioLegend, USA, 
dilution factor 1:100), PE-conjugated anti-human CD109 (323305, BioLegend, USA, 
1:100) and APC-conjugated anti-human p63 delta (NBP2-33090, Novus Biologicals, 
USA, 1:100).  
FACS was carried out using a FACSAria II sorter (BD, USA) (Figure 4.5). Limbal 
epithelial cells used for the cell sorting experiments were passage 1. The limbal 
epithelial cell staining was performed as above using FACS buffer (1% FBS in PBS) 
under aseptic conditions for both final candidate markers, CD200 and CD109. The 
stained cell suspension was then filtered through a 40 µm nylon filter to remove any 
cell clumps. 10% DAPI stain was added to a final cell suspension to eliminate dead 
cells. Side scatter and forward scatter profiles were used to eliminate cell doublets. 








Figure 4.5 Schematic representation of a cell sorting process. Firstly, sub-
confluent LSC colonies were enzymatically digested to single cell suspension by 
trypsin. The cell suspension obtained was then labelled by fluorescent antibody of 
interest and used for cell sorting. 
 
4.2.6 Colony-forming efficiency and clonal assay 
 
Colony-forming efficiency assay (CFE) was performed as previously described by Yu 
et al., 2016 (Yu et al., 2016).  Following staining with 1% Rhodamine B, colonies 
were counted under dissecting microscope (SMZ645, Nikon, Japan). The CFE was 
calculated as number of colonies formed/number of cells plated×100 for both positive 
and negative cell populations for three different donors (n=3). Each donor served as 
a biological replicate. Sorted limbal epithelial cells from three different donors were 
also plated for clonal assay (n=3) performed as described by Dziasko et al., 2014 
(Dziasko et al., 2014). Limbal epithelial cells used for the cell sorting experiments 
were passage 1. The sorted populations were re-plated for CFE and clonal assay. 
The clonal type was determined by  (1) the morphology of colonies and (2) the 
percentage of aborted colonies as follows: when <5% of the total colonies were 
terminally differentiated, the clone was scored as a holoclone; when more than 95% 
of colonies were terminally differentiated, the clone was scored as a paraclone and 
finally, when >5% but <95% of colonies were terminally differentiated, the clone was 
classified as a meroclone (Barrandon et al., 1989; Pellegrini et al., 1999a). 
140 
 
4.2.7 Fluorescence Immunohistochemistry and Microscopy 
 
Cultured limbal epithelial cells, human frozen corneal sections and paraffin sections 
of mouse and human cornea were fixed for 15 minutes either in 4% 
paraformaldehyde (CD200 staining) or in ice-cold methanol (CD109 staining). For 
human sections blocking step was performed by incubation in antibody diluent 
containing 1% bovine serum albumin (Sigma-Aldrich, UK) with 5% normal goat 
serum (Thermo Fisher Scientific, USA) for 30 minutes prior to staining. 
Permeabilization with 0.2% Triton X-100 in PBS was performed prior to staining with 
antibodies for internal cell markers. Cells were incubated with primary antibodies at 
4°C overnight and further incubated with secondary antibodies for 1 hour. The 
following primary antibodies were used at the indicated dilutions: anti CD109 (sc-
271085, Santa Cruz, USA, 1:200), anti-human CD200 (329201, BioLegend, USA, 
1:200), anti-mouse CD200 (AF3355, Novus Biologicals, USA, 1:100), anti p63 delta 
(NBP2-29467, Novus Biologicals, USA, 1:200), anti-cytokeratin 15 (ab52816, Abcam, 
UK, 1:100)and anti Ki67 antibody (ab15580, Abcam, UK, 1:100). Sections were 
mounted in Vecta shield (Vector Labs, USA) with Hoechst 33342 (1:1000, Thermo 
Fisher Scientific, USA). Images were obtained using Axio Imager microscope with 
ApoTome accessory equipment and AxioVision software (Zeiss, Germany). 
Immunostaining of mouse sections was performed on paraffin sections (5-7µm) of 
C57BL/6 mouse tissues, as described previously (Nasser et al., 2018) by our 
collaborators from Department of Genetics and Developmental Biology, The Ruth 
and Bruce Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, 
Haifa, Israel (Prof. Ruby Shalom-Feuerstein and Dr. Aya Amitai-Lange). 
 
4.2.8 Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT- 
PCR)  
 
As in previous experiments, passage one of cultured limbal epithelial cells obtained 
from three different donors were used for the cell sorting (n=3). The sorted cell 
populations were then subjected to qPCR analysis. cDNA was synthesised using the 
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Cells-to-cDNA™ II kit (AM1723, Ambion, Thermo Fisher Scientific, USA) directly from 
cell lysates as per the manufacturer’s protocol. Each reaction was set up using Go-
Taq® qPCR Master Mix (Promega, USA) and was composed of 5 µl 2X Master Mix 
buffer, 0.4 µl forward primer, 0.4 µl reverse primer, 0.8 µl template cDNA, 3.7 µl 
RNAse-free water and 0.1 µl COX. All reactions were analysed on a QuantStudio™ 7 
Flex Real Time PCR System (Thermo Fisher Scientific, USA) according to the 
manufacturer’s instructions using SYBR® Green as the detection dye, and ROX™ 
channel to detect COX as the reference dye. A standard, 40-cycle qPCR was 
performed for each sample.  The primer sequences used for qRT-PCR are listed in 


















Table 4.1 qRT-PCR Primers. 
 
4.2.9 Cell proliferation assay  
 
Passage one of limbal epithelial cells from three different donors (n=3) at 60-70% 
confluence were exposed to BrdU at a final concentration of 10 µM in cell culture 
medium and incubated for one, four and eight hours. Control cells were cultured 
without BrdU. After incubation, cells were stained with PE conjugated anti-CD200 
antibody (329205, BioLegend, USA) for 20 minutes on ice, then were washed, fixed 
Gene Direction Primer Sequence 
GAPDH Forward GTCAGTGGTGGACCTGACCT 
Reverse CACCACCCTGTTGCTGTAGC 
CD109 Forward GCCCGGAGGAAATGTGACTA 
Reverse TTGGGGTCTGATGGAAGAGTA 
CD200 Forward TGGGGACTGTGACCGACTTT 
Reverse TATTTAGGGCTCTCGGTCCTGA 
ΔNp63 Forward CTGGAAAACAATGCCCAGAC 
Reverse GGGTGATGGAGAGAGAGCAT 







BMI1 Forward CTGGTTGCCCATTGACAGCG 
Reverse AAATCCCGGAAAGAGCAGCC 
AXIN2 Forward AGCCAAAGCGATCTACAAAAGG 
Reverse GGTAGGCATTTTCCTCCATCAC 
FZD7 Forward GCCGCTTCTACCACAGACT  
Reverse TTCATACCGCAGTCTCCCC 
CDH3 Forward GGCGCTGGGGAAAGTATTCA 
Reverse GGAGCAACCACCCAATCTCT 
PAX6 Forward TCTTTGCTTGGGAAATCCG 
Reverse CTGCCCGTTCAACATCCTTA 
WNT7A Forward TGCCCGGACTCTCATGAAC 
Reverse GTGTGGTCCAGCACGTCTTG 
Ki67 Forward CGTCCCAGTGGAAGAGTTGT 
Reverse CGACCCCGCTCCTTTTGATA 
CK3 Forward CGTACAGCTGCTGAGAATGA 
Reverse CTGAGCGATATCCTCATACT 
CK14 Forward TTCTGAACGAGATGCGTGAC 
Reverse GCAGCTCAATCTCCAGGTTC 




and permeabilized before DNAse treatment. Following BrdU epitope exposure cells 
were stained with PerCP-CyTM5.5 conjugated anti-BrdU antibody (560809, BD, USA, 
5 µl per test) and DAPI stain for cell cycle analysis and analysed by LSR Fortessa 
(BD, USA) cell analyser. 
 
4.2.10 Hoechst 33342 and Pyronin Y Staining for G0/G1 Separation  
 
Quiescent cells, which are arrested in G0 phase, have lower level of RNA compared 
to active cells (G1 phase). Hoechst is an exclusive DNA dye while Pyronin Y reacts 
with both DNA and RNA. However, in the presence of Hoechst, Pyronin Y reaction 
with DNA is blocked, and Pyronin Y stains RNA only. When cells are stained first with 
Hoechst 33342 and then with Pyronin Y it is possible to distinguish DNA from RNA. 
Limbal epithelial cells from three different donors (n=3) were stained with APC 
conjugated anti-CD200 antibody for 20 minutes (329207, BioLegend, USA). For the 
separation of G0 and G1 cell cycle phases, limbal epithelial cells were stained with 
Hoechst 33342 (Sigma-Aldrich, UK) in a final concentration 10μg/ml and incubated at 
37oC for 45 minutes. After 45 minutes, 5μl of 100μg/ml Pyronin Y (Sigma-Aldrich, 
UK) was added directly to the cells and incubated at 37oC for a further 15 minutes. 
Single colour controls and negative control were also prepared.  LSR Fortessa (BD, 
USA) flow cytometer was used to analyse cells.  
4.2.11 siRNA Transfection 
 
To investigate the impact of CD200 downregulation on the clonal ability of limbal 
epithelial cells, RNA interference (RNAi) was performed using small interfering RNA 
(siRNA). Passage one human limbal epithelial cells from 3 different donors were 
grown on 3T3 feeder layer in complete epithelial medium supplemented with EGF, 
adenine, cholera toxin, hydrocortisone, insulin and triiodothyronine. A day before 
transfection, limbal epithelial cells (150x103) were re-seeded in 12-well plate without 
feeders in order to increase transfection efficiency. The day after re-seeding cells 
were transfected with CD200 Human Stealth siRNAs (set of 3: HSS106678, 
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HSS106679, HSS181160; 1299003, Thermo Fisher) and Stealth RNAi™ siRNA 
Negative Control Lo GC (12935200, Thermo Fisher) using Lipofectamine™ 
RNAiMAX Transfection Reagent (13778030, Thermo Fisher) according to the 
manufacturer’s protocol. The transfected cells were incubated for 48 hours for CFE 
and clonal assay. 
After 48h incubation with CD200 siRNA and control siRNA, cells we re-seeded back 
to 6 well plates in different densities (500 and 1000 cells/well) and cultured on 3T3 
feeders for next 14 days. The rest of the cells were used for RNA extraction and qRT-
PCR to confirm CD200 downregulation. 
4.2.12 Statistical Analysis  
 
GraphPadPrism 7.0 (San Diego, CA, https://www.graphpad.com/scien-tific-
software/prism/) was used to perform all statistical analyses. The data showed 
normal distribution therefore Student’s t-test was used to analyse differences 
between groups and p ≤ .05 was considered statistically significant. All experiments 














4.3.1 Flow cytometric based cell surface screening of limbal epithelial cell 
cultures 
 
After removing 3T3 feeder cells with EDTA, passage one sub-confluent limbal 
epithelial cells were lifted from the tissue culture plates using Trypsin-EDTA and 
stained with 361 human surface proteins and analysed by flow cytometry. The cell 
surface marker screening was performed three times and in each case, limbal 
epithelial cells from seven different donors were pooled to obtain sufficient cell 
number for this type of analysis. A summary of these results is shown in Appendix 1. 
LEGEND Screen™ analysis confirmed high expression of the commonly cited limbal 
epithelial cell markers: EGFR (88.81±6.02) (Zieske and Wasson, 1993; Chen et al., 
2004; Kim et al., 2004), SSEA-4 (54.02±5.93%) (Truong et al., 2011), CD71 
(88.76±5.92) (Chen et al., 2004; Hayashi et al., 2008), integrin β5 (91.45±1.24) 
(Stepp et al., 1993), integrin α6 (92.54±6.41) (Hayashi et al., 2008), E-cadherin 
(88.48±6.06) (Schlotzer-Schrehardt and Kruse, 2005) as well as many other general 
markers of corneal epithelium. The presence of other markers previously related to 
limbal epithelial cells was also confirmed: CD40 (26.00±6.94) (Iwata et al., 2002), 
CD117 (c-kit) (8.22±2.56) (Albert et al., 2012; Luznik et al., 2016b), CD146 
(67.04±2.87) and CD166 (95.08±0.97) (Albert et al., 2012) as well as the presence of 
putative LSC marker integrin α9/β1 (4.85±1.98) (Jones and Watt, 1993; Chen et al., 
2004; Kim et al., 2004; Schlotzer-Schrehardt and Kruse, 2005; Albert et al., 2012). 
The expression of the autophagy marker LAMP1 (84.82±11.89) was also high, 
corroborating with previously reported data on limbal epithelial cultures (Dhamodaran 
et al., 2015).  
Marker selection for further investigation was based on three criteria: (1) presence in 
a small subpopulation of cells (up to 10%) in accordance with label retaining cells in 
the limbal zone making up less than 10% of the total population (assessed on the 
basis of the percentage of radiolabelled thymidine retaining cells present in the limbal 
zone (Cotsarelis et al., 1989) and the studies of Umemoto and co-workers showing 
that approximately 10% of total limbal epithelial cells expressed the putative LSC 
marker ABCG2 (Umemoto et al., 2005); (2) passage or calcium differentiation 
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induced reduction in expression frequency in limbal epithelial cells and (3) presence 
in other epithelial stem or progenitor cells. CD200 (2.25±0.69%, n=3) was one of the 
few markers that fulfilled all these three criteria (Rosenblum et al., 2004; Ohyama et 
al., 2006; Ohyama, 2007; Gerhards et al., 2016) and was selected for further 
characterisation. In addition to LSC markers, we also selected putative transient 
amplifying cell surface markers based on similar expression to ΔNp63 (assessed by 
our group to be expressed in 45-60% of ex vivo expanded limbal epithelial cells (Yu 
et al., 2016) as well as passage and differentiation induced reduction in expression 
frequency in limbal epithelial cells. CD109 (56.29±13.96%, n=3) was amongst the cell 
surface marker that fulfilled these criteria and was selected for further 
characterisation (Bojic et al., 2018). 
 
4.3.2 The expression of CD109 in human limbal epithelial cell cultures, human 
and murine corneas   
 
The LEGEND Screen™ results were confirmed by flow cytometric analysis which 
showed CD109 to be expressed in a relatively high percentage of limbal epithelial 
cultures in p1 (47.51±9.35%, n=5) (Figure 4.6A) (Bojic et al., 2018). The expression 
of CD109 did not vary significantly through the first four passages (p>0.05) (Figure 
4.6A) (Bojic et al., 2018). Nonetheless, the expression of CD109 decreased 
significantly (p<0.05) after 5 days of calcium-induced differentiation under feeder-free 




Figure 4.6 CD109 expression during ex vivo differentiation of human limbal 
epithelial cells. (A) Quantification of CD109 expression through different passages of 
limbal epithelial cells by flow cytometry. Values represent mean ± SEM, n=3-5. (B) 
Quantification of ΔNp63 and CD109 expression during calcium induced differentiation 
of limbal epithelial cells by flow cytometry. Values represent mean ± SEM, n=3, 
*p<0.05.   
 
 
Using immunostaining, we determined the localisation of CD109+ cells in human 
ocular surface epithelial tissues (Figure 4.7A) (Bojic et al., 2018). CD109+ cells were 
exclusively located at the limbus and co-localised with ΔNp63 (Figure 4.7A), whilst 
undetectable in the suprabasal and superficial layers of limbal epithelium as well as 
in the all layers of central corneal epithelium (Figure 4.7A) (Bojic et al., 2018). In 
vitro, CD109+cells were present predominantly on the outer border of colonies 






Figure 4.7 CD109 expression in human cornea in vivo and during ex vivo 
expansion of human limbal epithelial cells. (A) Immunohistochemical staining of 
human corneal tissue cryosections for ΔNp63 and CD109 within the central cornea 
and limbus. Nuclei are shown by Hoechst counter staining. Scale bars 50 μm with 
exception of additional inset with higher magnification with scale bar of 20 μm. (B) 
CD109 immunohistochemical staining of human limbal epithelial colony in vitro. Nuclei 
are shown by Hoechst counter staining. Scale bar 50 μm. 
 
In murine corneal tissue, CD109 (Figure 4.8) was also exclusively located at the 
limbus and co-localised with ΔNp63 and CK15 while absent in central corneal 







Figure 4.8 CD109 expression in mouse cornea in vivo. Immunohistochemical 
staining of murine corneal tissue cryosections for CK15, ΔNp63 and CD109 within the 
central cornea and limbus. Nuclei are shown by DAPI counter staining. The dashed 
line indicates the stromal-epithelial junction. Red arrows point at the limbal region. 
Scale bars 20 μm. Abbreviations: st – stroma, ep – epithelium. 
 
4.3.3 Colony forming efficiency and proliferative ability of CD109+ cells 
 
To identify actively replicating cells, and thereby assess cellular proliferation, BrdU 
was applied to cells in culture and the number of cells in the S phase was monitored 
after 1 hour, 4 hours and 8 hours incubation with BrdU by flow cytometry. No 
statistically significant differences were found in the percentage of cells in the S 
phase of the cell cycle for CD109+ or CD109- population after incubation with BrdU 
for 1 hour and 4 hours. However, after 8 hours incubation with BrdU, there was a 
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significantly higher number of CD109+ cells in the S phase compared do CD109- cells 





Figure 4.9 Proliferative potential of sorted CD200 positive and negative 
population. (A) BrdU cell proliferation assay of CD109 negative and positive limbal 
epithelial cell population after 1-hour and 8-hours incubation with BrdU. Values 
represent mean ± SEM, n=3. (B) Quantification of cells in the S phase of the cell cycle 
in CD109+ and CD109- population after 1-hour, 4-hours and 8-hours incubation with 









Sorted positive and negative cells for both markers were tested for their colony 
forming efficiency and clonal potency (n=3). There were no significant differences 
between the positive and negative cells in colony forming efficiency (CFE) (Figure 
4.10C); however the relative colony-covered-area size was significantly greater in 
CD109+cells (p<0.01), meaning they formed larger colonies (Figure 4.10D and E) 
when compared to CD109- cells. Despite the fact that both CD109+ and CD109- cells 
formed colonies classified as meroclones, number of aborted colonies was 




Figure 4.10 Colony forming efficiency and clonal potential of sorted CD109 
positive and negative population. (A) Pie chart showing the distribution of formed 
and aborted colonies in CD109+ population. (B) Pie chart showing the distribution of 
formed and aborted colonies in CD109- population. (C) Comparison of colony forming 
efficiency between CD109+ and CD109- cell populations. (D) Colonies of CD109+ 
limbal epithelial cells stained with 2% rhodamine. (E) Colonies of CD109- limbal 
epithelial cells stained with 2% rhodamine. Values represent mean ± SEM, n=3-5. 
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4.3.4 The expression of CD200 in human limbal epithelial cell cultures, human 
and murine corneas   
 
CD200 was expressed in a small percentage of limbal epithelial cultures in p1 
(4.13±1.10%, n=10) (Figure 4.11A). Furthermore, the expression of CD200 
decreased significantly (p<0.05) and rapidly through subsequent passages (Figure 
4.11A). During calcium induced differentiation, the expression of CD200 disappeared 
from the culture after 5 days (p<0.05) (Figure 4.11B). For all the markers, including 
CD109, CD200 and ΔNp63, a lower expression was observed under feeder-free 
culture conditions used for the calcium-induced differentiation assays, which may 
suggest that the feeder-free culture is less conducive to LSC maintenance (Bojic et 
al., 2018). 
 
Figure 4.11 CD200 expression during ex vivo differentiation of human limbal 
epithelial cells. (A) Quantification of CD200 expression through different passages of 
limbal epithelial cells by flow cytometry. Values represent mean ± SEM, n=3-10, 
*p<0.05. (B) Quantification of CD200 expression during calcium induced differentiation 
of limbal epithelial cells by flow cytometry. Values represent mean ± SEM, n=3, 
*p<0.05.   
The presence of CD200+ cells was confirmed in the basal layer of the limbal 
epithelium, whilst its expression was absent in all the other layers of limbal and 





exclusively located at the limbus and co-localised with ΔNp63 and CK15 while absent 
in other parts of corneal epithelium (Bojic et al., 2018). 
 
Figure 4.12 CD200 expression in human cornea in vivo. Immunohistochemical 
staining of human corneal tissue paraffin sections for ΔNp63 and CD200 within the 





Figure 4.13 CD200 expression in mouse cornea in vivo. Immunohistochemical 
staining of murine corneal tissue cryosections for CK15, ΔNp63 and CD200 within the 
central cornea and limbus. Nuclei are shown by DAPI counter staining. The dashed 
line indicates the stromal-epithelial junction. Red arrows point at limbal region. Scale 
bars 20 μm.  Abbreviations: st – stroma, ep – epithelium. 
 
CD200+ cells were also present in ex vivo expanded limbal epithelial cell cultures, but 
in lower number compared to CD109+ cells and moreover were found scattered 
throughout the colonies (Figure 4.14A). CD200+ cells (3.66±0.25%) were much less 
abundant than ΔNp63+ cells (47.65±3.01%) (Figure 4.14A and B). All CD200+ cells 
were also ΔNp63+; however ΔNp63+ CD200+ cells represented only 6.23±0.97% of all 




Figure 4.14 CD200 and ΔNp63 expression during ex vivo expansion of human 
limbal epithelial cells. (A) Immunohistochemical staining of limbal epithelial cell 
colonies in vitro for CD200 and ΔNp63. Blue arrow points CD200+ cells. Nuclei are 
shown by Hoechst counter staining. Scale bar 50 μm. (B) Quantification of ΔNp63+ and 
CD200+ cells in limbal epithelial cell culture by immunohistochemistry. Values 
represent mean ± SEM, n=3. (C) Pie chart showing the distribution of CD200+ and 
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4.3.5 Colony forming efficiency and proliferative ability of CD200+ cells 
 
The proliferative potential of CD200+ cells was examined by Ki67 immunofluorescent 
staining of limbal epithelial cells cultured in vitro (Figure 4.15A). Interestingly, while 
some CD200+cells were Ki67+ (41.67±0.22%), there were more Ki67- cells in the 








Figure 4.15 CD200 and Ki67 expression during ex vivo expansion of human 
limbal epithelial cells. (A) Immunohistochemical staining of limbal epithelial cell 
colonies in vitro for CD200 and Ki67. Red arrows point to CD200+ Ki67+ cells; orange 
arrows point to CD200+Ki67- cells. Nuclei are shown by Hoechst counter staining. 
Scale bar 50 μm. (B) Pie chart showing the distribution of Ki67+ and Ki67- cells in 
CD200+ cell population. 
 
There were no statistically significant differences in CFE between CD200+ and 
CD200-  groups (Figure 4.16B), however CD200+ cells were exclusively able to form 
holoclones - large colonies with smooth, thick borders (Figure 4.16D), while CD200- 
cells formed meroclones which were characterised by irregular borders (Figure 
4.16E). The number of aborted colonies was significantly higher in CD200- population 
(p<0.01). Using the percentage of terminal colonies described in the methods, 
CD200+ colonies were scored as holoclones (Figure 4.16A) while CD200- colonies 
were scored as meroclones (Figure 4.16C) (Bojic et al., 2018). 




Figure 4.16 Colony forming efficiency and clonal potential of sorted CD200 
positive and negative population. (A) Pie chart showing the distribution of formed 
and aborted colonies in CD200+ population. (B)  Comparison of colony forming 
efficiencies of CD200+ and CD200- cells. Values represent mean ± SEM, n=3. (C) Pie 
chart showing the distribution of formed and aborted colonies in CD200- population. 
Values represent mean ± SEM, n=3. (D) Microscopic and macroscopic appearances 
of colonies formed by CD200+ cells. Scale bars 100 μm. (E) Microscopic and 
macroscopic appearances of colonies formed by CD200- cells. Scale bars 100 μm. 
 
CD200+ cells were slow to enter S phase: at 1 and 4 hours there were significantly 
less CD200+ in S phase when compared to CD200-; these differences became non-
significant at 8 hours (Figure 4.17 A and B). For that reason we used Hoechst 33342 
and Pyronin Y staining for G0/G1 separation. A larger part of G0 subpopulation was 
made up by CD200+ cells (59.30±3.12%) than CD200- cells (40.70±2.11%) (Figure 
4.17C). Interestingly, we also found that majority (78.66±3.20%) of side population 
(SP) cells were in the CD200+ population (Figure 4.18) whilst the CD200- population 
contained less SP cells (21.34±3.20%) (Figure 4.17D) (Bojic et al., 2018).  
A  B  C  




Figure 4.17 Proliferative potential of sorted CD200 positive and negative 
population. (A) BrdU cell proliferation assay of CD200 negative and positive limbal 
epithelial cell population after 1-hour and 8-hours incubation with BrdU. Values 
represent mean ± SEM, n=3. (B) Quantification of cells in the S phase of the cell cycle 
in CD200+ and CD200- population after 1-hour, 4-hours and 8-hours incubation with 
BrdU. Values represent mean ± SEM, n=3, *p<0.05. (C) The contribution of CD200+ 
and CD200- cell population to the total number of cells in the G0 phase of the cell cycle. 
Values represent mean ± SEM, n=3. (D) The contribution of CD200+ and CD200- cell 




B  A  




Figure 4.18 Side population cells. Representative dot plot showing gated SP cells 
and cells in the G0 phase of the cell cycle in whole population and CD200 positive 
population of cells. 
 
4.3.6 The expression of LSC markers in the CD109 and CD200 positive and 
negative populations  
 
To investigate the transcriptional profile of CD109+ and CD200+ cells, expression of 
putative LSC markers ΔNp63, ABCB5, C/EBPδ, BMI1, AXIN2, FZD7, CHD3, 
WNT7A, CK14, and CK15(Yoshida et al., 2006; Barbaro et al., 2007; Figueira et al., 
2007; Ksander et al., 2014; Mei et al., 2014; Sartaj et al., 2017; Kalha et al., 2018), 
corneal epithelial differentiation marker CK3 (Merjava et al., 2011) and marker of 
proliferative cells Ki67 (Sun et al., 2015) was assessed by qRT-PCR.  
The expression of CD109, was significantly higher (p<0.01) in CD109+ group 
compared to CD109- group, thus validating the flow activated cell sorting strategy. In 
addition, the expression of LSC markers PAX6 (p<0.05) and CK14 (p<0.01) and 
proliferative marker Ki67 (p<0.001) was also higher in the CD109+ group when 
compared to the CD109- (Figure 4.19). No statistically significant differences were 
found in the expression of other LSC markers ΔNp63, ABCB5, C/EBPδ, BMI1, 
AXIN2, FZD7, CHD3, WNT7A, and CK15 and corneal differentiation marker CK3 




Figure 4.19 Expression of putative LSC and corneal epithelial cell markers in the 
sorted CD109 positive and negative cell populations. Quantitative reverse 
transcriptase polymerase chain reaction expression data for CD109+ limbal epithelial 
cell population versus CD109- limbal epithelial cell population represented by the red 
line (value 1). Values represent mean ± SEM, n=3, *p<0.05, **p<0.01, ***p<0.001. 
 
 
CD200 was significantly upregulated in CD200+ cell population (p<0.001) along with 
the putative LSC markers ABCB5 (p<0.001), CDH3 (p<0.001), PAX6 (p<0.01), 
WNT7A (p<0.01), CK14 (p<0.01), and CK15 (p<0.001). On the other hand, ΔNp63 
and Ki67 (p<0.05) were significantly downregulated in CD200+ cell population 
compared to the CD200- cell population. There were no significant differences in the 
expressions of C/EBPδ, BMI1, AXIN2, FZD7 and CK3 between the CD200+ and 




Figure 4.20 Expression of putative LSC and corneal epithelial cell markers in the 
sorted CD200 positive and negative cell populations. Quantitative reverse 
transcriptase polymerase chain reaction expression data for CD200+ limbal epithelial 
cell population versus CD200- limbal epithelial cell population represented by the red 
line (value 1). Values represent mean ± SEM, n=3, *p<0.05, **p<0.01, ***p<0.001. 
 
4.3.7 CD200 siRNA transfection 
 
To investigate the impacts of CD200 downregulation on limbal epithelial cell cultures, 
RNAi was carried out using a pool of three different siRNAs as detailed in the 
materials and methods section. Quantitative RT-PCR analysis confirmed 
downregulation of CD200 in the group treated with CD200 siRNA compared to 




Figure 4.21 CD200 knockdown. Quantitative reverse transcriptase polymerase chain 
reaction expression data for control siRNA versus CD200 siRNA treated limbal 
epithelial cells. Values represent mean ± SEM, n=3, *p<0.05. 
 
 
Interestingly, the colony forming efficiency assay showed no significant difference in 
the percentage of formed paraclones or meroclones between the two groups (Figure 
4.22A and B), but holoclones completely disappeared from the  siRNA transfected 
group (Figure 4.22B and C), leading to a significant difference of the percentage of 









Figure 4.22 Effect of CD200 knockdown on clonal ability of limbal epithelial cells. 
(A) Pie chart showing distribution of paraclones, meroclones and holoclones formed 
by control siRNA treated cells and (B) CD200 siRNA treated cells. (C) Representative 
images of colonies formed in control and CD200 siRNA group, with 500 or 1000 cells 











To date, a few putative LSC markers (e.g. ΔNp63, ABCG2, C/EBPδ, BMI1, PAX6, 
WNT7A, ABCB5) have been associated with LSCs, however, amongst these, only 
ABCB5 represents a cell surface marker that enables enrichment of viable LSCs. 
Commonly used putative LSC marker, ΔNp63α is shown to be expressed not only in 
LSCs but also in early TACs. Moreover, as an internal marker it doesn’t allow 
isolation of viable LSCs. ABCB5, on the other hand, as a cell surface marker, 
appeared to be more promising in terms of LSC isolation and purification but recent 
study by Liu et al. showed that p63 is superior to ABCB5 as a marker for stemness, 
while ABCB5, either alone or in co‐expression patterns with p63 and CK3, identifies 
more committed progenitor cells (Liu et al., 2018). Moreover, ABCB5 marks around 
25% of limbal epithelial cells, which is much more than LSC compartment hence we 
tried to find a new marker specific to LSCs. Having in mind that viable LSCs could be 
isolated only using a cell surface marker we focused on LEC surface marker 
screening in the process of identification of potential candidate markers. In this study 
we used the LEGEND Screen™ Lyophilized Antibody Panel to assess the 
expression of 361 cell surface markers in ex vivo expanded limbal epithelial stem 
cells and selected CD200 and CD109 as cell surface markers of interest for further 
investigation.   
Up to date, there are no reports of either CD109 or CD200 expression or functional 
significance in the corneal epithelium. CD109 is a glycosylphosphatidylinositol (GPI)–
anchored glycoprotein whose expression is upregulated in several types of human 
cancers, particularly squamous cell carcinomas, whilst in normal human tissues 
CD109 expression is limited to certain cell types including myoepithelial cells of 
mammary, lacrimal, salivary, and bronchial glands, basal cells of the prostate and 
bronchial epithelium (Mii et al., 2012), human hepatic progenitor cells (Li et al., 
2014a), endothelial cells and a subpopulation of bone marrow CD34+ cells enriched 
in hematopoietic stem and progenitor cells (Murray et al., 1999). CD109 has been 
shown to enhance EGF-signalling in the SK-MG-1 glioblastoma cell line through the 
interaction of membrane anchored N-terminal CD109 fragment with EGFR (Zhang et 
al., 2015), and to negatively regulate TGF-β1 signalling in keratinocytes by either 
directly modulating receptor activity or by binding of soluble CD109 to type I TGF-β 
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receptor (Finnson et al., 2006; Hagiwara et al., 2010). TGF-β is an important cytokine 
that negatively regulates proliferation of different cell types including primary cultured 
human limbal epithelial cells (Chen et al., 2006). Mii et al. reported that CD109-
deficient mice exhibit epidermal hyperplasia and chronic skin inflammation, and 
CD109 regulates differentiation of keratinocytes in vivo (Mii et al., 2012). Taken 
together these data show that the CD109 molecule plays an important role in 
epithelial cell proliferation through the positive regulation of EGF and negative 
regulation of TGF-β signalling as well as being involved in epithelial cell 
differentiation. 
Our results showed that CD109 is expressed in both human and mouse corneal 
epithelium and is co-localised with ΔNp63 in the basal layer of the limbal epithelium 
whilst is absent in the other layers of the limbal epithelium and all layers of the central 
corneal epithelium. In vitro, CD109+ cells were located at the edge of growing 
colonies, similar to ΔNp63 expression in proliferating cells at the periphery of 
holoclones as previously reported (Meyer-Blazejewska et al., 2010).  Moreover, 
CD109 expression decreased during calcium-induced differentiation in a similar 
manner to ΔNp63 expression. There were more CD109+ cells in S phase of the cells 
cycle after 8 hours incubation with BrdU. This observation together with the higher 
Ki67 expression and larger colony area formed by the CD109+ cells suggest that 
CD109 represents a cell surface marker for proliferating corneal epithelial progenitor 
cells. 
CD200 (also known as OX-2) is a 45 kDa transmembrane immune-regulatory protein 
that belongs to the immunoglobulin superfamily (Barclay et al., 2002; Gorczynski, 
2005). The human CD200 cDNA encodes a 278 amino acid (aa) precursor that 
includes a 30 aa signal sequence, a 202 aa extracellular domain (ECD), a 27 aa 
transmembrane segment, and a 19 aa cytoplasmic domain. The ECD is composed of 
one Ig-like V-type domain and one Ig-like C2-type domain (McCaughan et al., 1987a; 
McCaughan et al., 1987b). A splice variant of CD200 has been described and has a 
truncated cytoplasmic tail. Within the ECD, human CD200 shares 76% amino acid 
sequence identity with mouse and rat CD200.  
CD200 is widely distributed across tissues, including lymphocytes, endothelial and 
neuronal cells but not ubiquitously expressed (Wright et al., 2001). Its cognate 
receptor (CD200R) is also an immunoglobulin transmembrane glycoprotein restricted 
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primarily to mast cells, basophils, macrophages, and dendritic cells, which suggests 
myeloid cell regulation as the major function of CD200 (Fallarino et al., 2004; 
Cherwinski et al., 2005; Shiratori et al., 2005).  CD200 transmits an immuno-
regulatory signal through its receptor (CD200R) to attenuate inflammatory reactions 
and promote immune tolerance (Rosenblum et al., 2004). CD200/CD200R mediated 
intracellular communication among different epidermal cell sub-populations may have 
an important role in preventing undesired immune responses in the skin (Matsue, 
2005). 
Previous studies have suggested the presence of a stem cell niche at the bulge 
region of the hair follicle, which contains CD200+ cells (Rosenblum et al., 2004; 
Rosenblum et al., 2005; Ohyama et al., 2006; Kloepper et al., 2008; Gerhards et al., 
2016) and have shown enrichment of human bulge stem cells by positive selection 
using CD200 as a cell surface marker (Ohyama and Kobayashi, 2012). Hair follicles 
represent one of the few sites of “immune privilege” (Meyer et al., 2008), possibly 
with the aim of preserving keratinocyte stem cells (Paus et al., 2003). The CD200 
molecule therefore may play a vital role in this “protection” since CD200/CD200R 
interaction attenuates perifollicular inflammation and prevents hair follicle specific 
autoimmunity, thereby protecting the epidermal stem cell reservoir from autoimmune 
destruction (Rosenblum et al., 2006). Additionally, CD200 has a clinical importance in 
allo- and xenotransplantation (Gorczynski et al., 1999). CD200 overexpression in 
transgenic mice increases skin, cardiac and renal allograft survival (Gorczynski et al., 
2013) by suppression of inflammation and acquired immunity. Apart from normal 
tissues, high CD200 expression was found in colon cancer, myeloma, breast and 
brain cancer, melanoma and normal mesenchymal stem cells (Zhang et al., 2016). It 
is closely related to tumour immunosuppression and has been proposed as a cancer 
stem cell marker in colon cancer (Zhang et al., 2016). CD200 has also been 
proposed as a putative marker of corneal endothelial cells that enables their 
differentiation from stromal keratocytes and corneal stromal fibroblasts (Cheong et 
al., 2013). We also observed CD200+ corneal endothelial cells in human corneal 
sections corroborating data published by Cheong et al. (Cheong et al., 2013) (data 
not shown). Recently Rauner et al. showed that expression of CD200 and its 
receptor CD200R1 marks distinct mammary repopulating units subpopulation with 
stem and progenitor characteristics (Rauner et al., 2018). 
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Taking into consideration this published literature and the low frequency of CD200+ in 
our limbal epithelial cultures (< 5%), we hypothesised that CD200 may represent a 
potential cell surface marker of LSCs. Using immunostaining in human and mouse 
corneal tissue we showed that CD200 is exclusively located at the base of the limbal 
epithelium. In addition, its expression is significantly and rapidly decreased upon 
subsequent passaging and calcium induced differentiation of limbal epithelial cells in 
keeping with a stem/transient amplifying cell phenotype. CD200+ cells obtained from 
hair follicle have been shown to possess a high CFE potential (Ohyama et al., 2006); 
however our findings do not support these results. We found no significant difference 
between the CFE of CD200 positive and negative populations. However, we showed 
that only CD200+ cells were able to form holoclones which are derived from LSCs, 
whilst CD200- cells produced meroclones which are known to descend from transient 
amplifying cells. Moreover, we showed that CD200+ cells are slow cycling and only 
start to enter the S phase of the cells cycle after eight hours long incubation with 
BrdU, whereas CD200- cells enter the S phase one hour after incubation with BrdU. 
Importantly, downregulation of CD200 by RNAi led to complete loss of holoclones, 
thus indicating an important role for CD200 in the maintenance and /or self-renewal 
of LSCs from which the holoclones are derived. 
Both quiescent and active stem cell subpopulations coexist in several tissues, in 
separate yet adjoining locations (Li and Clevers, 2010). Moreover, mammalian adult 
stem cells are predominantly detected in quiescent state (Cotsarelis et al., 1990; 
Potten et al., 1997; Arai et al., 2004). We observed a higher number of Ki67- cells 
and lower expression of Ki67 within the CD200+ population when compared to 
CD200- cells, suggesting that CD200+ may represent the quiescent LSCs. Indeed, a 
larger part of cells in G0 phase was made up with CD200+ cell population which in 
itself contained 79% of the side population cells, corroborating previously published 
findings by Umemoto et al. that limbal epithelial side population are quiescent and do 
not demonstrate proliferative capabilities in ex vivo culture conditions (Umemoto et 
al., 2006). Several studies showed that only 0.3-0.5% of cells in the limbal epithelium 
exhibit the SP phenotype (Watanabe et al., 2004; Budak et al., 2005; Umemoto et al., 
2006). However, as with cell surface markers, possession of an SP phenotype is not 
a universal property of stem cells, in some tissues the SP fraction may not contain 
the stem cells. Combining SP determination with cell-surface marker phenotyping 
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has led to efficient and reliable characterization of one of the most pure and potent 
adult stem cell populations, the HSC subset (Shaharuddin et al., 2014).  
We also observed a consistently higher expression of putative LSC markers including 
WNT7A, PAX6, ABCB5, CDH3, CK14 and CK15 (Yoshida et al., 2006; Chen et al., 
2010; Meyer-Blazejewska et al., 2010; Ksander et al., 2014; Eghtedari et al., 2016; 





In summary, we report herein the identification of a new cell surface marker for LSCs 
(CD200) as well as a cell surface marker for proliferating progenitor cells (CD109). 
We believe that the identification of these two new cell surface markers will 
significantly aid live enrichment of these two cell types and their biological and clinical 




















CCR10 9.88 6.08 3.51 
CD278 (ICOS) 0.54 0.44 0.25 
IFN-γRβ chain 4.09 0.71 0.41 
CD46 89.41 10.00 5.77 
CD70 75.17 6.31 4.46 
CD1a 2.55 0.68 0.39 
CD2 0.52 0.31 0.18 
β2- microglobulin 96.39 6.21 3.58 
B7-H4 1.61 0.57 0.40 
Cadherin 11 9.52 5.56 3.94 
CD10 4.75 2.27 1.31 
CD100 15.67 4.35 2.51 
CD103 0.40 0.05 0.04 
CD105 25.92 2.58 1.83 
CD106 8.33 11.19 7.92 
CD107a (LAMP-1) 84.82 16.81 11.89 
CD107b (LAMP-2) 52.27 20.80 14.71 
CD109 56.29 24.19 13.96 
CD111 (Nectin 1) 89.02 9.24 5.33 
CD112 (Nectin-2) 94.99 1.55 1.10 
CD114 2.96 0.60 0.35 
CD116 5.45 5.12 2.96 
CD117 (c-kit) 8.22 3.61 2.56 
CD119 (IFN-γR α chain) 82.47 3.18 2.25 
CD11a 1.07 0.18 0.10 
CD11b 2.11 0.48 0.28 
CD122 1.03 0.58 0.33 
CD123 4.88 5.78 4.09 
CD126 (IL-6Rα) 3.83 2.03 1.17 
CD127 (IL-7Rα) 4.21 2.52 1.45 
CD13 8.40 4.42 2.55 
CD131 1.95 1.04 0.60 
CD134 2.27 0.32 0.18 
CD135 3.98 2.40 1.38 
CD137 (4-1BB) 4.66 4.81 2.78 
CD137L (4-1BB Ligand) 45.49 3.09 2.19 
CD138 40.68 0.81 0.57 
CD14 5.91 4.27 3.02 







CD140b 16.94 4.62 3.27 
CD141 91.27 4.61 3.26 
FCD142 93.07 1.10 0.78 
CD143 5.26 2.77 1.60 
CD146 67.04 4.05 2.87 
CD148 87.18 7.33 5.18 
CD15 1.82 0.19 0.14 
CD150 (SLAM) 4.43 5.70 3.29 
CD151 34.92 26.45 18.71 
CD154 2.28 0.18 0.13 
CD156c (ADAM10) 95.26 1.20 0.84 
CD158e1 (KIR3DL1, NKB1) 3.50 0.57 0.40 
CD16 1.09 0.20 0.12 
CD161 1.44 0.57 0.33 
CD162 1.90 0.62 0.36 
CD163 4.45 3.64 2.58 
CD164 82.83 20.96 12.10 
CD165 86.01 8.51 4.91 
CD166 95.08 1.37 0.97 
CD169 0.46 0.65 0.46 
CD170 (Siglec-5) 86.58 2.69 1.90 
CD172a/b 77.01 19.31 13.66 
CD172g 7.25 4.35 2.51 
CD178 (Fas-L) 2.49 0.90 0.52 
CD179a 33.90 20.41 14.43 
CD179b 7.81 9.28 5.36 
CD18 2.68 1.36 0.79 
CD180 (RP105) 2.70 3.14 1.81 
CD182 (CXCR2) 9.52 9.80 5.66 
CD183 10.44 12.99 7.50 
CD185 1.67 0.33 0.23 
CD19 3.53 4.02 2.32 
CD191 1.47 0.68 0.48 
CD194 1.56 0.78 0.55 
CD1b 9.76 9.52 5.50 
CD1c 5.92 8.43 4.86 
CD200 2.25 0.97 0.69 
CD200 R 3.66 1.77 1.26 
CD202b (Tie2/Tek) 3.22 1.18 0.68 
CD203c (E-NPP3) 1.36 0.49 0.35 
CD205 5.17 3.68 2.13 
CD206 (MMR) 1.34 0.52 0.30 
CD207 (Langerin) 1.14 0.52 0.30 
CD21 0.78 0.25 0.14 







CD213α2 17.22 18.25 10.53 
CD218a (IL-18Rα) 7.87 8.92 5.15 
CD221 (IGF-1R) 84.03 18.08 10.44 
CD223 2.53 0.65 0.46 
CD226 (DNAM-1) 9.08 5.90 3.41 
CD227 85.43 13.71 9.69 
CD229 (Ly-9) 1.11 0.30 0.17 
CD23 2.61 3.49 2.01 
CD231 (TALLA) 15.77 12.52 7.23 
CD244 (2B4) 1.21 0.45 0.26 
CD245 (p220/240) 14.58 5.04 2.91 
CD25 1.64 0.69 0.40 
CD252 (OX40L) 80.15 4.98 2.88 
CD261 (DR4,TRAIL-R1) 36.67 12.04 8.51 
CD262 (DR5,TRAIL-R2) 88.98 9.99 5.77 
CD263 (DcR1,TRAIL-R3) 10.23 14.34 8.28 
CD266 (Fn14,TWEAK Receptor) 82.43 21.74 12.55 
CD268 (BAFF-R, BAFFR) 1.24 0.56 0.32 
CD27 1.58 0.81 0.47 
CD271 78.24 8.38 4.84 
CD275 (B7-H2, B7-RP1,ICOSL) 12.99 14.29 8.25 
CD276 90.00 8.92 5.15 
CD277 15.60 3.07 1.77 
CD279 (PD-1) 1.06 0.53 0.31 
CD28 66.33 6.73 4.76 
CD29 89.56 9.18 5.30 
CD290 3.21 1.55 1.10 
CD298 89.72 9.47 5.47 
CD3 1.79 0.97 0.56 
CD30 2.38 0.76 0.44 
CD300c 3.04 1.98 1.40 
CD309/VEGFR2 2.16 1.04 0.74 
CD31 1.44 0.51 0.29 
CD314 (NKG2D) 2.36 0.83 0.48 
CD317 3.16 0.56 0.32 
CD324 (E-Cadherin) 88.48 10.49 6.06 
CD325 6.64 5.85 3.38 
CD328 (Siglec-7) 1.37 0.61 0.43 
CD33 3.33 1.37 0.79 
CD334 (FGFR4) 1.09 0.57 0.33 
CD335 (NKp46) 0.77 0.57 0.33 
CD336 (NKp44) 1.42 0.88 0.51 
CD337 (NKp30) 1.03 0.49 0.28 
CD34 2.25 1.64 0.95 







CD344 (Frizzled-4) 8.77 3.50 2.02 
CD35 1.30 0.55 0.32 
CD354 (TREM-1) 1.97 0.97 0.56 
CD360 4.36 1.92 1.11 
CD365 (Tim-1) 5.05 1.20 0.69 
CD366 (Tim-3) 1.61 0.64 0.37 
CD367 (CLEC4A) 2.22 0.16 0.12 
CD36L1 92.76 1.87 1.33 
CD38 1.76 1.11 0.79 
CD39 0.72 0.23 0.16 
CD4 1.12 0.68 0.39 
CD40 26.00 12.02 6.94 
CD41 0.50 0.33 0.19 
CD42b 1.35 0.28 0.20 
CD43 21.87 1.41 0.99 
CD44 87.57 11.29 6.52 
CD45 0.48 0.20 0.11 
CD47 88.18 11.48 6.63 
CD48 2.86 1.32 0.76 
CD49a 45.98 34.13 19.70 
CD49b 94.98 1.20 0.84 
CD49c 84.20 14.17 8.18 
CD49d 19.80 20.60 11.90 
CD5 1.41 0.66 0.38 
CD50 (ICAM-3) 1.44 1.44 1.02 
CD54 37.33 14.57 8.41 
CD55 84.41 15.51 8.95 
CD56 4.83 2.49 1.44 
CD58 90.10 10.03 5.79 
CD6 1.04 0.82 0.47 
CD61 2.84 2.97 1.71 
CD62E 1.59 0.99 0.57 
CD62L 2.39 2.86 1.65 
CD62P (P-Selectin) 3.47 3.67 2.12 
CD63 88.99 9.01 5.20 
CD64 2.97 1.48 0.85 
CD69 1.44 1.34 0.77 
CD73 90.19 10.44 6.03 
CD74 11.49 4.81 2.78 
CD79b 3.83 3.05 1.76 
CD8 24.09 33.55 23.72 
CD80 1.84 0.03 0.02 
CD81 87.97 9.49 5.48 
CD82 90.20 9.23 5.33 







CD85g (ILT7) 1.24 0.86 0.50 
CD85k (ILT3) 1.27 0.32 0.18 
CD87 39.07 10.93 7.73 
CD89 9.21 11.53 6.66 
CD8a 1.47 0.99 0.57 
CD9 89.54 8.93 5.16 
CD90 (Thy1) 23.76 3.16 1.82 
CD93 5.50 6.77 3.91 
CD94 1.45 0.47 0.27 
CD95 88.73 10.10 5.83 
CD96 7.16 5.82 3.36 
CD97 42.88 1.67 1.18 
CD99 72.68 24.04 13.88 
CXCL16 1.36 0.54 0.39 
DLL1 0.56 0.38 0.22 
DLL4 0.55 0.31 0.18 
DR3 (TRAMP) 2.61 1.63 0.94 
EGFR 88.81 10.42 6.02 
GITR 1.29 0.78 0.55 
GPR19 2.59 1.25 0.89 
GPR56 6.31 0.79 0.56 
HLA-E 22.87 3.11 2.20 
HVEM (TR2) 6.89 4.22 2.99 
Ig light chain k 0.34 0.36 0.21 
IgM 0.43 0.23 0.13 
IL-21R 1.87 1.17 0.83 
Integrin α9β1 4.85 3.43 1.98 
Jagged 2 9.83 7.29 4.21 
Ksp37 0.91 0.43 0.31 
LAP 0.90 0.16 0.12 
LY6G6D 1.52 0.71 0.50 
MERTK 7.20 0.76 0.54 
MSC (W7C6) 61.89 11.78 8.33 
MSC and NPC (W4A5) 7.67 7.78 4.49 
MSCA-1 (MSC, W8B2) 1.11 0.30 0.17 
MUC-13 1.63 0.57 0.41 
NKp80 3.06 3.03 1.75 
Notch 1 34.03 16.13 9.31 
Notch 3 4.74 2.25 1.30 
Notch 4 44.84 16.48 9.52 
NPC (57D2) 11.47 5.49 3.17 
NTB-A (NTBA) 1.48 0.83 0.59 
PSMA 0.75 0.83 0.48 
ROR1 30.05 12.17 8.61 







Siglec-7 2.03 1.64 1.16 
Siglec-8 3.13 2.66 1.53 
Siglec-9 1.28 0.51 0.29 
SSEA-5 14.48 4.35 2.51 
SUSD2 20.11 8.42 5.95 
TCR a/ß 4.49 5.01 2.89 
TCR g/d 10.80 12.05 8.52 
Tim-4 3.21 2.67 1.54 
TLT-2 1.79 0.80 0.46 
TM4SF20 0.75 0.25 0.18 
TRA-2-49 2.65 1.60 1.13 
TRA-2-54 1.42 0.29 0.21 
TSLPR (TSLP-R) 1.20 0.56 0.32 
VEGFR3 2.51 2.19 1.55 
APCDD1 1.43 0.92 0.65 
BTLA 6.33 7.47 4.31 
CCR8 12.04 12.49 8.83 
CCRL2 5.84 6.02 4.26 
CD102 1.82 1.26 0.73 
CD104 94.75 0.04 0.03 
CD124 3.19 2.18 1.26 
CD130 1.05 0.18 0.13 
CD144 3.12 2.61 1.85 
CD152 (CTLA-4) 2.85 2.75 1.59 
CD155 (PVR) 88.77 10.78 6.22 
CD158b (KIR2DL2/L3,NKAT2) 4.70 4.34 2.51 
CD184 (CXCR4) 2.65 1.59 0.92 
CD186 2.01 2.05 1.45 
CD192 1.75 1.36 0.97 
CD197 (CCR7) 3.53 3.30 1.90 
CD199 7.59 7.81 5.52 
CD209 (DC-SIGN) 4.38 3.84 2.72 
CD217 11.89 4.31 3.05 
CD230 (Prion) 94.36 1.41 1.00 
CD24 86.76 10.67 6.16 
CD243 3.11 2.09 1.20 
CD26 1.67 0.37 0.21 
CD269 2.52 1.90 1.34 
CD282 (TLR2) 2.91 2.39 1.38 
CD284 (TLR4) 9.84 9.13 6.46 
CD301 18.78 17.88 10.32 
CD303 1.12 0.48 0.28 
CD304 4.29 0.15 0.11 
CD307 1.70 1.48 0.86 







CD357 (GITR) 3.10 3.23 1.86 
CD36 1.16 0.84 0.49 
CD369 (Dectin-1/CLEC7A) 3.06 2.31 1.64 
CD370 (CLEC9A/DNGR1) 1.42 0.63 0.36 
CD371 (CLEC12A) 0.76 0.44 0.25 
CD45RO 1.26 0.54 0.31 
CD51 88.38 10.66 6.16 
CD59 92.05 10.32 5.96 
CD7 1.97 0.63 0.36 
CD71 88.76 10.26 5.92 
CD84 6.99 5.93 3.42 
CD88 2.78 1.76 1.01 
CRTAM 3.78 3.24 1.87 
erbB3/HER-3 7.62 2.22 1.28 
FPR3 10.45 12.25 8.67 
Ganglioside GD2 1.72 0.96 0.68 
GPR83 9.98 8.37 5.92 
HLA-A,B,C 89.33 9.33 5.39 
HLA-DR 0.71 0.20 0.12 
Ig light chain λ 0.52 0.08 0.05 
IgD 1.66 0.28 0.20 
IL-28RA 1.25 1.12 0.79 
integrin b5 91.45 1.75 1.24 
KLRG1 3.86 1.98 1.40 
LOX-1 3.25 1.68 1.19 
MICA/MICB 33.12 7.48 4.32 
MSC (W3D5) 18.53 8.58 4.95 
Notch 2 3.02 1.32 0.76 
TACSTD2 94.24 0.71 0.50 
TIGIT 0.82 0.66 0.47 
C3AR 2.70 1.62 1.15 
CCX-CKR 2.56 0.62 0.44 
CD11c 2.30 0.91 0.53 
CD129 (IL-9 R) 6.29 4.82 2.78 
CD158 2.34 0.38 0.27 
CD181 (CXCR1) 17.50 2.16 1.53 
CD193 (CCR3) 3.64 1.04 0.60 
CD196 13.70 4.70 3.32 
CD1d 7.54 6.44 3.72 
CD20 0.71 0.51 0.30 
CD22 1.42 0.22 0.13 
CD220 5.23 1.50 1.06 
CD235ab 0.52 0.51 0.30 
CD258 (LIGHT) 12.51 12.37 8.75 







CD319 (CRACC) 9.52 4.58 2.64 
CD32 1.85 1.25 0.72 
CD326 (Ep-CAM) 89.35 8.23 4.75 
CD338 (ABCG2) 23.13 17.96 10.37 
CD368 (CLEC4D) 4.83 2.45 1.74 
CD45RA 0.73 0.10 0.06 
CD45RB 0.45 0.23 0.13 
CD49e 91.04 12.99 7.50 
CD52 4.31 2.13 1.23 
CD66a/c/e 34.26 10.27 5.93 
CD85h (ILT1) 4.29 2.04 1.18 
CD85j (ILT2) 4.30 0.27 0.15 
CD86 5.00 5.55 3.21 
CD92 93.29 2.72 1.93 
CXCR7 35.08 8.00 5.66 
Delta Opioid Receptor 3.32 0.67 0.39 
Dopamine Receptor D1 (DRD1) 1.74 0.49 0.35 
EphA2 95.24 1.53 1.08 
FceRIa 0.49 0.43 0.25 
GARP (LRRC32) 1.29 0.54 0.31 
IL-15Rα 1.84 0.68 0.48 
Lymphotoxin β Receptor (LT-βR) 85.41 15.89 9.17 
MRGX2 2.74 0.24 0.17 
TMEM8A 14.46 14.29 10.11 
CD254 5.06 1.75 1.01 
CD318 93.86 0.77 0.55 
CD255 (TWEAK) 8.21 7.64 5.40 
SSEA-4 54.02 10.27 5.93 
Sialyl Lewis X 81.43 13.63 9.64 
TRA-1-81 2.14 1.12 0.65 
CD160 0.77 0.22 0.16 
CD57 5.94 7.94 4.59 
CD66b 1.50 1.07 0.62 
TRA-1-60-R 0.74 0.27 0.16 
CD115 14.67 16.34 9.44 
CD201 (EPCR) 88.53 1.36 0.96 
CD120b 3.02 0.33 0.23 
CD210 (IL-10 R) 13.15 13.81 9.77 
CD267 (TACI) 4.04 2.58 1.49 
CD294 25.34 11.99 8.48 
CD49f 92.54 11.10 6.41 
CD85a (ILT5) 1.55 1.02 0.72 
CD85d (ILT4) 5.78 1.79 1.03 
integrin b7 1.06 0.22 0.13 







Podoplanin 85.82 9.68 5.59 
CD132 4.05 1.71 1.21 
CD195 (CCR5) 2.57 0.72 0.41 
CX3CR1 3.24 1.11 0.64 
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